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Abstract 
Background: Temporomandibular disorder (TMD) is a common and costly problem often 
leading to chronic pain.  There exists moderate evidence for physical therapy (PT) interventions 
in the management of TMD.  A known relationship between TMD and the cervical spine exists 
with some evidence to support cervical intervention treatments.  Cervical spine thrust joint 
manipulation (TJM) is an effective PT intervention explored in a limited fashion for this 
population.   
Objectives:  To determine the immediate and short term (1 and 4 week) effects of cervical TJM 
on pain, dysfunction, and perception of change in individuals with a primary complaint of TMD.   
Methods:  In this single blind randomized clinical trial, individuals with TMD (n=50) were 
randomly assigned to receive cervical TJM or sham manipulation in 4 PT visits over 4-weeks.  
All participants also received behavioral education, a home exercise program, and soft tissue 
mobilization.  Primary outcomes included jaw range of motion (ROM), Numeric Pain Rating 
Scale (NPRS), TMD Disability Index, Jaw Functional Limitation Scale (JFLS), Tampa Scale of 
Kinesiophobia (TSK-TMD), and Global Rating of Change (GROC).  Self-report and objective 
measurements (with blinded assessor) were taken at baseline, immediately after baseline 
treatment, 1-week, and 4-weeks.  A 2 x 4 mixed model ANOVA was used with treatment group 
as the between-subjects factor and time as the within-subjects factor.  Separate ANOVAs were 
performed for dependent variables and the hypothesis of interest was the group by time 
interaction.   
Results:   Statistically significant 2-way interactions were noted in JFLS (p = .026) and TSK-
TMD (p = .008), favoring the thrust manipulation group.  Both groups showed statistically 
significant main effects in all measures over time. GROC and PASS favored the thrust 
manipulation group with statistically significant differences in successful outcomes noted 
immediately after baseline treatment (NNT = 5) and at 4-weeks (NNT = 4).    
Conclusion: Both groups received identical multi-modal treatments with the addition of the 
randomized intervention: cervical TJM or sham manipulation.  Differences between groups were 
small, however, improvements favored the TJM on all measures.  Cervical TJM may be 
beneficial in the treatment of TMD.   
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Thrust Joint Manipulation to the Cervical Spine in Participants with a Primary Complaint of 
Temporomandibular Disorder (TMD): A Randomized Clinical Trial 
CHAPTER 1: INTRODUCTION 
Chapter 1 will outline pertinent background information and establish a basis of need for 
the study.  Primary aims and hypothesis are explained.   
Background 
Orofacial pain refers to heterogeneous conditions contributing to pain in the head, neck or 
face.  Orofacial pain includes headache, temporomandibular disorder (TMD), cancer, 
autoimmune conditions, burning mouth syndrome, trigeminal neuralgia, and dental pain.3,4  
TMD is the most common diagnosis associated with orofacial pain syndromes,5 referring to a 
group of common musculoskeletal conditions6 present in up to 60% of the population.7-10  TMD 
symptoms may include pain in the jaw, head, and neck regions, headaches, periauricular pain, 
tinnitus, palpable tenderness, joint sounds, limited jaw opening, and loss of function.7,9   
Only a small percentage of individuals with TMD (5-10%) seek treatment.6,9  Increased 
likelihood to seek care is associated with female gender,11,12 age 20-40,9,11 and greater intensity 
of pain.13  Current conservative treatment for TMD includes the use of dental appliances, 
medical pharmacological intervention, injection therapy, education, behavioral modification, 
chiropractic care, and physical therapy (PT).14,15  Physical therapists who treat TMD 
acknowledge biomechanical limitations, neurophysiologic input, and the complicated interplay 
of psychological and social factors in treating pain.9  Specific PT interventions for TMD have not 
been well described in the literature, and evidence supporting the effectiveness of these 
interventions is moderate at best.16-19  Commonly utilized treatments reported in the literature 
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include behavioral education, modalities, manual therapy, and exercise for both the masticatory 
system and the cervical spine.18   
Manual therapy directed at the jaw, thoracic spine, and cervical spine have been 
addressed in a limited fashion in the TMD literature.  There is a strong correlation (r=.82, r=.95) 
between jaw dysfunction and neck disability in persons with chronic TMD.20,21 While research 
supporting cervical treatments in the TMD population exists,16,22,23 further evidence is needed to 
clarify relationships and expected outcomes.  The aim of this randomized clinical trial is to 
examine the effects of cervical spine thrust joint manipulation (TJM) alongside commonly 
utilized education, soft tissue mobilization, and exercise in a population with specific pain and 
dysfunction related to TMD.    
The Temporomandibular Joint Complex 
The temporomandibular joint is a true synovial joint consisting of 2 bony joint surfaces, a 
joint capsule, synovial fluid, ligaments, cartilage, and muscles.   The joint sits just anterior to the 
external auditory meatus24 and is formed between the mandibular condyles and the mandibular 
fossa of the temporal bone.  During movement, the mandibular condyle also comes in contact 
with the convex articular eminence of the temporal bone.  While most synovial joint surfaces are 
covered in hyaline cartilage, the mandibular condyle is covered primarily in fibrocartilage.25  An 
avascular meniscus, or intra-articular disc, made of fibrocartilage fills the space between the two 
joint surfaces.  The temporomandibular disc divides the joint into two functional sections.  The 
upper compartment is a planar joint between the superior disc surface and the mandibular 
fossa/articular eminence.  The inferior compartment is a hinge joint between the inferior surface 
of the disc and the mandibular condyle.24  The disc is firmly attached to the mandibular condyle 
on all sides by ligament (medial and lateral), capsule (anterior), and retrodiscal tissue (posterior).  
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The posterior retrodiscal tissue is vascularized and highly innervated, potentially creating a 
nociceptive source for pain in patients with TMD.26  The primary muscles of mastication are the 
masseter, temporalis, medial pterygoid, and lateral pterygoid.  Secondary muscles include the 
supra-hyoids, infra-hyoids, and digastrics.  These masticatory muscles along with muscles of the 
cervical spine play a role in both stability and mobility of the temporomandibular joint.7  The 
trigeminal nerve (cranial nerve V) supplies sensation to most of the face, and the mandibular 
branch of the trigeminal nerve innervates the temporomandibular joint and masticatory muscles.   
A general understanding of the anatomy of the teeth is necessary in examination of 
patients with TMD to allow for visual inspection and objective range of motion (ROM) 
assessment.  The incisors are the teeth most centrally located in the mouth with 2 on the top 
(maxillary incisors) and 2 on the bottom (mandibular incisors).  The molars are the most 
posterior teeth on the right and left sides on both the mandibular and maxillary surfaces.  The 
incisors are used for measurement of ROM of the jaw and the molars for joint mobilization 
techniques used in treatment of TMD.   
Examination of the biomechanics of the temporomandibular joint reveals important 
considerations in evaluation and treatment of TMD.  Opening of the mouth begins with rotation 
of the lower compartment of the joint followed by anterior translation.9  Under normal 
conditions, the disc moves with the mandibular condyle during translation, maintaining a 
functional relationship in which the center of the disc is in contact with the superior surface of 
the mandibular condyle.7  Normal function of the jaw in movement requires simultaneous motion 
of both the right and left joints.  Dysfunction can occur when the disc no longer maintains the 
functional relationship with the condyle.   
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Temporomandibular Disorders  
TMD refers to conditions, pathologies, or dysfunctions impacting the temporomandibular 
articular joints, masticatory muscles, and associated musculoskeletal and neurovascular 
structures.7  The term TMD, synonymous with craniomandibular disorders and 
temporomandibular dysfunction, was supported and advocated by the American Dental 
Association in 1983.27  Another term, the stomatognathic system, refers to musculoskeletal 
structures, including innervation and vascularity, relevant to the mouth and jaw.28  The head, 
neck, and jaw are referred to as the craniocervicomandibular system.  The remainder of this 
dissertation will focus on pain and dysfunction associated with the stomatognathic system, and 
therefore, will utilize the term TMD.   
Patients with TMD often present with pain in and around the temporomandibular joint or 
masticatory muscles, impaired ROM, and a change or exacerbation of symptoms with functional 
activity.  Joint noise, earaches, and tinnitus have also been associated with TMD.9,29  Pain is 
frequently described as throbbing, tender, or shooting.30  TMD pain may be related to disc 
displacement, however, the number of people with true disc displacement is low.4  Pain may also 
be related to inflammation, joint or muscle activation, ligament stretch, or other peripheral or 
central pain mechanisms.4 
Diagnostic Criteria and Classification of Temporomandibular Disorders 
Close to 40% of the general population has at least one sign of TMD.31  Diagnosis of 
TMD is generally made via clinical symptom presentation.  An initial screening tool has been 
established by Gonzalez32 et al, demonstrating high specificity (0.97) and sensitivity (0.99) to 
identify those with and without TMD See Appendix 7.  Internal reliability is excellent with a 
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coefficient α of 0.87.32  The screening tool is recommended for clinical and research use to 
determine the presence of pain-related TMD and the potential need for treatment.33  The screen 
includes inquiry of pain in the last 30 days in the jaw or temple, morning pain or stiffness, and 
pain that changes with functional movement of the jaw such as chewing hard or tough food.32  
Responses are scored and total scores range from 0-4; a score of 2 or higher yields a positive 
screen.32   
TMDs are heterogeneous, and the classification system has changed over time.  The 
Research Diagnostic Criteria for TMD (RDC-TMD) was devised in 1992 to provide order and 
evidence supporting diagnostic classification; it was later modified and revised.  This system 
utilized a dual axis evaluation system including the pathoanatomical classification (Axis I) and 
consideration of psychosocial and behavioral factors (Axis II).  Revisions to the system ensued, 
and the most recent classification is the Diagnostic Criteria-TMD (DC-TMD) published in 
2010.34  Both the RDC-TMD and DC-TMD use the 2 axes above and classify TMD patients into 
the following broad categories: myalgia, arthralgia, disc displacement with reduction, disc 
displacement without reduction, and subluxation.  Distinctions are made to further divide these 
categories into more specific subcategory diagnoses.7   
Myalgia refers to pain in muscles impacted by jaw movement and function.  Myalgia is 
the most common category of TMDs, and it is often difficult to distinguish this category from 
arthralgia.  Arthralgia, or joint dysfunction, also refers to pain impacted by jaw movement and 
function, however, this pain originates in the joint itself.  Patients may frequently have both 
myalgia and arthralgia diagnoses.35  Disc displacement refers to abnormal biomechanical 
positioning of the disc.  If the disc reduces, a click may be heard or palpated.  When the disc no 
longer reduces, it is referred to as disc displacement without reduction, or closed lock.  While 
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disc displacement can present in different ways, normal disc positioning is not a pre-requisite to 
reduction in pain or improved function in those with TMD.36  The DC-TMD added another 
category called subluxation, referring to hypermobility and potential open lock.  In subluxation, 
the mandibular condyle clicks beyond the convex articular eminence of the temporal bone.35   
While there is some support for the diagnostic accuracy of special tests in TMD, the 
ability to distinguish between the categories of myogenic, arthrogenic, and disc displacements is 
not as strong.24  The difficulty differentiating various categories of TMD may relate to difficulty 
classifying all patients in only one category and findings of some patients fitting into no 
category.7  Visscher37 et al found the RDC-TMD to demonstrate high sensitivity and low 
specificity when examining patients with persistent TMD pain, those with dental pain, and 
healthy controls.  Visscher37 et al concluded the RDC-TMD was best used to confirm absence of 
TMD, rather than to rule in the diagnosis.  Current study of the validity of the DC-TMD is 
lacking.  Other limitations of the RDC-TMD and DC-TMD include lack of information 
pertaining to the cervical spine and pain science.7  The importance of acknowledging the cervical 
spine is further discussed in this dissertation.  Pain neuroscience education refers to a 
management strategy in chronic pain conditions focused on teaching patients both biology and 
physiology of pain.38,39  As acknowledgement of the biopsychosocial model impacts discussions 
of other pain disorders, and specifically chronic pain syndromes, the importance of broadening 
diagnostic categories has been recognized.7   
Imaging is often performed as part of routine evaluation by dental practitioners seeing 
patients with TMD.  Diagnostic imaging is the reference standard for ruling in the joint and disc 
related pathologies of TMD.35  As physical therapists have less access to imaging, this limitation 
adds difficulty integrating the classification system into a PT research or clinical setting.  
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Understanding normal biomechanical relationships is important, and anatomical changes may be 
noted in imaging; however, the course of treatment likely remains unchanged.40  As with other 
chronic pain conditions, radiographic or image findings demonstrating abnormal positioning of 
the disc or other anatomical abnormalities are poorly correlated with pain, tenderness, and/or 
dysfunction.7  Chantaracherd41 et al performed a cross-sectional study looking at imaging 
findings and pain, function, and disability associated with TMD.  These authors concluded there 
was no relationship found between joint status and pain or dysfunction.  Stern42 et al suggest 
imaging is not actually indicated in all TMD patients.   
Both the RDC-TMD and the newer DC-TMD rely heavily on palpatory findings in 
diagnosis, leaving further debate about the reliability and validity of these diagnostic criteria.37  
The RDC-TMD Consortium is a network of international TMD experts who have worked to 
make the changes to the original RDC-TMD and continue to meet to discuss the DC-TMD.  The 
Consortium acknowledges the continued lack of specificity with the various diagnostic 
categories and has made suggestions for continued discussion in a Next Steps article published in 
2016.43 At the present time, the lack of reliability and validity of the DC-TMD make it difficult 
to integrate into research practice.   
Some authors have suggested intervention studies utilize a diagnostic classification 
system to determine the effectiveness of interventions in a subset of individuals with TMD; 
however, it is possible the interventions may be effective regardless of diagnostic classification.  
Orhrbach27 et al acknowledge the DC-TMD focuses on the ‘bio’ of biopsychosocial, and that 
treatment for chronic TMD may be less dependent on Axis I criteria than previously 
hypothesized.  This study will utilize the cost effective general TMD screen proposed by 
Gonzalez32 et al instead of the more specific anatomical diagnoses of the classification systems.   
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Prevalence of Temporomandibular Disorder  
Prevalence of those reporting to a physician for TMD associated symptoms is listed 
anywhere from 3.9% to 60% of the population.8,31,44-46   Difficulty classifying or diagnosing this 
population has led to varying reports of prevalence.  In 2013, Okeson47 et al reported TMD signs 
and symptoms occurred in 35% or more of the sampled populations.  TMD is the third most 
common chronic pain condition,40 with an estimated 15% of those with TMD developing chronic 
pain.6  Previous reports of cross sectional studies have indicated TMD was more common in 
women and Caucasians; a negative correlation was found between age and presence of TMD.48,49  
Associative claims made in these cross sectional studies have been challenged with several 
authors noting a distinction between demographic descriptions of those currently showing signs 
of TMD and the risk factors of development.13,50,51   
Beginning in 2006, a large prospective analysis titled Orofacial Pain: Prospective 
Evaluation and Risk Assessment, or OPPERA, began collecting data with National Institute of 
Health (NIH) funding support.  The OPPERA study examined over 3,000 participants without 
baseline symptoms and approximately 1,000 individuals with chronic symptoms of TMD.  
Participants were examined at baseline and followed for 2-5 years.46  Subsequent analysis of this 
data conducted between 2005 and 2012 is referred to as OPPERA-1 analysis, while data 
analyzed and reported from 2012-2017 is known as OPPERA-2.  There have been over 30 
publications reporting results from OPPERA data.   
Slade44 et al reported data from an OPPERA-1 case control analysis, noting 3 times 
greater risk in women and a positive association with age and chronicity of TMD symptoms. 
Two years later, in 2013, Slade50 et al examined data in an OPPERA-2 prospective cohort study, 
noting approximately equal prevalence of TMD for male and female participants and an average 
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of 4% of participants with initial onset TMD each year.  While previous literature has supported 
up to 2-4 times greater prevalence in women,8 this study contradicts those findings.  It is possible 
the previous gender association with TMD was confounded by influences to seek medical care.51   
Over 33% of the participants without baseline TMD symptoms had 1 or more episodes of 
facial pain, and this number continued to increase each year of follow-up.45  An episode of facial 
pain was defined as 5 or more days per month for 1 month or longer.45  This number represents a 
portion of the population with symptoms that did not, or perhaps would not, seek care.  Incidence 
of TMD was highest in individuals in their teens and twenties to early thirties with reduction in 
incidence in those over the age of 45.51 
OPPERA results indicate the initial onset of symptoms was twice as likely in African 
Americans as compared to Caucasians.45  OPPERA followed the first onset TMD patients noting 
about half of them still had symptoms 6 months after initial onset.46  TMD was more likely to 
persist in women and Caucasians.46  The results of these studies indicate previous TMD 
prevalence estimations may have been an indication of those seeking care and those with chronic 
symptoms rather than actual prevalence of first onset TMD.   
Economic Impact of Temporomandibular Disorder   
Pain in the craniofacial region is associated with impaired health status.52  Chronic TMD, 
like other chronic pain conditions, can affect quality of life and place an economic burden on 
society.40,53  The overall healthcare costs for persons seen at least once for a diagnosis of TMD is 
1.6 times higher than that of persons without a TMD diagnosis.11  Annual healthcare costs 
associated with TMD are estimated up to $4 billion.6,54  Work days lost have been estimated at 
17.8 million for every 100 million working adults.51  In 2016, a review of healthcare costs for 
10 
 
individuals with TMD concluded that consultation was the heaviest financial aspect of care as 
compared to medication and intervention.  The authors hypothesized that individuals with TMD 
may seek consultation from multiple providers due to persistent symptoms, ineffective 
treatments, or poor communication and collaboration among dental and medical providers of 
care.3  Effective treatment interventions may have an impact on the economic burden of TMD 
related pain and dysfunction.  
Statement of the Problem 
Individuals with TMD frequently report first to a dental practitioner,40 making this 
profession the most likely referral base to PT.  However, dental literature frequently reports lack 
of quality research supporting the effectiveness of PT in the TMD population.10,55  PT literature 
supports manual therapy and exercise (jaw, cervical, and postural) for persons with TMD, but the 
research is lacking clear description,56 quality,18,57 and consistency.16,17   
The relationship between the cervical spine and TMD has been established, yet treatment 
interventions directed at the cervical spine have only been examined in a limited fashion.  
Manual therapy, including cervical non-thrust mobilization, and exercise targeting the cervical 
spine reduced pain and improved pressure pain thresholds in subjects with TMD.22,23 Large 
effect sizes were seen in pain and disability reduction with thoracic spine TJM as part of a 
multimodal approach in a case series examining participants with myofascial TMD.58  There is 
some support for the use of cervical TJM in individuals with TMD; however, previous studies 
examining cervical TJM utilized a population of children with a history of trauma, subjects with 
the presence of latent trigger points as opposed to jaw pain or dysfunction, or multimodal 
intervention plans without randomization of TJM.16,59  The specific effect of cervical spine TJM 
on adults with a primary complaint of TMD has yet to be examined.   
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Further research is needed to support the role of the physical therapist in treatment of 
individuals with TMD.  Understanding the effect of various interventions on pain modulation 
and functional change can guide informed and evidence-based clinical practice.  While cervical 
spine TJM is only one part of potential intervention packages, a better understanding of the 
specific effect of this intervention using a randomized design may guide decision making in PT 
treatments for the TMD population.   
Specific Aims and Hypothesis 
Specific Aims: 
1. Investigate the effectiveness of cervical spine TJM compared to sham manipulation when 
combined with behavioral education, soft tissue mobilization, and a home exercise program 
(HEP) in a well-defined sample of patients with TMD. 
2. Investigate immediate response, 1 week, and 4 week outcomes for pain, ROM, fear, and 
function.   
Hypothesis:   
Participants who receive the combined treatment of cervical spine TJM alongside 
behavioral education, soft tissue mobilization, and a HEP will achieve greater reduction in pain, 
improved scores on functional outcome measures, greater improvement in ROM, and greater 
increase in PPT (at all 3 initial data collection points) than those receiving sham manipulation, 
behavioral education, soft tissue mobilization, and a HEP.  
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Relevance and Significance 
The NIH and National Institute of Dental and Craniofacial Research (NIDCR) recognize 
that the TMD population is often left with no clear path to specialists in TMD.6,54  Physicians 
may offer pharmacological treatment for pain and frequently refer patients with orofacial pain to 
dental practitioners with occasional referral to physical therapists.  Dentists and physical 
therapists acknowledge lack of training or knowledge depth specific to this diagnosis in their 
formal educational programs.15  Dental practitioners and physical therapists also lack specialists 
in TMD.60  In the United States, patients with jaw pain may encounter practitioners without 
experience or confidence in treating their condition, possibly influencing access to care and 
outcomes.  Barriers to PT treatment may include limited access to clinicians who are comfortable 
treating individuals with TMD and insufficient evidence of PT effectiveness.   
Brown61 et al reported persons with TMD do not spontaneously recover without 
treatment intervention.  Successful treatment can be defined by return to normal function and 
reduction in pain.62  While current evidence is insufficient, manual PT, exercise, and education 
have demonstrated effectiveness in the successful treatment of TMD.18,22,23,58,63  A systematic 
review of manual therapy for TMD reported moderate to high evidence to support manual 
intervention in reducing pain, increasing pressure pain threshold (PPT), and improving maximal 
mouth opening (MMO).64  A subsequent systematic review with meta-analysis reported similar 
findings for effectiveness of manual therapy approaches.16  Fair evidence supporting multimodal 
intervention for TMD was supported in a systematic review by Brantingham65 et al in 2013.   
Cervical spine TJM is a manual therapy intervention utilized by physical therapists since 
the 1920s, and part of standard PT practice.66 Cervical TJM  has been used in multimodal 
intervention studies addressing treatment for TMD.16,59  Biomechanical and neurophysiological 
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relationships between the cervical spine and temporomandibular joint support the potential 
benefit of cervical spine TJM on TMD related pain and dysfunction.  Evidence supporting 
cervical spine non-thrust mobilizations demonstrated effectiveness in treatment of TMD.22,23  
Evidence supporting the use of TJM of cervical and thoracic spine is available but limited.67  
Atlanto-occipital TJM produced immediate improvement in mouth opening ROM and PPT in a 
population of women with neck pain,68 and a population of individuals with latent myofascial 
trigger points in muscles of mastication.69  A 2016 case report noted cervicothoracic TJM 
combined with exercise and education had positive outcomes in a patient with primary complaint 
of TMD.67   
Research and clinical practice guidelines promote use of cervical spine TJM for various 
conditions including neck and upper extremity pain and dysfunction.63,70  There is growing 
support for a neurophysiological effect of spinal TJM with changes seen in pain inhibition, 
muscle recruitment, and/or function.22  The effect of spinal TJM on remote locations has 
demonstrated both local and remote effects.71,72  Previous research using cervical TJM for the 
TMD population has been unable to clarify the specific impact of this intervention.  Evidence to 
support TJM of the cervical spine may lead to consideration of this potentially useful 
intervention in treatment of individuals with TMD.  Implementation of effective treatments may 
have an impact on patient outcomes and/or progression to chronicity for the underserved TMD 
population.  Further research is needed to examine cervical spine TJM on individuals with TMD 
using a randomized design.   
Scope of Investigation  
While previous studies provide sufficient evidence to support the hypothesis of interest, 
there is a need to produce high quality evidence for the effectiveness of TJM of the cervical 
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spine in individuals with TMD.17,18  This study included 4 visits over 4 weeks with 
measurements taken at baseline, immediately after first treatment, 1 week, and 4 week follow-
ups.  The design randomized cervical TJM and sham manipulation, and utilized a specified 
population of those with a primary complaint of TMD.     
Participants for this study had a primary compliant of TMD and were recruited from the 
general public, dental offices, and PT clinics.  Physical therapists with post professional training 
in cervical TJM and experience with the TMD population were the treating clinicians.  Blinded 
assessors measured outcomes of interest.  Self-report scales were used at all data collection 
points.  All clinicians and blinded assessors were trained by the principal investigator (PI) in 
standard operating procedures.   
Participants completed a standardized evaluation before intervention.  Participants were 
randomly assigned to 1 of 2 groups and blinded to group allocation.  Treatments took place at the 
initial visit, week 1 and week 2.  One group received cervical spine TJM while the other group 
received sham manipulation.  All participants received standardized behavioral education, soft 
tissue mobilization of the suboccipital region, and home exercise instruction.  The final 4-week 
visit included measurement only, and the therapist could continue treatment, discharge, or refer 
out at their discretion.  The randomized design and standardized procedures were necessary to 
examine the specific effect of cervical spine TJM in the TMD population; the TJM effect was the 
primary focus of this study.   
Definition of Terms Used in this Dissertation 
1. Bruxism: Repetitive clenching and grinding of the teeth, could be nocturnal or diurnal4  
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2. Central Sensitization: A prolonged increase in excitability of neurons in central pathways; 
over-activity of descending pain facilitation, hypersensitivity, and impaired function of 
descending inhibitory pathways73 
3. Craniomandibular: The head, cervical spine, temporomandibular joints, and surrounding soft 
tissues, vasculature, and nerve structures4 
4. Manual Therapy: Any hands-on treatment provided by the PT including joint non-thrust joint 
mobilization (NTJM), thrust joint manipulation (TJM), soft tissue treatments, passive muscle 
stretching or joint movement, or manual resistance activity74   
5. Masticatory Muscles: Muscles used for mastication, or chewing food4 including the masseter, 
temporalis, medial pterygoid, and lateral pterygoid 
6. Non-thrust Joint Mobilization (NTJM): Manual therapy technique utilizing skilled passive 
movement of a joint at varying speeds and amplitudes, excluding thrust joint manipulation, 
intended to improve motion or reduce pain, or optimize function74 
7. Occlusal Therapy: Dental intervention designed to normalize occlusion and teeth contact, this 
may include reversible or irreversible treatments4 
8. Occlusion: Static relationship between the surfaces of the mandibular and maxillary teeth 
upon closure4 
9. Orofacial: Related to the mouth and face4 
10. Parafunction: Nonfunctional activities of the orofacial region including nail biting, clenching 
the teeth, bruxism, chewing on the lips, cheeks, or other inanimate objects4 
11. Regional Interdependence: A concept describing impairments that are directly or indirectly 
related to other impairments, including musculoskeletal impairments and peripheral or 
central nervous system impairments75 
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12. Stomatognathic: Related to the mouth (“Stoma”) and jaw (“Gnathic”)4  
13. Stomatognathic System: A functional unit including the teeth, maxilla, mandible, 
temporomandibular joints, masticatory muscles,4 vascular and nerve structures28 
14. Temporomandibular Disorders (TMD): Broad and heterogeneous diagnosis category of 
orofacial pain related to temporomandibular joint, masticatory muscles, or both;4 also known 
as craniomandibular disorders 
15. Thrust Joint Manipulation (TJM): Manual therapy technique utilizing skilled passive high-
velocity, short-amplitude movement of the joint intended to improve motion, reduce pain, or 
optimize function74 
16. Tinnitus: Subjective complaint of ringing or buzzing in the ear4 
17. Trigeminal Nerve: Mixed sensory and motor cranial nerve V with 3 branches: ophthalmic, 
maxillary, and mandibular4 
18. Trigeminocervical Nucleus: One of the nuclei of the trigeminal nerve that consists of shared 
grey matter between the trigeminal nerve and the upper cervical nerve roots.  This nuclei 
contains 3 subnuclei4 
Summary 
TMD is a common and costly problem often leading to chronic pain and dysfunction.  
Diagnosis of TMD is generally based on clinical findings.  While diagnostic criteria exist, their 
high sensitivity values demonstrate greatest value in ruling out the condition.  A general 
screening tool is less able to differentiate types of TMD, but better at ruling the diagnosis in from 
a general perspective.   
There is evidence to support a relationship between neck pain or dysfunction and TMD.  
Further evidence supports cervical spine intervention in this population.  Cervical spine TJM has 
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not been examined specifically in a TMD population using a strong randomized design.  Further 
evidence to support effectiveness of specific PT interventions could describe the potential benefit 
in minimizing pain and dysfunction in the underserved TMD population.  Individuals with TMD 
may not seek treatment or know what treatment options exist.  Evidence to support effective 
interventions may contribute to earlier access to care, improved interdisciplinary collaboration, 
and improved outcomes related to pain and function.      
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CHAPTER 2: HISTORICAL OVERVIEW: 
Theory and Research Literature Specific to the Topic 
Introduction 
Chapter 2 describes historical and current literature surrounding intervention specific to 
temporomandibular disorder (TMD) from a dental and physical therapy (PT) perspective.  The 
relationship between the cervical spine and TMD is discussed.  Current evidence of cervical 
spine intervention for the TMD population as well as the theory to support manual cervical spine 
thrust joint manipulation (TJM) will be covered.  A focus on intervention options, effectiveness, 
and safety are described and used to support the relevance and significance of the study.    
TMD Interventions 
Individuals with TMD are primarily treated with medication, dental splint therapy, PT, 
orthodontic care, and counseling.19  Surgical intervention is an option, but less frequently 
utilized.  Evaluation and treatment are primarily performed by physical therapists (PTs) and 
dentists;7 however, patients frequently present with symptoms of TMD to their dentist first.35 
Among dental professions, there is variation in education, implementation of evaluation and 
treatment procedures, and consistency of orofacial pain management.40,76 Similar variation in 
educational preparation, experience, and confidence treating TMD exists for PTs.  Available 
evidence supporting various PT interventions is sparse.  The following sections in this chapter 
will summarize peer reviewed dental and PT intervention use and effectiveness before moving 
focus to cervical spine TJM, the specific intervention of interest in this study.   
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Dental Intervention 
Dentists treat based on an assumed relationship between the contact of teeth, or 
occlusion, and TMD.  Dental intervention for TMD primarily includes use of medications, 
injections, and splint therapy.  These interventions are generally considered to be conservative 
and reversible therapies and are preferred to irreversible interventions like surgery, occlusal 
adjustments, or long duration repositioning devices.77  Occlusal splinting is removable and 
therefore considered reversible; however, there is controversy related to the effectiveness of 
occlusal splinting for the TMD population.78-80  Occlusal adjustments are considered irreversible 
therapies and have not been shown to prevent or improve symptoms of TMD.81   
Intra-oral splinting is the most commonly utilized conservative intervention for TMD82 
and has alternative names including intra-oral device, intra-oral appliance, occlusal stabilization, 
occlusal appliance, and splint therapy.  There are several types of splints used in clinical practice, 
with stabilization, anterior repositioning, and anterior bite appliances utilized most frequently.79  
A stabilization splint focuses on ideal occlusion, or symmetry in occlusion.40  The theory 
suggests optimal positioning of occlusion improves jaw position resulting in the least muscular 
strain,79 equal distribution of load, proprioceptive improvement,83 and reduction of pain.84 It is 
also possible a placebo effect plays a role in efficacy.83  These splints can be hard or soft and 
applied to either the maxillary or mandibular arches.  Anterior repositioning appliances are used 
to move the mandible and mandibular condyle anteriorly to align the condyle and disc closer to 
anatomical position (centric position) and minimize compression of the highly vascular posterior 
retrodiscal tissue;40  however, some patients have reported an increase in pain with the anterior 
repositioning appliance.84   
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Most splints are custom-made to fit individual patients and are adjusted over time for 
proper fit.  Splints are removable and generally worn at night with occasional suggestion for 
daytime use.   A systematic review by Al-Ani80 et al in 2005 suggested evidence was insufficient 
to support stabilization splinting was superior to other active treatments (including non-
occluding splints, acupuncture, biofeedback, exercise and relaxation).  These authors, however, 
stated splinting may be more effective than no treatment in reducing pain.80  In 2009, Thurman83 
et al performed a systematic review of randomized controlled trials reporting the same 
conclusions as Al-Ani80 et al; occlusal splints were superior to no treatment but no statistically 
significant difference was noted between occlusal splinting and other therapies.83  In 2010, 
Fricton79 et al reported evidence was mixed, however, a meta-analysis supported the use of 
splinting over no intervention.  List77 et al published a review of systematic reviews in 2010 
concluding there was no evidence to support occlusal adjustments but some evidence to support 
occlusal appliances, exercise, postural training, and medication use.   
While occlusal splinting is generally seen as a conservative and reversible intervention, 
there is some evidence that this intervention can cause irreversible change in occlusion.85  The 
evidence of a causal relationship between occlusal splinting and subsequent occlusal change is 
debated; however, there is potential need for future dental work or orthodontics in the event of 
occlusal change.  Therefore, other truly conservative and reversible interventions, like PT, should 
be considered as a first-step intervention.  Reid86 et al reported dentists have an ethical obligation 
to explore conservative management of TMD in an exhaustive fashion before resorting to more 
invasive interventions like occlusion adjustments, orthodontics, or mandibular repositioning 
procedures.  Surgical, invasive, and irreversible intervention should be reserved for cases in 
which conservative management is ineffective.40,84,87  While many dentists are working together 
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with physical therapists, the interdisciplinary collaboration or consideration of PT first is 
inconsistent.88  Kraus suggests improved outcomes are more likely when the patient receives PT 
intervention prior to or in conjunction with use of an occlusal splint.36     
Physical Therapy Intervention 
The American Academy of Craniomandibular Disorders and the American Academy of 
Orofacial Pain support PT evaluation and treatment for the TMD population.  From a broad 
perspective, PT intervention for TMD is similar to that of other joints or chronic pain conditions: 
manage pain, improve ROM and joint mobility, address deficits in strength, flexibility, and 
neuromotor control, and ultimately improve function.  There is some evidence to suggest PT 
exercise, relaxation, and biofeedback are more effective than occlusal splints at decreasing pain 
and increasing mouth opening ROM.57,89  Fricton79 et al report that most cases of TMD can be 
treated with self-care, exercise, and PT interventions, even suggesting these be done before an 
appliance is issued, or in combination with an appliance.    
Research has compared PT to occlusal splint therapy, however, many reports in dental 
journals neglect to define the PT intervention, or describe PT as a modality-only intervention.90  
While some individual studies have suggested PT intervention did not improve outcomes over a 
control,91,92 evidence from systematic reviews and meta-analyses do suggest PT intervention also 
produces better outcomes than no treatment.18,57  Paco19 et al performed a systematic review and 
meta-analysis published in 2016 examining PT intervention effectiveness for the outcomes of 
pain and jaw ROM.  Authors only examined randomized controlled trials and utilized 
standardized mean difference to compare effectiveness.  Methodological quality was assessed 
with the PEDro scale (physiotherapy evidence database) and revealed scores of 5-10/11.  Six of 
the 7 articles included had strong quality ratings (score higher than 7).19  Results demonstrated 
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statistically significant differences for pain reduction at rest with PT versus controls.  Although 
authors found no statistically significant changes in active motion of the jaw, the trend favored 
PT intervention versus control.   
It should be noted that modalities are frequently mentioned as potential treatment options 
for PT.  Six studies looking at electrophysical modalities were examined in a 2006 systematic 
review.  This review concluded there is was no evidence to support use of these modalities to 
reduce TMD pain; however, there was some support for the use of low level laser and 
biofeedback training in improving mouth opening ROM.18  Another systematic review with 
meta-analysis in 2006 reported some evidence supporting biofeedback and laser, but no evidence 
to support ultrasound.  In 2010 a systematic review of systematic reviews reported no reviews 
indicate modalities were effective in reducing pain.77 Frequently, reports of PT utilization in 
dental studies describe modality-only intervention.  It is important for researchers and clinicians 
to remind medical professionals and the general public that the ‘modality-only’ view of physical 
therapy is quite limited.36  The results of these studies may also incorrectly undermine the value 
of PT intervention.   
Multimodal intervention combinations may produce greater and longer lasting 
improvement in pain, function, and quality of life than isolated interventions.93  Fair evidence 
supporting multimodal intervention for TMD was supported in a systematic review by Medlicott 
in 200657 and by Brantingham65 et al in 2013.  The proposed study will utilize manual therapy 
including soft tissue mobilization of the suboccipital musculature and cervical spine TJM, 
therapeutic exercise, and education including behavioral modification. 
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Manual Therapy 
Manual therapy involves hands-on, skilled intervention provided by a physical therapist 
in the treatment of pain and restricted movement.  This may include soft tissue intervention, 
passive movements or movements against resistance of the therapist, and non-thrust joint 
mobilization or TJM.36  Manual therapy interventions are used to inhibit pain via facilitation of 
descending inhibitory pathways and/or improve ROM.94  Manual therapy reported in the 
treatment of TMD includes intervention directed at the temporomandibular joint, masticatory 
muscles, cervical spine, and cervical musculature.64  The systematic reviews and meta-analyses 
mentioned here include multiple types of manual therapy; specific examination of cervical 
manual therapy will be discussed in a subsequent section.  
A review of literature by Kalamir95 et al (2007) found 8 randomized controlled trials 
(RCTs) worthy of inclusion in examination of the effects of manual therapy on TMD.  While 
authors do not report on the validity of the assessments used to determine inclusion, they do 
draw conclusions based on these 8 RCTs.  Kalamir95 et al report their review suggests manual 
therapy is a reasonable treatment option and more cost effective than dental intervention.  
Another review of 27 articles in 2011 suggested evidence did support improvements in pain, 
motion, and function related to manual therapy for TMD.  These authors acknowledged the use 
of terms manual therapy, TJM, and mobilization were difficult to differentiate, and suggested 
future study of individual manual techniques.96   
A systematic review published by Brantingham65 et al in 2013 reported level b evidence 
(defined as limited) suggesting manual therapy was helpful in 3-6 month short-term follow-ups.  
In 2015, Calixtre64 et al examined the specific and isolated effects of manual therapy for TMD in 
a systematic review of RCTs.  These authors report moderate to high evidence to support the use 
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of manual therapy techniques for TMD in reducing pain while increasing pressure pain threshold 
(PPT) and maximal mouth opening (MMO).64  Martins16 et al performed a meta-analysis 
comparing manual therapy to other active interventions.  Authors report overall level b evidence 
supporting manual therapy (including TJM) for short term treatment of TMD noting statistical 
support for manual therapy in decreasing pain and increasing active ROM for mouth opening.16   
Armijo-Olivo17 et al performed a systematic review with meta-analysis (2016) examining 
both manual therapy and jaw exercise.  Meta-analysis supported manual therapy with jaw 
exercises for improvement in jaw ROM and pain reduction.  The combined treatment was 
superior to splint use, self-care, and medication with a moderate effect size reported.17  However, 
in this same study, pooled results showed exercise alone did not demonstrate the same statistical 
superiority or effect over splint use, acupuncture, or other active treatments.  Authors suggested 
manual therapy was needed in addition to exercise, and concluded that while results of manual 
therapy effectiveness were mixed, the data was ‘promising’.17 
Soft Tissue Mobilization 
Manual soft tissue mobilization of masticatory and cervical musculature has been utilized 
clinically and reported in TMD literature.  Several authors support the use of soft tissue 
mobilization in muscles of mastication over no treatment at all,97 and suggest results are 
equivalent to occlusal splints.98  Heredia-Rizo suggests the use of myofascial techniques are 
superior to sham or placebo intervention with placement of hands on the temporomandibular 
joints without pressure.  In this study, participants who received the manual intervention had 
notable improvement in mouth opening and PPT reduction, however, the difference between 
groups was not statistically significant.99  Kalamir100 et al randomized TMD participants into 1 of 
2 groups: 1) intra-oral myofascial work or 2) education, self-care, and exercise.  Pain reduction 
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was greater in the intra-oral myofascial group; however, even though the difference was 
statistically significant, it was not clinically significant (change of ≤2 on Numeric Pain Rating 
Scale (NPRS)).  There was no difference between groups for mouth opening ROM.100   
Oliveira-Campelo69 et al randomized 122 volunteers with the presence of latent trigger 
points to 1 of 3 groups: 1) suboccipital soft tissue mobilization, 2) atlanto-occipital TJM, or 3) no 
intervention (control).  While immediate results favored the manipulation group, both treatment 
groups demonstrated statistically significant improvement in mouth opening and PPT of the 
temporalis, indicating cervical suboccipital soft tissue mobilization may be helpful in reducing 
TMD related pain.   
This study utilized soft tissue intervention only at the cervical spine.  While soft tissue 
mobilization of masticatory musculature is supported in the literature and utilized in clinical 
practice, the focus of this intervention study is an examination of cervical spine TJM.  Kalamir100 
et al suggested education and exercise can provide clinically equivalent results to intra-oral soft 
tissue mobilization; therefore, there is no reason to believe participants in this study will be 
undertreated or receive sub-standard care.  It is common clinical practice to utilize soft tissue 
mobilization to the cervical spine before application of TJM, and evidence supports the potential 
benefit to the TMD population.  A case series performed by the principal investigator (PI) prior 
to this dissertation did not include soft tissue mobilization, leading to the decision to include it in 
order to provide a more pragmatic approach.   
Behavioral Modification 
Behavioral modification education is frequently part of pain management interventions.  
Specific to TMD, behavioral modification has shown comparable results to intra-oral 
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appliances.101  Suggestions include improving sleep and diet, avoiding caffeine, minimizing 
stress, relaxation techniques, and avoiding parafunctional habits.  Parafunctional habits are 
movements of the jaw that are not necessary for normal function;9 these habits include gum 
chewing, awake clenching and grinding, biting the tongue or cheeks, holding the jaw forward in 
protrusion, biting fingernails, and smoking.9,102,103   
Bruxism, or grinding of the teeth, has been emphasized in TMD evaluation and 
treatment; however, there is no indication bruxism causes TMD.  Bruxism can occur at night or 
during wake hours.  Control of wake time bruxism should be emphasized in educational training.  
Sleep bruxism may require a dentist to evaluate the wear patterns of the teeth and determine need 
for an oral appliance to protect the teeth.  OPPERA results demonstrated tooth wear or clinician 
notation of joint noises were not predictors of TMD first onset,46  and as noted previously, the 
use of the oral appliance to control bruxism has mixed results regarding symptom relief of 
TMD.78-80   
Other behavioral modifications include emphasizing chewing softer foods, avoiding wide 
open mouth positions such as biting a large sandwich or apple, and avoiding chewing only on 
one side.14  Patients with pain at end range of opening or hypermobility in opening should be 
taught to place the tongue on the roof of their mouth during yawning to control the degree of 
opening.14 General education related to behavioral change includes making the patient aware of 
the habits or behaviors and encouraging reduction in frequency or abolishment.  This approach 
was utilized in the study. 
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Home Exercise Program/Exercise 
Jaw exercises are the most commonly reported interventions for TMD after patient 
education and intra-oral appliances.77  The use of oral and postural exercises for TMD is 
supported in the literature and considered to be a safe and cost-effective conservative 
intervention.56  The Rocabado 6x6 is the most commonly reported exercise intervention,14,104 but 
other exercises have been evaluated.105  Therapeutic exercise including jaw, cervical, and 
postural exercise is supported for the TMD population,56,106 however, evidence is lacking support 
for superiority of any specific exercise.  Most research utilizing exercise includes multimodal 
approaches making it difficult to discern the specific impact of exercise.  
A systematic review by McNeely18 et al in 2006 reports there is evidence to support 
exercise in reducing TMD-related pain and dysfunction.  However, this review was based on 4 
studies, and each study was given a weak quality rating by the authors.  Medlicott’s systematic 
review in 2006 suggested active exercise of the jaw and postural training were supported in the 
literature.57  The previously mentioned systematic review and meta-analysis by Paco19 et al in 
2016 informs readers that the exercise mentioned in some studies could represent any exercise 
suggested to the patient, even by non- PT providers.  The lack of consistency led these authors to 
only include studies in their analysis if they used physical therapists.  Again, results of this study 
suggested PT intervention was superior to control for pain reduction, but unclear for mouth 
opening.  The 2016 Armijo-Olivo17 et al meta-analysis supports the use of exercise (jaw, 
postural, cervical) in the treatment of TMD.  These authors showed statistically significant 
change in mouth opening and subjective reports of less interruption of daily life in TMD patients 
treated with postural education versus controls.17   
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This project utilized a combination of the Rocabado 6x6, postural exercise, and cervical 
exercise in a standardized fashion for all participants.   
Relationship Between Cervical Spine and Temporomandibular Disorder 
Regional interdependence refers to the biomechanical and neurophysiological 
relationship between various joints and pain responses attempting to explain why impairments at 
one region may contribute to pain in another region.75,107,108  Multiple authors have used the 
concept of regional interdependence as a theoretical basis for evaluation and treatment of the 
cervical and thoracic spine in TMD patients.67,75,107,109 The biomechanical and 
neurophysiological relationship between the cervical spine and TMD is recognized.  While the 
original definition of regional interdependence indicated these relationships existed for 
‘seemingly unrelated’75 locations, a newer perspective suggests the area of primary pain 
complaint ‘may be directly or indirectly related or influenced by impairments from various body 
regions and systems regardless of proximity to the primary symptom(s).’75   
Patients with TMD often have neck pain complaints and some neck pain patients have 
findings of TMD related impairment.  Several authors have reported on the prevalence of 
cervical spine pain in TMD patients.22,52,110  Okeson8 et al examined 357 patients with TMD and 
found 43.7% of subjects cited coexisting cervical myofascial type pain.  In an examination of 
511 patients with TMD, 68%  reported neck pain.15  There is also a strong correlation between 
jaw dysfunction and neck disability in persons with chronic TMD;20,21  Orofacial Pain: 
Prospective Evaluation and Risk Assessment (OPPERA) results demonstrate high correlation 
between muscle pain of the neck and shoulder and both acute and chronic TMD pain.5  Armijo-
Olivo reported a strong positive correlation of r= 0.82 between neck disability and jaw 
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disability.111   Bevilaqua-Grossi112 et al examined 100 women with TMD, noting increases in 
TMD pain were associated with increases in cervical pain.    
Armijo-Olivo found reduced cervical spine flexion and extension muscle endurance 
(although not statistically significant) in persons with TMD compared to healthy subjects.111  
Grondin et el examined 12 patients with TMD in a 2017 case series and treated each based on 
individual impairments.  In this case series, all patients had a positive cervical flexion rotation 
test, indicating limited motion of the upper cervical spine in rotation.  By the end of the 4-week 
study, only 50% had a positive test.  Neck pain with cervical motion was present in over 58% of 
patients at the beginning of this study and less than 17% of patients at the conclusion.  Authors 
use this information to provide support to the relationship between neck pain and TMD.113 
Although less frequent than reports of cervical pain with TMD impairment, presence of 
TMD pain in individuals with a primary complaint of cervical pain has been reported.110  
Cervical spine disorders can exacerbate or contribute to orofacial pain complaints.47,114  Ferão115 
et al examined patients seen in PT for neck pain, noting up to 90% of those patients had TMD 
symptoms.  Von Piekartz116,117 et al added soft tissue mobilization to the orofacial masticatory 
muscles to cervical spine manual therapy in a population of individuals with neck pain and 
cervicogenic headache.  This group was compared to a group that only received the cervical 
intervention.  Authors found statistically significant changes in headache intensity, neck 
function, cervical ROM, and manual mobility assessment of the C0-3 in the group that added 
orofacial muscle treatment.116,117  The trend of improvement in the combined intervention group 
was maintained at 6 months.  While the emphasis of this dissertation was cervical spine 
intervention for individuals with TMD, it is interesting to note that the relationship may work the 
other way as well.   
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The association of jaw and neck pain and dysfunction is well documented.  Regional 
interdependence concepts utilize biomechanical and neurophysiological (including central 
sensitization) theories to explain these relationships.  From a perspective of regional 
interdependence, the relationship between areas of pain is important in both diagnosis and 
treatment.  It is possible that treatment of a location outside the primary area of pain can provide 
clinically meaningful change in the primary location of pain.75   
Biomechanical Relationships  
A biomechanical relationship exists between the cervical spine and TMD.  Jaw opening is 
the primary functional movement at the temporomandibular joint, and this motion occurs with 
upper cervical extension while closing is coupled with cervical flexion.118,119  Greater cervical 
motion occurs during jaw opening than jaw closing.118  Immobilization of the head and neck will 
decrease available ROM and muscle activity at the temporomandibular joint.120  Masticatory and 
cervical muscles contract together during activities like chewing and talking.36  Kraus suggests 
cervical muscle contractions occurring during daily activity or higher load functional activity 
may lead to increased frequency or intensity of simultaneous masticatory muscle contraction.36 
Between 50-90 % of individuals with TMD have limited motion of the upper cervical 
spine (C0-C3), as compared to 16-46% of healthy controls.121  Grondin122 et al found significant 
limitation in the cervical flexion rotation test in individuals with TMD compared to healthy 
controls; however, no significant difference was noted with flexion/extension ROM.   
A correlation between TMD and postural change is supported.28,123  Forward head 
posture (FHP) may contribute to neck pain, shortness of the suboccipital musculature, cervical 
ROM, cervical muscle activation, and headaches.99,124,125  FHP may contribute to TMD related 
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symptoms, however causal relationships have not been supported.126  Both PPT and mouth 
opening are different in various cervical postures.  Greater opening was seen in FHP than neutral 
posture,2 possibly related to coupled cervical extension.  PPT was highest in the neutral position 
and lowest in the FHP.2  From a biomechanical perspective, the FHP elongates the hyoid 
musculature, which is responsible for depression of the mandible.  This tension may draw the 
mandible inferiorly requiring over-activity of the elevators of the jaw (temporalis, masseter, 
medial pterygoid).  FHP also contributes to alteration in the resting position of the mandible, 
leading to posterior movement of the mandibular condyle and potential compressive forces on 
the highly vascularized and innervated retrodiscal tissue.67,127  The altered mandibular position 
could also impact occlusion or tooth contact.15,28,128,129   
OPPERA analysis of first onset TMD showed cervical tenderness to palpation was a risk 
factor in the development of TMD.130  Masticatory and cervical spine trigger points (both active 
and latent) are found in higher frequency and larger areas in individuals with TMD as compared 
to healthy controls.131  PPT, an objective measure of tenderness, was reduced in masticatory 
muscles as well as cervical spine joints and musculature in patients with chronic neck pain who 
did not have TMD.132  PPT was also lower in masticatory muscles, C5-C6 facet joints, and 
tibialis anterior in patients with TMD without associated comorbidities, demonstrating 
widespread sensitivity.133  Individuals with widespread pain in the cervical spine or regions 
outside of the temporomandibular joint itself may be less likely to experience the same degree of 
improvement as those with localized TMD.134   
Neurophysiological Relationships and the Trigeminal System 
The trigeminal nerve, or cranial nerve five (CN V), innervates the temporomandibular 
joint and is responsible for sensation to the face and masticatory muscle activation.  The 
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trigeminal nerve has 3 branches innervating most of the head and face.  From superior to inferior, 
the divisions are the ophthalmic, maxillary, and mandibular branches.  The trigeminal nerve is 
mixed, providing both sensory and motor information.  The mandibular division of CN V 
innervates the masticatory muscles, tensor veli palatine, and tensor tympani.  A branch off the 
mandibular division, the auriculotemporal nerve, innervates the temporomandibular joint.4  The 
trigeminal sensory nucleus begins in the midbrain and ends in the dorsal horn of the cervical 
spinal cord.  The trigeminal nucleus projects inferiorly converging with grey matter and nerve 
cell bodies of the upper cervical spine (C1-3) in what is known as the trigeminocervical 
nucleus.15,135  Afferent input from the trigeminal nerve branches, cranial nerves VII, IX, and X, 
and the upper cervical spine (C1 to C3 or C4) converge onto the trigeminal nucleus suggesting 
the nucleus processes nociception from each of these areas in one shared location.113,136,137  
These upper cervical nerves form the cervical plexus, which innervates the subocciptal region, 
posterior head and neck, upper cervical facet joints, cervical multifidi and other musculature, 
superior shoulder, and upper thoracic region.4,36  The presence of active and latent trigger points 
in the neck and shoulder in patients with TMD was used to support the concept of afferent fiber 
convergence from the jaw and neck.131   
The body processes sensory information in a relay style system.  The first order 
nociceptive neurons send an impulse from the skin or musculoskeletal nociceptors of structures 
innervated by cranial nerves V (trigeminal), VII (facial), IX (glossopharyngeal), and X (Vagus), 
or C1-3.  This impulse travels to the dorsal horn of the spinal cord, trigeminal nucleus, or brain 
stem and meets the second order neurons located in the trigeminal nucleus.  At this location, the 
afferent input converges as it is then sent to the third order neuron in the thalamus, terminating in 
the primary somatosensory cortex.  The brain will receive sensory input (pain or temperature) 
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and subsequently interpret the input to determine response.4  While examined around the intent 
to understand cluster and migraine headaches, Bartsch and Goadsby examined second-order 
neuron responses when noxious stimulation was applied to trigeminal afferents.  This study, 
along with an examination of trigger points and headache, showed changes in cervical and 
trigeminal systems with increased sensitization of the second-order neurons extending through 
C3.137,138  The convergence of afferent inputs of the upper cervical spine and the trigeminal nerve 
in the shared grey matter of the trigeminocervical nucleus may explain why stimulation of 
affected tissues could result in pain perceived in a distant location.  The increased sensitization 
shown in the Bartsch and Goadsby work may also describe a process of central sensitization, 
leading to increased excitability or responsiveness to stimulation.26,137 This theory implies pain in 
the neck or jaw region does not necessarily indicate pathology in that specific location.  The 
convergence mechanism is an example of the neurophysiological relationship between the 
cervical spine and TMD.   
There is evidence to suggest neurophysiological change occurs in individuals with TMD.  
An examination of heat and cold pain thresholds in women with myofascial TMD demonstrated 
thermal hyperalgesia at the masseter and frontalis as well as an extra-trigeminal region at the 
wrist.  The temperature pain thresholds were statistically different from that of healthy controls 
in each region.139  The changes in temperature thresholds were associated with the intensity and 
duration of pain symptoms, indicating increased excitability or changes in processing of both 
peripheral and central nervous systems with reduced pain inhibition in patients with TMD.139  An 
examination of anatomical size and volume changes in the trigeminal nerve revealed no local 
changes in this nerve in a TMD population, while there were changes in patients with trigeminal 
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neuralgia and trigeminal neuropathy.  This study led authors to propose that the hyper-
excitability existed beyond the trigeminal nerve in the TMD population.30  
Central Sensitization  
The neurophysiologic relationships noted above can be described as segmental 
mechanisms of pain control.  Central mechanisms of control relate to cortical or subcortical 
structures in the brain, with subsequent changes in descending inhibition.69  Central sensitization 
refers to a mal-adaptive process of reduced stimulus threshold with increased facilitation based 
on potential overload of nociceptive afferent information to second order neurons.4,73  There is 
often a simultaneous reduction in inhibitory responses.  The increased responsiveness to 
stimulation presents clinically as pain without tissue provocation, hypersensitivity to stimulus 
(hyperalgesia), or pain from normally non-painful stimuli (allodynia).73,133  Where previous 
theories of pain transmission suggested noxious stimulus was necessary for pain generation, 
more recent theories acknowledge nociceptive pain can come from low threshold stimulus.73  
Clinical signs of central sensitization include reduction in PPT, sensitivity to thermal stimuli, and 
temporal summation, or wind-up pain produced after a single or repetitive low threshold 
stimuli.140   
Patients with chronic TMD have demonstrated widespread pain, abnormal central 
nervous system changes in the brain,141 and signs of central sensitization alongside peripheral 
sensitization.140,142  Patients with chronic TMD, like other patients with chronic pain, often have 
additional comorbidities. There is a positive association between pain intensity and the number 
of comorbidities in the TMD population.143  Common comorbidities associated with TMD 
include headache, depression, chronic fatigue syndrome, interstitial cystitis, restless leg 
syndrome, fibromyalgia, irritable bowel syndrome, and sleep disruption.40,143  Individuals with 
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TMD who also have comorbidities have higher incidence of central sensitization and 
allodynia.73,144,145  Chronic TMD is associated with concomitant headache, neck pain and 
dysfunction, and impaired endogenous pain modulation, which may be related to central 
sensitization.146 
Changes in PPT are related to central sensitization.73  Patients with TMD have notable 
changes in pain and temperature thresholds.133,147-149  La Touche132 et al examined PPT in 23 
patients with mechanical neck pain demonstrating reduced PPT in masticatory muscles (masseter 
and temporalis) as well as the upper trapezius and C5-6 facet joint.  They also examined a remote 
location at the anterior tibialis.  While statistically significant changes in PPT were present for 
the masticatory and cervical regions, the difference between groups (neck pain and healthy 
controls) at the anterior tibialis was not statistically significant.132  The results of this study differ 
from the previously mentioned results of Fernandez-de-las-Penas150 et al, who did show 
differences in the anterior tibialis.133  LaTouche140 et al published a meta-analysis examining 
central sensitization in patients with TMD in 2017.  The meta-analysis indicated statistically 
significant reduction in PPT levels was present in both trigeminal and remote areas in patients 
with TMD, suggesting both peripheral and central nervous system involvement. 
Cervicothoracic Intervention for Temporomandibular Disorder: Evidence 
Manual therapy directed at the jaw, thoracic spine, and cervical spine has been addressed 
in a limited fashion in the TMD literature.16,17,64  A 2013 case series reported on the use of 
mobilization with movement to the jaw and cervical spine, TJM to the thoracic spine, and trigger 
point dry needling of the temporalis and masseter muscles in 15 participants.  Statistically 
significant change in mouth opening and pain reduction were reported.58  Packer109,151 et al 
performed a randomized controlled trial evaluating the effect of thoracic spine TJM versus sham 
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manipulation on a population of individuals with TMD.  In this trial, there was no statistical 
difference between groups at immediate or short-term (2-4 day) follow-up for mouth opening, 
electromyography (EMG) activity of the masticatory muscles, pain rating, or PPT.109,151  
Jayaseelan67 et al added cervicothoracic TJM to manual therapy, education and exercise in a case 
study reported in 2016.  The participant in this case had statistically significant change in neck 
disability, pain rating, and global rating of change.  Cervical TJM has been studied previously as 
part of a multimodal treatment package demonstrating some indication of support for use with 
the TMD population.59,152   
Cervical Spine Non-Thrust Joint Mobilization 
Cervical spine non-thrust joint mobilization has been studied and demonstrated value in 
the treatment of TMD.  La Touche22 et al (2009) examined the impact of cervical intervention 
including non-thrust joint mobilization and exercise on 19 individuals with a primary diagnosis 
of TMD.  All participants received 10 treatments solely focused on the cervical spine over 5 
weeks; treatment included manual supine upper cervical flexion mobilization and prone C5 
central posterior to anterior mobilization, with a supine cranio-cervical flexor stabilization 
exercise.  Results showed a large within group effect size for decreasing pain (d > 3.0), 
increasing active mouth opening (d > 0.08), and increasing PPT of both the masseter and 
temporalis (d > 1.0).  This effect was noted at a 48-hour assessment and maintained at a 12-week 
follow-up.22   
In 2013, La Touche23 et al published an article reporting the impact of upper cervical 
spine mobilization over 3 treatment sessions (in 2 weeks) on pain, PPT, and sympathetic system 
response (heart rate, skin conductance, breathing rate and skin temperature).  Clinicians 
performed prone posterior to anterior (PA) mobilization of C0-C3 segments.    While their first 
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study did not have a control group, the second study utilized a sham technique as a control.  The 
sham mobilization was performed utilizing the same handgrip, but without any delivery of force 
or mobilization.  The 2013 study did show statistically significant changes favoring those with 
the cervical mobilization intervention over the sham mobilization group,23 and the reported 
magnitude between groups demonstrated a very large effect.64   These between group effect sizes 
were not reported; see Table 2.1 for hand calculations completed at the 2 week, post treatment 
visit.  
TABLE 2.1 
EFFECT SIZE ESTIMATES 
(BETWEEN GROUPS) AT 2 
WEEKS 
 
Variable 
 
d 
Pressure pain threshold  
       Masseter 1; right -2.13 
       Masseter 1; left -2.05 
       Temporalis 1; right -2.53 
       Temporalis 1; left -2.44 
Visual Analogue Scale -2.59 
Abbreviations: d, Cohen’s d effect size calculation. 
 
In 2016, Calixtre153 et al reported on a single group pre-test, post-test analysis of 12 
women with TMD treated with cervical mobilization and exercise modeled after La Touche23 et 
al.  These authors investigated improvement at 5 weeks in function of the jaw, subjective pain 
reports, PPT, and mouth opening.  Within group effect sizes were reported using Cohen’s d.  
Mouth opening had the greatest effect, d = 0.64.  The PPT effect was variable for each location 
with some improvements and some worsening.  Both pain scores and PPT were low at baseline 
leaving little room for change with intervention.  The mean baseline pain score was 1.0/10 on the 
NPRS.   
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Cervical Spine Thrust Joint Manipulation for Temporomandibular Disorder 
  Cervical spine TJM is supported for acute and chronic neck pain, as well as cervicogenic 
headache.154-157 An update and revision of the cervical spine clinical practice guidelines158 
suggests B level evidence (moderate strength) to support cervical spine TJM in subacute or 
chronic neck pain with headache, as well as chronic neck pain with radiating pain.  C level 
evidence (weak support) exists for the use of cervical TJM in acute, subacute, and chronic neck 
pain with mobility deficits.  A clinical predication rule (CPR) has been derived for the use of 
cervical spine TJM in patients with neck pain.159  This CPR is currently in the process of 
validation, and may provide further evidence surrounding the use of cervical spine TJM for neck 
pain.   
 Specific to TMD, cervical spine TJM has been utilized as part of multimodal treatments.  
It has also been tested in populations with primary complaints other than TMD.  A systematic 
review and meta-analysis in Manual Therapy examined 8 articles using manual treatment in 
association with TMD.  Martins16 et al concluded that there was evidence to support manual 
therapy intervention for this population.  Of the 8 articles, 3 of them utilized cervical spine TJM.  
The population tested in these TJM studies included children with a history of trauma,16,160 and 
subjects with noted latent trigger points as opposed to jaw pain or dysfunction.16,69  The third 
study, Mansilla-Ferragut161 et al, examined the immediate (5 minutes post-intervention) effects 
of atlanto-occipital TJM on mouth opening and PPT in a population of women with a primary 
complaint of neck pain and found statistically significant improvements in both.  The magnitude 
of the effect within groups in this study was large for mouth opening (d = 1.5), and moderate for 
PPT (d = -0.05).64  Between group effect size was not reported; hand calculation reveals a large 
effect for both mouth opening (d = 2.08) and PPT (d = 1.28).  Other studies that were included in 
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this systematic review utilized TJM in addition to other manual interventions, making the 
specific effect of TJM difficult to determine.16,152   
Oliveira-Campelo69 et al completed a study (mentioned in the review above) examining 
122 volunteers with latent trigger points in the masseter and temporalis.  There were 3 arms of 
this study: 1) atlanto-occipital TJM, 2) suboccipital soft tissue mobilization, and 3) no 
intervention control group.  Examination of 2-minute immediate effects revealed statistically 
significant changes between both of the intervention groups and the control; however, the 
between group effect for both mouth opening and PPT was small (d = 0.28, d = 0.22).  This 
study suggests cervical spine TJM or cervical soft tissue mobilization may have an impact on 
MMO or PPT.  It is important to remember that the population tested did not have a TMD or 
neck pain diagnosis, however they did have presence of latent trigger points in the muscles of 
mastication.   
Cuccia152 et al utilized multimodal intervention in 2 groups of patients with TMD.  One 
group received osteopathic cervical spine TJM as well as other manual osteopathic interventions 
of soft tissue treatment, myofascial release, muscle energy, and craniosacral therapy.  The other 
group received ‘conventional’ care of occlusion splinting, PT stretching and relaxation, hot and 
cold packs, and electrical stimulation.  While there was no difference in pain or mouth opening 
between groups, the group treated with osteopathic intervention had statistically significant 
reduction in the use of both anti-inflammatory medications and muscle relaxers.152  
A systematic literature review by Adelizzi59 et al in 2016 examined literature surrounding 
the use of cervical spine TJM for TMD, noting most of the evidence was based on weak study 
designs, limited availability of research, small samples, and multimodal or combined treatment 
intervention packages.  Only 6 studies were included in the review and 3 articles scored 0/11 on 
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the PEDRO scale (case reports).  One case series utilized an ‘activator’ for spinal treatment.  There 
were only 2 RCTs and both were scored 8/11.  Authors neglect to acknowledge the study designs 
used in their review include various populations of interest, none of which include individuals with 
a primary complaint of TMD.  One RCT utilized a population of women with a primary complaint 
of neck pain, however, they did have limited mouth opening.68 Another RCT (the Oliveira-
Cammpelo study mentioned above) utilized a population of individuals with confirmed presence 
of latent trigger points in masticatory muscles, but no diagnosis of TMD.69  Despite the limitations 
noted above, Adelizzi59 et al reported all 6 studies demonstrated improvements in pain, mouth 
opening ROM, and PPT; concluding cervical TJM may be beneficial in the TMD population.      
Cervical Spine Thrust Joint Manipulation for Temporomandibular Disorder: Theory 
The biomechanical and neurophysiological relationships between the jaw and cervical 
spine have been established161 and support evaluation and treatment of the cervical spine in the 
TMD population.  The regional interdependence model is used to support thoracic or cervical 
intervention for shoulder pain,162-166 and this theory also supports cervical spine intervention for 
TMD.  Cervical spine non-thrust joint mobilization has demonstrated effectiveness, giving 
reason to believe cervical spine TJM may also impact pain and dysfunction of TMD.  The 
specific impact of cervical spine TJM is yet to be determined in the TMD population and was the 
focus of this dissertation.   
The specific nature of spinal TJM effectiveness is not fully understood.  Historically, 
manual physical therapists have looked at their interventions from a biomechanical perspective.  
Biomechanical theory surrounding cervical spine TJM in TMD includes relationships with 
mouth opening or posture.  MMO is a functionally relevant measurement in subjects with TMD, 
and this measurement is dependent on cervical posture.2  Forward head posture is said to 
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contribute to neck pain, shortness of the suboccipital musculature, headaches, and potentially 
TMD.99  It is possible cervical spine TJM can have an impact on cervical ROM and posture, 
therefore leading to a change in mouth opening or function for individuals with TMD.   
There is also growing support for the neurophysiological effect of TJM to the spine 
through biochemical, spinal segmental, and central mechanisms.  A systematic review and meta-
analysis demonstrated biochemical changes in substance-p, neurotensin, oxytocin, interleukin, 
and cortisol with spinal TJM.  These biochemical changes were used to support the theory that 
spinal TJM can result in pain modulation.167  The interaction between both central and peripheral 
nervous systems supports central nervous system change as well as peripheral pain modulation 
after localized intervention.168,169  Changes in muscle activation/recruitment, resting muscle tone, 
pain inhibition, sympathetic nervous system activity, and/or function have been documented with 
spinal TJM.19,22,169,170  Increased PPT in local and remote regions after spinal TJM also suggests 
a possible combined peripheral and central mechanism of control.171,172  Manual therapy has a 
role in pain inhibition at the location of pain or treatment and even at remote locations.169,173  
Therefore, it is possible that intervention directed at the cervical spine may have local cervical 
spine effects as well as distant effects in the face, jaw, or other regions of the body.   
Sault174 et al described a case study of a woman with bilateral TMD and cervical pain.  
Manual therapy and exercise treatment directed at both the temporomandibular joint and cervical 
spine resulted in reduction of pain, improved function of the jaw, and increased PPT at the jaw 
and a remote location at the thenar eminence.  Fernandez-de-las-Penas150,175 et al reported 
changes in PPT at C5/6 facet joints after cervicothoracic junction TJM150 as well as changes in 
PPT at bilateral elbows after C5/6 TJM.175  The proposed mechanism of pain reduction relates to 
inhibition of nociceptors, altered sensorimotor integration, and changes in descending pathways 
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of the spinal cord.176  The convergence mechanism previously described refers to the shared grey 
matter in the trigeminocervical nucleus and extends to C3.15,135  The convergence of the upper 
cervical nerve roots (C1-3) with the trigeminal nerve suggests a segmental relationship with 
possible central activation of inhibitory pathways with spinal TJM.  
This study utilized cervical spine TJM of bilateral atlanto-occipital (C0/1) joints and an 
upper/mid-cervical (C2/3) location.   
Cervical Spine Thrust Joint Manipulation Safety 
Cervical spine TJM is considered standard PT practice, and both thrust and non-thrust 
mobilizations are routine interventions in orthopaedic PT practice.  TJM is considered an entry-
level skill and required in first professional Doctor of Physical Therapy Programs.  However, the 
perception of risk associated with cervical spine TJM should be considered.  Mild side-effects 
are an expected potential consequence of TJM, and these include neck pain, headache, and 
fatigue.159  The risk for mild side-effects is estimated to be 1-2%, with 74% of these symptoms 
resolved in 24 hours.177  Mild side-effects will be distinguished from discussions of potential 
adverse events.   
While causal relationships are not supported, adverse events including death and stroke 
have been associated with cervical spine TJM.  Given the large number of cervical TJMs that 
occur on an annual basis within the chiropractic and PT community, the numbers show that 
actual adverse events are relatively low.  The relative risk involved with cervical TJM is 
unknown, but estimated to be 1/50,000 to 1/5.85 million.178  The definition of an adverse event 
and tracking have led to difficulty defining the exact prevalence.   
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Puentedura178 et al provided a narrative literature review of adverse events suffered by 
persons receiving cervical TJM.  Events were classified as preventable, unpreventable, or 
unknown and the use of cervical TJM was classified as appropriate or inappropriate based on 
known examination findings.  Ninety-three case reports examined 134 cases of adverse event.  
Of these 134 cases, 44.8% were preventable, 10.4% were unpreventable, and the remaining were 
unknown.  The authors concluded ruling out contraindications would have allowed clinicians to 
prevent at least 44.8% of the reported adverse events with appropriate screening and testing.  
However, 10.4% of adverse events were unpreventable, yielding acknowledgement of a rare risk 
association.  In this study, physical therapists were the treating clinician in 3.7% of the cases of 
adverse events, but none of the noted cases of death. 
The arterial dissection associated with serious adverse events can occur with trauma or 
even spontaneously.  Trauma can be as significant as a high speed motor vehicle accident or 
something like a cough, sneeze, performing yoga,179 or the positioning of the neck during hair 
washing at the beauty parlor.180,181  A 2015 report examined risk factors for those with cervical 
arterial dissection (not only those associated with cervical TJM) and reported cardiovascular risk 
factors were not “important risk factors”182 for dissection and “may not be useful indicators or 
risk”182; however, this study will still exclude those with uncontrolled hypertension, 
hyperlipidemia, and diabetes.  
Adelizzi59 et al report perception of risk may explain their difficulty finding research 
support for cervical spine TJM in the TMD population.  These authors advocate for further 
research on the topic of TJM.  The systematic review and meta-analysis by Armijo-Olivo17 et al 
reported there were no reports of adverse events with manual therapy and exercise in the TMD 
population for the few trials that actually reported adverse events.  The revised Clinical Practice 
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Guidelines for neck pain mention risk with any cervical spine intervention, noting ‘while major 
adverse events can and do occur on a patient-by-patient basis, reports of serious events in 
randomized controlled trials are ostensibly absent… For manipulation, rare but serious adverse 
events such as stroke or serious neurological deficits were not reported in any of the trials.’158   
In this study, all participants were screened according to the International Federation of 
Orthopaedic Manipulative Physical Therapists (IFOMPT) safety recommendations.  Participants 
were screened for general red flags and appropriateness of physical therapy as well as 
contraindications to TJM before enrollment.  The PI and all treating therapists were licensed 
physical therapists with post professional manual therapy training including the specific study of 
TJM procedures, background, safety, and assessment.  A side-effect questionnaire was used to 
document and report any side-effects. 
Relevance and Contribution to the Field of Physical Therapy 
Physical therapists often report lack of preparation and lack of confidence in treating the 
TMD population.15  In the United States, patients with jaw pain may encounter practitioners 
without experience or confidence in treating their condition.  Understanding the effectiveness of 
various interventions on pain modulation and changes in function guide informed and evidence-
based clinical practice, and may have an impact on outcomes.  Effective interventions may 
minimize the development of chronicity or central sensitization,5 both of which can be difficult 
to manage.   
Cervical spine TJM is part of standard PT practice.66  Frequency of cervical spine TJM 
use by physical therapists in the US is much less than that of lumbar and thoracic TJM.183,184  
There are a few studies looking at the effectiveness of cervical spine non-thrust mobilization and 
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TJM treatment for TMD, however, none specifically examine the impact of cervical spine TJM 
independently in this population.  A consideration of cervical spine TJM in the treatment of 
TMD could be an important adjunct to current standard practice interventions of soft tissue 
mobilization, behavioral modification, and exercise.  Physical therapists treating patients with 
jaw pain may be unaware of an important treatment option, and evidence supporting 
effectiveness of TJM may have an impact on utilization in clinical practice.  If cervical TJM is an 
effective intervention, these results could be utilized to guide clinical practice.  It is also possible 
that cervical spine intervention could be preferable to direct treatment to the jaw.  As noted by 
Sault174 et al, manual intervention directed at the cervical spine had a larger impact on pain and 
was better tolerated than treatment directed at the jaw.  LaTouche22 et al suggests cervical spine 
manual intervention be considered as an adjunct to TMD intervention as well as a consideration 
for those individuals with TMD related allodynia who may not tolerate palpation or intervention 
directly around the temporomandibular joint. 
  Adding to the body of literature will support the role of the physical therapist in normalizing 
function, decreasing pain, and/or improving quality of life in those with TMD.  Research 
examining the effectiveness of cervical spine TJM has the potential to improve the confidence of 
physical therapists looking for the most effective way to treat the TMD population, support the 
role of the physical therapist on the interdisciplinary team, and support future study of 
comparative analysis of interventions as well as cost analysis and impact. 
Summary 
Confidence in the effectiveness of PT interventions for those with TMD is moderate at 
best.16-18  Dental intervention primarily includes the use of occlusal splinting, and despite 
inconsistent evidence, this is the most commonly utilized treatment intervention.  There is little 
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evidence to support interdisciplinary care.  Calixtre64 et al acknowledge clinical practice 
frequently utilizes multimodal interventions, however, these authors advocate for study of the 
specific impact of each intervention in order to make clinical decisions relevant to the most 
effective intervention choices.  In a 2016 systematic review and meta-analysis of PT intervention 
for TMD, Paco19 et al reported more evidence has been published to support PT intervention for 
this population.  However, these authors and Armijo-Olivo17 et al acknowledged the evidence 
lacks RCTs, and recommended future RCTs in the TMD population.17,19   
A strong correlation between TMD related disability and neck disability has been 
found.21  Biomechanical and neurophysiological relationships between the cervical spine and 
TMD are acknowledged.  Cervical spine TJM is a commonly utilized, safe, and effective PT 
intervention.  Much of the current evidence surrounding cervical spine TJM for TMD utilized 
this intervention with other interventions or on different populations, making the specific impact 
of TJM for individuals with TMD difficult to determine.  While this study also utilized other 
interventions, 2 groups were used and only one group received TJM while the other received a 
sham manipulation.  The goal of this dissertation was to study the impact of cervical spine TJM 
in the TMD population.   
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Chapter 3: Methodology  
Introduction 
 This chapter outlines the methodology used for investigating the effects of cervical spine 
thrust joint manipulation (TJM) on individuals with temporomandibular disorder (TMD).  The 
methodology and reporting follow Consolidated Standards of Reporting Trials (CONSORT) 
guidelines.185 CONSORT established guidelines to improve consistency, transparency, and 
accuracy of reporting randomized controlled trials while supporting efforts to minimize bias and 
uphold the standards expected of this level of evidence.  Additionally, this trial was registered 
prospectively with the US National Library of Medicine via clicaltrials.gov (ID: NCT03300297). 
 This outline describes clinician background requirements, training and procedural 
methods for clinicians and data collectors, participant recruitment, and facilities.  Further 
information regarding research design including blinding, random assignment, description of 
subjects, procedures, measurement tools, interventions, and sample size estimations.  Data 
safety, data monitoring, and funding will also be discussed.   
Research Design and Methods 
This dissertation project was a prospective, longitudinal randomized clinical trial 
examining the effect of an intervention following the CONSORT guidelines.  Two parallel 
groups were compared over time in a factorial design consisting of 25 participants per group.  
Eligible participants were randomly assigned to 1 of 2 groups: sham or manipulation.  Three 
locations for data collection included Rock Valley Physical Therapy (RVPT), an outpatient 
practice with locations in Peoria and Washington, Illinois, Bradley University (BU) Department 
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of Physical Therapy and Health Sciences, and University of Nevada Las Vegas (UNLV) 
Department of Physical Therapy.    
The 3 clinicians trained to assist in data collection were licensed physical therapists, 
known to the principal investigator (PI).  All clinicians had specific post-graduate level spinal 
TJM training (documentation of coursework or residency/fellowship training) and used cervical 
spine TJM regularly in practice.  A Manual of Standard Operating Procedures (MSOP) was 
created by the PI.  Each clinician received this manual and underwent detailed training before 
data collection began.  The live training was performed by the PI and DPT student research 
assistants at BU.  This 5-hour training included review of human subjects research, 
standardization of assessments, flow of procedures, common education language/instruction, and 
standardization of treatments.  Clinicians received a copy of the MSOP.  See Appendix 10.  
Video recordings from the training session were taken of each assessment and treatment 
procedure and an electronic file was shared with clinicians to use as needed for repetition.  One 
of the clinicians trained for data collection never completed the Collaborative Institutional 
Training Initiative (CITI) training and therefore never collected any data for the study.  Another 
trained clinician, located in Washington, IL, did not have participants interested in that location. 
Therefore, all data was collected between 2 clinicians (the PI and Dr Emilio Putentedura, PT) at 
the locations mentioned previously.  
Blinded assessors (blinded to treatment group allocation) were used for objective data 
collection.  The blinded data collectors included 6 physical therapists, 1 physical therapist 
assistant, and 5 doctoral PT students who underwent a separate 4-hour detailed training before 
data collection began.  The training was performed by the PI and included review of human 
subjects research, standardization of assessments and measurements, common language to be 
49 
 
used, and documentation of findings.  Blinded assessors received the MSOP.  See Appendix 10.  
The blinded assessors were trained to measure pressure pain threshold (PPT) as well as active 
range of motion (AROM) of the neck and jaw.  Video recordings from the training session were 
taken of each assessment procedure and an electronic file was shared with blinded assessors to 
use as needed for repetition.  Interrater reliability was tested at the end of this training using 
healthy volunteers (college students).   
Blinded assessors at University of Nevada Las Vegas (UNLV) were trained by the 
treating clinician at that location using the MSOP and videos shared by the PI.  These blinded 
assessors were DPT graduate assistants and had prior experience with similar data collection in a 
neck pain study.   
Front office staff at RVPT were trained to assist in scheduling and flow of research.  
Research assistants in IL and NV organized schedules with a blinded assessor, clinician, and 
participants. Participant demographic and contact information was collected and kept in a locked 
file at RVPT, BU, or UNLV in NV.  All files were ultimately transferred to a locked file cabinet 
located at Bradley University in IL.  Demographic information collected for descriptive purposes 
included age, gender, race, body mass index (BMI), occupation, physical activity level, 
medications, medical history, smoking history, onset/location of symptoms, 
aggravating/relieving factors, and frequency of episodes.  Self-report measures were completed 
by participants and treating therapists performed all objective assessment/screening procedures 
excluding those measures that would be used for objective data collection and analysis.  See 
Appendix 7 and Appendix 8 for outcome measures and data collection forms.  
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Recruitment Procedure  
Participants were recruited from Peoria, IL, Washington, IL, Morton, IL, and Las Vegas, 
NV.  Recruitment flyers were posted in several public locations (BU campus, local dental 
offices, RVPT clinics) to recruit from the general public.  See Appendix 2.  Electronic 
advertisement was shared in BU News (weekly announcements sent to BU faculty and staff) and 
Hilltop Happenings (weekly announcements sent to BU students).  At UNLV, persons interested 
in participating in a neck pain clinical prediction rule validation study who complained of TMD 
symptoms more than neck pain were asked if they would like to participate in this study.   
Consecutive persons sent to RVPT (IL) for evaluation and treatment of TMD were 
invited to participate in the study if interested.  The PT evaluation and treatment performed at 
RVPT did not require entry into the research study as all procedures were standard of care.  
RVPT office staff handled scheduling as they did with any new referral.  Invitation to participate 
in the study was provided by office staff or research assistants over the phone or in person as 
follows: “Rock Valley Physical Therapy is collaborating with Bradley University’s Physical 
Therapy Department in a study to determine the effectiveness of physical therapy treatments for 
temporomandibular dysfunction or pain.  You are being invited to participate in this study 
because of complaints of jaw or TMD pain.  All of the procedures associated with this study are 
routinely used by physical therapists.  Would you be interested in participating in this study?” 
Persons interested in participation in NV were told “UNLV’s physical therapy 
department is collaborating with Bradley University in IL for a study to determine the 
effectiveness of physical therapy treatments for temporomandibular dysfunction or pain.  You 
are being invited to participate in this study because of complaints of jaw or TMD pain.  All of 
the procedures associated with this study are routinely used by physical therapists.  Would you 
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be interested in participating in this study?” NV volunteers understood they were participating in 
research, and if they were not interested or did not qualify, information was provided to suggest 
other treatment options.   
The treating clinician issued and reviewed the informed consent with each participant.  
Once this information was reviewed, participants were informed they could change their mind at 
any time and withdraw from the study without consequence.  Once a participant was entered into 
the study they were not removed from analysis or discussion.64  
Concealed Random Allocation 
A research assistant not involved in subject recruitment or intervention created a 
computer-generated randomization list with equal numbers of participants in each group for a 
total of 42 participants.  A document stating “sham group assignment” or “manipulation group 
assignment” was placed in a concealed opaque envelope.  After initial screening, evaluation, and 
baseline assessments were complete, eligible participants were randomly assigned to one of two 
groups by opening the next envelope.  In NV, a random table generator was used for group 
assignment of the subsequent 8 participants (https://www.randomizer.org/).  As clinicians were 
performing treatment, they could not be blinded to group allocation, however patients and 
assessors used to measure objective data for analysis were blinded to treatment group.  
Treatment began immediately after assignment. 
Description of Human Subjects 
A total of 50 participants with a primary compliant of TMD related pain and dysfunction 
who met inclusion and exclusion qualifications participated in the study. All participants 
consenting to participation were screened for eligibility using a health record form, physical 
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objective examinations, and self-report measures.  See Appendix 7 and Appendix 8.  Participants 
were screened by the evaluating physical therapist according to a general screening tool for a 
broad inclusion of TMD related pain and dysfunction.  This initial screening tool has been 
established and demonstrated high specificity (0.97) and sensitivity (0.99) to identify those with 
and without TMD.32  It is suggested that this tool be used to determine the presence of pain 
related TMD and the potential need for treatment.33   
TMD Screen 
1. In the last 30 days, on average, how long did any pain in your jaw or temple area on 
either side last?32   
a. No pain 
b. From very brief to more than a week, but it does stop 
c. Continuous   
2. In the last 30 days, have you had pain or stiffness in your jaw on awakening? 
a. No 
b. Yes 
3. In the last 30 days, did chewing hard or tough food change any pain (that is make it better 
or make it worse) in your jaw or temple area on either side? 
a. No 
b. Yes 
Scoring: all “a” responses are scores as 0, “b” response is 1 point, and “c” response is 2 points.  
A threshold of a total score of 2 is needed for a positive screen.32 
Inclusion Criteria: 
1. Numeric Pain Rating Scale (NPRS) score ≥ 2 in jaw at baseline 
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2. Pain-free mouth opening ≤ 50 mm   
3. Age 18-65 
4. Primary complaint of TMD pain 
5. TMD pain confirmed by screen listed above 
6. Proficiency in the English language 
7. Availability to attend 4 appointments in 4 weeks 
The following paragraphs explain the choices made for inclusion criteria.  A minimum level 
of disability was established to increase likelihood of capturing change in pain or function.  
While functional outcome measures are generally used to establish this minimum level of 
disability, there is not enough evidence utilizing TMD specific outcome tools to determine an 
appropriate minimum score; therefore, both pain and mouth opening were used to determine a 
minimum level of disability.  There is no established minimum level of disability for the TMD 
population with NPRS, therefore a score of  ≥ 2 at baseline was chosen based on previous 
research156,186 related to neck pain and the minimum NPRS score noted in a case series 
performed by the PI before the start of this study.  This case series reported the outcomes of 5 
individuals with a primary complaint of TMD and treated them with education, exercise, and 
cervical TJM.  The minimum level of pain as measured by the Numeric Pain Rating Scale 
(NPRS) for these participants was 2.  A minimal level of mouth opening was established as ≤ 50 
mm.  While 40 mm of opening is often considered normal or functional opening, it is actually a 
lower range of normal, which is listed between 40-55 mm.7,9,187  The use of ≤ 50 mm establishes 
a cut off likely to allow for some improvement over time.  The minimum age of 18 was chosen 
to include those old enough to legally consent to participation.  The maximum age of 65 was 
chosen to exclude those with higher probability of narrowing of the cervical central canal.188   
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Cervical TJM has been studied in a population of persons with neck pain, however, the intent 
of this study is to look at the impact of cervical spine TJM in a TMD population; therefore, 
persons included had to have a primary complaint of TMD pain and test positive on the screen. 
Requiring English language proficiency was necessary for completion of self-report scales and 
data collection and agreement to participating in 4 visits was included to ensure participants had 
an intent to complete the study duration.  
Exclusion Criteria: 
1. Traumatic onset of symptoms in the last year 
2. History of whiplash in the last 6 weeks; Prior neck surgery 
3. Temporomandibular locking in the last month 
4. Medical red flags suggestive of non-musculoskeletal origin of pain, systemic or 
neurological disease 
a. Two or more signs of cervical nerve root compression (major muscle weakness, 
diminished upper extremity reflexes, diminished or absent pinprick sensation in a 
dermatomal pattern); Evidence of central nervous system involvement 
(hyperreflexia, gait disturbance, nystagmus, impaired facial sensation, change in 
taste, loss of visual acuity, positive pathological reflexes (Hoffman, Babinski, 
Inverted supinator, clonus)); unremitting night pain or non-mechanical pain 
5. Contraindications to TJM: active cancer, history of prolonged corticosteroid use, acute 
fracture or tumor in the area to be treated, osteoporosis, joint ankyloses, dislocation, 
cervical ligament ruptures, acute active inflammatory or infectious disease, rheumatoid 
arthritis, vertebral artery abnormalities, connective tissue disease (Muscular dysplasia, 
Marfan syndrome, Down syndrome, Ehlers Danlos syndrome), prolonged anticoagulant 
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therapy, signs of cranial nerve involvement, drop attacks, dysarthria, dysphagia, 
nystagmus, new or recent onset of dizziness, new or recent onset of neck pain or 
headache “unlike any other”, previous cerebrovascular accident or transient ischemic 
attack, or uncontrolled hypertension, diabetes, or hyperlipidemia 
6. Previous cervical spine TJM intervention in the last 3 months; Worker’s compensation or 
any pending litigation regarding their pain or injury   
Evaluation Procedures 
Treating therapists issued the Health History Form and Self-Report Outcome Measures to 
be completed by the participants before the session began.  Table 3.1 describes subsequent 
assessments, which are described in further detail in the MSOP (See Appendix H). 
TABLE 3.1 EXAMINATION AND EVALUATION ASSESSMENT 
 
 
Demographic/History 
 
Safety Screening (per IFOMPT 
Guidelines) 
 
Objective Assessment by Blinded 
Assessor 
Review health Record 
Form designed to screen for red 
flags or contraindications to 
treatment as well as other 
inclusion and exclusion criteria 
History clarification if needed; 
Blood pressure, testing/screening 
of the following: cranial nerves, 
upper cervical ligaments, vertebral 
artery, myelopathy signs, reflexes, 
sensation, UE myotomes, 
nystagmus, and cervical spine TJM 
position hold 
Cervical ROM, jaw ROM, PPT 
with digital algometer at 3 
locations (1 temporalis, 1 masseter, 
and 1 remote location at 1st dorsal 
interossei) 
Abbreviations: UE, upper extremity; TJM, thoracic joint manipulation; ROM, range of motion; PPT, 
pressure pain threshold.
 
A blinded assessor measured baseline and immediate change in cervical and jaw ROM, 
and PPT on day one.  A blinded assessor was also present at the 1-week and 4-week visits to 
repeat these measurements before treatment.  The blinded assessor was not present during 
treatments to protect the integrity of blinding.   
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If any participant was excluded, declined to participate, did not meet inclusion criteria, or 
was lost to follow up, this data was recorded for future reporting.  Every effort was made to fully 
describe these happenings.     
Data Collection 
All subjects completed several commonly used instruments to assess pain and function in 
patients with TMD. There is no consensus in the literature regarding the most appropriate 
outcome measures to use with this population, and psychometric property analysis of TMD 
outcome measures is sparse.189  While there is some evidence to support use of the 
temporomandibular scale, this outcome measure has 97 items and is not clinically efficient.189  
Therefore, this study used a spectrum of outcome measures that attempt to capture the effect of 
treatment across multiple constructs including patient’s perceived recovery, TMD related 
disability and functional limitations, neck disability, fear of movement, and pain rating.  These 
instruments are commonly utilized in practice and/or research.   
Other measurements for cervical ROM, jaw ROM, and PPT were taken by an assessor 
blinded to treatment group allocation.  The timing of data collection for the self-report and 
outcome measures is listed below in Table 3.2.  See Appendix 7 for copies of all Self-report 
Measures. 
TABLE 3.2 TIMING OF DATA COLLECTION 
 
Measurement 
 
Baseline 
 
Immediate 
 
1 week 
 
2 weeks 
 
4 weeks 
ROM Jaw Yes Yes Yes No Yes 
NPRS Yes Yes Yes No Yes 
JFLS Yes No Yes No Yes 
NDI Yes No Yes No Yes 
TMD Disability Index Yes No Yes No Yes 
GROC No Yes Yes No Yes 
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PASS No No No No Yes 
TSK-TMD Yes No No No Yes 
ROM Cervical Spine Yes Yes Yes No Yes 
Pressure Pain Threshold Yes Yes Yes No Yes 
PHQ-2 Depression Screen Yes No No No No 
Side Effect Questionnaire No No No No Yes 
Abbreviations: ROM, range of motion; NPRS, Numeric Pain Rating Scale; JFLS, Jaw Functional 
Limitation Scale; TMD, temporomandibular disorder; GROC, Global Rating of Change; PASS, 
Patient Acceptable Symptom State; TSK-TMD, Tampa Scale of Kinesiophobia for 
Temporomandibular Disorders; PHQ-2, Patient Health Quetionnaire-2.  
 
AROM of the Jaw 
A disposable tool (TheraBite ROM scale) was utilized to measure seated MMO and supine 
lateral deviation.  Mouth opening is an essential function of chewing and speech and often a 
limitation in those with jaw or neck pain.9,161  Normal mouth opening has been reported in large 
ranges in the literature, however, 40-557,9,187 mm is generally accepted.  Without control for 
cervical head position, 42-68 mm is a normal range for males and 40-57 mm for females.190,191  
Measurement of MMO has shown excellent interrater reliability.  Lobbezoo192 et al report 
Pearson r = .86 (.82-.90).  Kropmans193 et al report that both interrater and intrarater reliability 
data in their study show Pearson r values range from .90-.96; however, these authors do not 
provide point estimates of findings.  Walker187 et al report intrarater and interrater reliability of 
TMJ ROM using interclass correlation coefficient (ICC).  For mouth opening, intrarater 
reliability was excellent, ICC (3,1) = 0.94, for both of their raters in those with TMJ disorder.  
The numbers were lower (adequate to excellent respectively) in those without TMJ with ICC 
(3,1) reported at 0.77 and 0.89 for each rater.  Intrarater reliability ICC (2,k) = 0.99 in those with 
TMJ disorder and 0.98 in those without TMJ disorder.187  Minimal detectable change (MDC) 
ranges from 1.73-6 mm.190,193,194  Minimal clinically important difference (MCID) has not been 
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established.   While norms have been established, comparison to normal values is not as useful as 
comparison or change within an individual.7  Participants in this study were told to sit up tall and 
open as far as possible without pain.69,187  Measurement of the distance between maxillary and 
mandibular central incisor edges was taken using the most vertical incisor (see Figure 1).113 The 
tooth used as the most vertical incisor was recorded on the data collection form for consistency at 
future measurements.  
FIGURE 3.1 MEASUREMENT OF MAXIMAL MOUTH OPENING 
 
 
Lateral deviation of the jaw was measured in supine with the TheraBite.  A measurement is 
taken relative to the resting/starting position to measure mm of displacement between the central 
incisors of the mandible and maxilla.  It can be difficult to stabilize the measurement tool during 
lateral deviation, making consistency with this measurement challenging.7  Clinical experience 
led the PI to choose the supine position to improve consistency as much as possible (See Figure 
3.2).  Normal lateral deviation is approximately 10 mm of motion in each direction for adults.7   
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FIGURE 3.2 MEASUREMENT OF LATERAL DEVIATION 
 
 
Numeric Pain Rating Scale (NPRS) 
The NPRS allows patients to quantify their pain on an 11-point scale used to measure pain 
intensity.  Pain is given a number from 0 (representing no pain) to 10 (representing the worst 
pain imaginable).195  Psychometric property analysis relevant to the TMD population is limited, 
however, the scale has been suggested for use in the TMD population.7,42  One study looking at 
NPRS in the TMD population reported fair reliability (0.36 Kappa).196 Sum scores have been 
suggested to improve reliability,165 and were utilized for this study.  Participants were asked to 
rate their current pain as well as the best and worst pain scores over the last 24 hours resulting in 
an average pain score165,197 that was recorded for jaw pain, neck pain, and headache.  A sum 
score NPRS has demonstrated responsiveness with a MCID of 1.3 in a neck pain population198 
and 2.17 in a shoulder pain (surgical and non-surgical) population.199 Another study of patients 
with cervical radiculopathy demonstrated MCID of 2.2 on the NPRS, however, this number was 
lower than the 4.1 change found for MDC.200 This study did not utilize the sum score for NPRS.  
A study of a large heterogeneous chronic pain population revealed an average change of 2 points 
60 
 
reflected clinically meaningful change on the NPRS.201 Farrar201 et al examined the NPRS in 
patients with chronic pain reporting a 1.74-point decrease represented clinically meaningful 
change.  Kalamir97,100 et al used ≥ 2 NPRS to define clinically important change in an 
intervention study with a population of TMD participants.  
The NPRS was used in a case series by Calixtre153 et al utilizing cervical mobilization and 
exercise treatment for the TMD population.  Authors report 2 of 14 participants actually started 
with a pain rating of 0 and overall statistically significant changes in NPRS were still observed 
for the group over a 9 week period.153  
Pain Body Diagram 
A pain body diagram is used to record the location and nature of pain by drawing it on a 
human figure.7  There has been an inconsistency in evidence supporting use of a pain diagram in 
diagnosis, however, there is some clinical utility in localizing areas of primary complaint.202  
Participants were asked to mark their current pain on a pain body diagram.  
Jaw Functional Limitation Scale (JFLS) 
The JFLS is a 20 item self-report scale assessing three constructs (mastication, vertical jaw 
movement, emotional/verbal expression) to quantify functional limitation.203  Each item is scored 
by the patient from 0 (no limitation) to 10 (severe limitation).  The recorded score is the total 
score of the 20 items; higher scores represent increased level of disability.  An 8-item version has 
also been introduced, but this study will utilize the 20-item version, as this version was suggested 
for study of intervention effects.189  Excellent internal reliability (Alpha 0.95)189 and temporal 
stability (Alpha 0.87)204 have been seen in the TMD population with the 20-item JFLS.  Content 
validity was supported using expert clinicians in a qualitative review.189,203 Construct validity 
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(discriminate and convergent)204 has been supported in literature with low correlation (0.02-0.26) 
seen between JFLS and depression, anxiety, and somatization, and moderate correlation (0.49-
0.57) with pain and jaw symptoms.204  A floor effect, or score of 0 on all responses, was only 
reported in 7% of subjects and fewer than 3% reported ceiling effects.204  While no MCID has 
been established, moderate to large effect sizes have been documented for treatments (d = 0.41-
0.92).106,204  The psychometric properties mentioned are based on 2 articles; further support is 
needed.     
Neck Disability Index (NDI) 
The NDI is a 10 question self-report scale assessing levels of neck pain and related disability.  
NDI is highly responsive205 and has previously shown test-retest reliability, as well as content 
and construct validity in a neck pain population.200 Each item is scored from 0-5 with a 
maximum score of 50 points.  The total score is doubled and interpreted as a percentage of 
patient perceived disability.  Higher scores represent increased level of disability.  MDC for NDI 
in a neck pain population has been reported as 5-10.5;206,207 a 10%-21% improvement in 
perceived disability is the minimum change required to demonstrate true change occurred.  
MCID reports range from 5-19; a 10-38% change in perceived disability is clinically meaningful 
change.206 A study of patients with cervical radiculopathy demonstrated MCID of 8.5 (17%) on 
the NDI, however, this number was lower than the 13.4 (26.8%) change found for MDC.200 A 
systematic review published in 2009 reported a score of 5 (10%) for MDC and 7 (14%) for 
MCID.206   
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TMD Disability Index 
The TMD Disability Index is a 10 question self-report scale utilized in research including a 
study of manual therapy for TMD.208  Each item is scored 1-5 with a minimum score of 10 and a 
maximum score of 50.  Higher scores are representative of higher levels of disability.  While this 
scale has been used in clinical practice and published studies of intervention 
effectiveness,58,208,209 there are no reports of psychometric property analysis in the literature.  
Previous use of the TMD Disability Index demonstrated improvement of 21.7 points (43.4%) in 
one study, while another study showed progress in participants with only a 13.9% change in the 
TMD Disability Index.   
Global Rating of Change (GROC) 
The GROC scale asks patients to rate their perception of overall change.  The scale ranges 
from -7 (a very great deal worse) to 0 (about the same), then to +7 (a very great deal better).210,211  
Intermittent descriptors of worsening or improving are assigned values from –1 to –7 and +1 to 
+7 respectively.  The global rating was administered at the follow-up examinations only and 
served as the reference criterion for establishing when a successful outcome occurs.  While not 
specific to the TMD population, face validity (high)212 and test-retest reliability (ICC .90)213 have 
been reported in the literature.  GROC scores have been used to identify those with true change 
in a cervical radiculopathy population noting a change of ≥ +3 in those that had improved and a 
GROC score of -2 to +2 in those who remained unchanged.200  Intervention studies have used a 
GROC score ≥+4 or ≥ +5 to dichotomize successful outcome.154,156,214,215  A score of +4 or +5 
has been used to define moderate change, while +6 and +7 represent large change.211  A 3 point 
change from baseline on GROC has been used to define MCID.211    
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Patient Acceptable Symptom State (PASS) 
The PASS is a single question asking patients if their current status is acceptable or 
unacceptable.216  Some authors have noted patients who found their current state acceptable often 
had “unexpectedly high”217,218 pain ratings.  The PASS demonstrated high reliability (K=.86) in 
stable patients with ankylosing spondylitis,219 but has not been tested in a TMD population. The 
use of this tool allows for a better understanding of the participant’s perception of their well-
being218 and may suggest they are unlikely to seek further treatment.220  
Wording was modeled after Mintken221 et al in 2016; “Taking into account all the activities 
you have during your daily life, your level of pain, and also your functional impairment, do you 
consider that your current state is satisfactory?”221  Individuals responded yes or no; those 
responding yes were categorized as a success. 
Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD) 
TSK-TMD is a self-report scale modified from the original Tampa Scale for Kinesiophobia 
utilized to assess fear of movement commonly associated with chronic pain conditions including 
neck and back pain.222  It is a 12-item measure assessing fear of movement/(re)injury.  Patients 
rate each item on a 4-point Likert scale and total scores range from 11-48.  Higher scores 
represent higher levels of fear.  The TSK-TMD has demonstrated both internal consistency and 
good reliability (ICC 0.73 for 12-item version)223 in the TMD population.  It is well accepted that 
chronic TMD, along with other chronic pain conditions, are multidimensional.224  Some 
functional limitations in the TMD population have demonstrated a stronger association with fear 
than pain,223 and the association of fear of movement and chronicity of TMD has been 
supported.225  Consideration of the construct of kinesiophobia is important to measure in the 
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TMD population.  MDC and MCID have not been established for the TMD population or use of 
the TMD specific TSK tool.  TSK for other chronic conditions, like low back pain, have 
demonstrated MDC of 5.6226  An examination of over 900 persons with chronic musculoskeletal 
pain disorders helped establish cut off points for severe (43-52), moderate (33-42), mild (23-32), 
and subclinical (13-22) categories of fear using the TSK-13.227  The TMD version has only 12 
questions, therefore care is used with comparisons to these cut points.   
AROM of the Cervical Spine 
The relationship of the cervical spine to TMD has been previously described.  Measurement 
of cervical motion in this study is necessary as it relates to the clinical picture of TMD42 and the 
cervical intervention performed.  A bubble inclinometer was used to measure seated 
flexion/extension, and supine rotation.  Use of an inclinometer has demonstrated good intrarater 
(ICC 0.94) and interrater (ICC 0.84) reliability as well as validity in healthy subjects and those 
with neck pain.228  Statistically significant between-group change in cervical ROM has been 
demonstrated in previous TJM studies, while other studies have revealed no significant between 
group differences.229  A change of ≥ 5º in cervical flexion or extension (within one session) has 
demonstrated predictive value in estimating between session change in motion.230  Fletcher231 et 
al report the standard error of measurement is between 2.5º and 4.1º, and that at least 5º is 
necessary to demonstrate true change.   
Pressure Pain Threshold (PPT) 
PPT is defined as the minimum amount of pressure needed to cause a sensation of pain and is 
a quantifiable palpatory assessment.232  A digital algometer was used to assess PPT at the 
masseter, temporalis, and a remote location in the C8 dermatome at the hand.  Masticatory 
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muscle anatomical standards for PPT were modeled after La Touche23 et al and Heredia-Rizo99 et 
al and included 1 point on the masseter and 1 on the anterior temporalis.  The first dorsal 
interossei represents a remote site (ulnar nerve innervation, C8/T1), distant to the dermatomal 
site of interest (C0-3).233,234 Reduced thresholds have been seen in distant sites as well as 
contralateral locations with chronic TMD conditions, leaving speculation of the role of central 
sensitization.149,235,236  Previous studies examined facial and cervical musculature and the lateral 
epicondyle;149 this study will examine a more distal location innervated by lower cervical nerve 
roots.  Previous studies have indicated the first dorsal interosseous PPT is reliable (ICC, 0.91).234  
Assessment location is described as the midpoint of the muscle belly.234,237   
A stencil was created to standardize measurement for PPT of the masticatory muscles (Figure 
3.3).  A mean of 3 trials was used for each site tested with a 10 second pause between testings.148  
One hand applied the load through the algometer while the other hand provided a counterforce 
on the head to prevent movement.  Upon beginning the test, the patient was asked to sit upright 
with the lips together and teeth apart.  The algometer was applied perpendicular to the region of 
interest, and the patient was asked to tell the examiner when the sensation of pressure turned to 
pain.99,233 
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FIGURE 3.3 STENCIL PLACEMENT FOR MASTICATORY MUSCLE PPT 
 
Masseter 
 
 
Temporalis 
 
 
Locations: (MSOP images included in Appendix F) 
a. Masseter 1 (M1): 2.5 cm anterior and 1.5 cm below the tragus23,99 
b. Temporalis 1 (T1): 3 cm above an imaginary line drawn between the edge of the lateral 
eye and the superior external ear and 2 cm posterior to the anterior edge of the temporalis 
muscle23,99 
c. Dorsal interossei (DI): Forearm pronated and resting on solid surface, applied at middle 
medial aspect of first metacarpal (MC)1 
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Pain thresholds are lower in persons with TMD,133 however, the OPPERA analysis 
concluded the lower threshold was not a predictor of onset of symptoms, but instead a 
repercussion.46  Increases in PPT are generally seen as pain and function improve, with increase 
noted in masticatory muscles in intervention studies for those with TMD, myofascial facial pain, 
and neck pain.22,23,153,238  Adequate to excellent intrarater reliability (ICC 0.69-0.92) has been 
reported for PPT of the temple and parietal region in healthy adults.239  Adequate interrater 
reliability was demonstrated for PPT in the TMD population with ICC values of .64.148  Two 
studies have reported MCID values of ≥1.10 kg/cm2, however, it is important to note these were 
performed on healthy participants.237,240  While no specific MCID has been established for PPT 
in the TMD population, moderate to large effect sizes have been seen in PPT change with 
cervical mobilization for TMD pain.22,23,153  Voogt241 et al performed a systematic review finding 
8 of 13 articles included reported PPT changes of  ≥15% change in PPT, noting this value had 
been reported by previous authors as a MCID.   
PHQ-2 Depression Screen 
Patient health questionaire-2 (PHQ-2) is a 2-question screen used to identify persons at risk 
for depression.  Previous studies have acknowledged the relationship between anxiety, 
depression, and chronic TMD symptoms while other authors contradict this finding.51  It is 
acknowledged that the potential presence of depression would indicate a need for 
interdisciplinary examination or treatment.  This test is not diagnostic for depression, however is 
recognized as a brief and effective first step.242,243  Any participant who scored ≥3 was referred 
to their primary care physician for follow-up, but was allowed to continue participation in the 
study.   
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Side-Effects Questionnaire 
At visit 4 (week 4), patients completed a questionnaire asking about side effects or adverse 
events associated with their treatment.  See Appendix 7.   
Treatment Interventions 
General Procedure 
Participants were randomized to cervical TJM or sham manipulation groups and received 
this intervention at visit 1, 2, and 3.  Both groups received behavioral education, suboccipital soft 
tissue mobilization, and exercise instruction at the same time intervals.  The final visit did not 
include prescribed treatment, only assessment. 
Group One 
Treatment included suboccipital release (2 minutes), cervical spine TJM (5 minutes or 
less), behavioral modification (10 minutes), and exercise (15 minutes).  Suboccipital release was 
used to allow the patient to gain comfort with manual cervical contact.  Cervical spine TJM was 
performed in supine using a rotational up-slope manipulation at C2/3 and a distraction 
manipulation at C0/1.  Cervical TJM was performed on the right and left side and followed 
common research practice154 to include delivery of a high-velocity, low amplitude (HVLA) 
thrust.  If cavitation occurred on the first trial, the therapist moved to the next location.  If there 
was no cavitation, the participant was repositioned, and the procedure was performed a second 
time.  A maximum of 2 trials at each level on each side were performed yielding 4-8 HVLA 
thrusts.  See Appendix 9 for handouts that were issued describing behavioral modification and 
exercise.   
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Group Two 
Treatment included suboccipital release (2 minutes), sham manipulation (5 minutes or 
less), behavioral modification (10 minutes) standardized as described above, and exercise (15 
minutes) standardized as described above.  Sham manipulation was performed in a similar supine 
position as noted above.  Clinicians placed the participant in the manipulation position, stopping 
short of tissue tension, held for 15 seconds,150 and repositioned to neutral or resting 
position.175,244,245  A thrust was not performed and while cavitation could occur, it was rare and 
there was no expectation of cavitation.  The participants in the sham group received 4 manual 
sham manipulation techniques, 1 at each of 4 locations. 
Verbal instruction for cervical intervention was modeled after the cervical spine 
mobilization versus sham mobilization study by La Touche23 et al in 2013.  Therapists gave all 
participants the same verbal description, regardless of group assignment.  Therapists said “I am 
going to apply a technique to your neck with my hands placed here.  The purpose of this 
technique is to obtain change in your jaw and/or neck pain.”23 
Specific Interventions: Suboccipital Release 
The patient was positioned supine for comfort.  The therapist placed both hands on the 
posterior aspect of the neck, allowing the fingertips to sink into the space between the occiput 
and the spinous process of C2.  The base of the head was supported with approximately 90º of 
flexion at the metacarpophalangeal (MCP) joints of fingers 2-4 on both hands (Figure 3.4).246  
The therapist allowed slight traction cranially.  This technique was performed for 2 minutes69 in 
all participants at each treatment session. 
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FIGURE 3.4 SUBOCCIPITAL RELEASE 
 
 
Specific Interventions: C0/1 Distraction Thrust Joint Manipulation 
The patient was positioned supine without a pillow.  For C0/1 distraction TJM on the 
right side, the therapist would passively side-bend the head and neck to the right and rotate to the 
left.  The first MCP joint of the right hand contacts the right mastoid process.  The therapist 
passively moves the occiput into slight extension while maintaining left rotation.  Slight traction 
is performed, and the right hand will direct the force of the TJM in a cranial direction, 
perpendicular to the surface of the right atlanto-occipital (C0/1) joint, with a gentle rotatory force 
(Figure 3.5).69,247  The patient will be told to inhale and TJM will be performed after exhalation.  
This procedure will be repeated to the other side.  
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FIGURE 3.5 C0/1 DISTRACTION THRUST JOINT MANIPULATION 
 
 
 
Specific Interventions: C2/3 Upslope Thrust Joint Manipulation 
The patient was positioned supine for comfort.  For C2/3 upslope TJM on the right side, 
the therapist used a cradle hold contacting the posterior right articular pillar of C2 with the lateral 
border of the proximal or middle phalanx.  The left hand was under the head with the fingers 
spread out to maximize contact.  The therapist passively moved the head and neck into right 
side-bending and left rotation with no significant degree of flexion or extension.  The right hand 
directed the force of the TJM in a direction upward toward the patient’s left eye (Figure 
3.6).154,247  This procedure was repeated to the other side. 
 
 
 
72 
 
FIGURE 3.6 C2/3 UPSLOPE THRUST JOINT MANIPULATION 
 
 
Specific Interventions: Behavioral Modification 
Behavioral modification is frequently part of pain management programs; as previously 
mentioned, this education is frequently utilized in the TMD population.  All participants in this 
study were issued written instructions at their first visit and these instructions were reviewed by 
the evaluating therapist at each subsequent treatment visit.  See Appendix 9.  Participants were 
informed of modifications they could make daily to help control their pain.  Participants were 
instructed to maintain the “lips together, teeth apart” position as often as possible to aide in 
masticatory muscle relaxation.84  They were also educated to avoid parafunctional habits and 
chewing hard and tough foods.  Suggestions for eating, minimizing stress, and getting a good 
night sleep were also included.9,14,102,103 
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Specific Interventions: Exercise 
The Rocabado 6x6 includes jaw, cervical and postural exercise.  It has been utilized in 
practice and research; 248 while there is minimal evidence to support use, there are no 
comparative exercise studies to date.  Lateral jaw movement training has been suggested in 
research and is utilized in clinical practice.103,249  Lack of coordination with jaw motion has been 
reported in the TMD population as well.56   
Participants in this study were instructed to perform 6 standardized exercises as part of 
their home exercise program (HEP).  See Figure 3.7 and Appendix 9.  They utilized a 
hyperboloid (small silicone material used by some clinicians in TMD practice) between the 
central incisors to perform small ROM lateral jaw movement to address this plane of motion as 
well as coordinative movement.  Participants also performed the following exercises from the 
Rocabado 6x6: resting position of the jaw, controlled opening with tongue placed on the soft 
palate, scapular retraction, and C0/1 self-mobilization.  The final exercise was the 3-finger 
exercise for active cervical spine rotation used in previous examination of individuals with neck 
pain.154,159  
FIGURE 3.7 HOME EXERCISE PROGRAM 
 
 
Resting Position 
 
 
Controlled Opening 
 
Hyperboloid Lateral Jaw 
Movement 
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C0/1 Self-mobilization 
 
 
3 Finger Cervical Rotation 
 
 
Scapular Squeeze 
 
  
 
Treating clinicians fully reviewed this home exercise handout with each participant. 
Clinicians described and demonstrated each exercise, then asked the participant to perform the 
exercise in front of them.  After all exercises had been instructed, the therapist asked the patient 
to demonstrate each exercise again with as few verbal cues as necessary.     
Full Descriptions of Each Visit 
Visit 1:  Baseline and First Treatment 
Informed consent was obtained followed by completion of self-report scales and the 
health record form.  Clinicians reviewed this health record and completed objective evaluation 
excluding measurements taken by the blinded assessor.  The initial goal was to screen for 
inclusion and exclusion criteria to ensure participants were eligible and safe to proceed.  The 
blinded assessor entered the room to measure cervical ROM, jaw ROM, and PPT.  The blinded 
assessor then left the area so that they could not hear or see which treatment group a patient had 
been randomized to.  As noted above, suboccipital release, behavioral education, and exercise 
were standardized and consistent between groups.  The first treatment provided to all participants 
was the suboccipital release/soft tissue work.  Group One (cervical spine TJM group) received 
C0/1 and C2/3 TJMs as described previously.  Group Two (minimal intervention group) received 
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sham manipulation (15 second hold before tissue tension) as described previously.  After 
TJM/sham, all participants received education and instruction in the HEP utilizing the handouts 
for reference.  Participants were given a chart to track compliance with the HEP.  Blinded 
assessors then returned to take immediate response measurements.  Final measurement of self-
report NPRS and GROC were done at the completion of the visit.  
Visit 2: 1-Week 
Self-report scales were issued upon arrival.  Measurements of cervical and jaw ROM and PPT 
were taken by the blinded assessor before intervention.  Assessment included review of 
concerning symptoms, blood pressure and heart rate, and a general screen for nystagmus and 
vertebral artery.  Barring no change in medical history or known contraindications, treatment 
began with 2 minutes of suboccipital release for both groups followed by cervical spine TJM or 
sham.  All participants received review of behavioral education and home exercise instructions. 
Visit 3: 2-Week 
No measurement or self-report scale data was collected on this date.  Assessment 
included review of concerning symptoms, blood pressure and heart rate, and a general screen for 
nystagmus and vertebral artery.  Barring no change in medical history or known 
contraindications, treatment began with 2 minutes of suboccipital release for both groups 
followed by cervical spine TJM or sham.  All participants received review of behavioral 
education and home exercise instructions. 
Visit 4: 4-Week 
No prescribed treatment was performed on this date, only assessment.  Self-report scales 
were issued upon arrival.  Measurements of ROM and PPT were taken by the blinded assessor.  
Clinicians debriefed participants explaining the intent of the research study, group allocation, and 
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potential impact of results.  Continued treatment frequency, duration, and intervention plan were 
at the discretion of the treating clinician.  Referral to another provider (medical, dental, or other) 
was done on this date if needed.   
Sample Size Estimation/Power Analysis 
Sample size estimations were completed before data collection began using G-Power, a 
free online downloadable program.  An F-test family with analysis of variance (ANOVA): 
Repeated measures, within-between interaction protocol was selected.  While it is optimal to 
power sample size estimations around a functional outcome measure, the limited use of 
functional measures in this population created an obstacle.  One study by Mulla106 et al utilized 
JFLS to assess differences between conventional PT (not well described) and the Rocabado 
exercise program with temporomandibular mobilization.  The between group effect size reported 
for JFLS was d = 0.55.106  Another study by Cuccia152 et al utilizes an index that rates disability, 
however, this index is time consuming and not clinically applicable.  In general, studies utilizing 
functional outcome tools had small sample sizes and/or large effect sizes, yielding smaller 
sample size estimations for this research project.   
Examination of effect sizes surrounding mouth opening were examined next.  Mouth 
opening is the most frequently reported objective outcome related to TMD and an important 
consideration in temporomandibular function.  Mouth opening effect sizes ranged from d = 0.22 
to 2.08.  PPT is another commonly reported outcome in TMD related research.  An examination 
of this outcome in a relevant study of upper cervical spine mobilization versus sham mobilization 
in TMD patients demonstrates effect sizes ranging from d = 1.040 to 2.129.23   
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One study analyzed 50 participants (25 per group) comparing multimodal intervention of 
cervical spine TJM, myofascial soft tissue work, and muscle energy techniques to oral 
appliances, PT muscle stretching, relaxation exercises, and modalities.152  This study found a 
large effect size (d=1.01) for mouth opening at 6 months favoring the cervical TJM group.  
Another study compared mobilization of the upper cervical spine to sham mobilization following 
patients for 2 weeks.23  Large effect sizes were seen for pain (Visual Analogue Scale) and PPT 
favoring the mobilization group. 
Several studies related to TMD intervention (cervical or other) did not report effect sizes 
but did provide enough information for these to be calculated.  Other studies did not report or 
provide adequate detail to allow for calculation.  Table 4 below summarizes outcomes relevant to 
this study as well as estimates of effect size.  A * indicates the effect size was calculated by the 
PI of this project due to lack of description provided in the article.  The last column represents 
the suggested sample size for this RCT based on calculations. 
TABLE 3.3 REPORTED AND CALCULATED EFFECT SIZE ESTIMATES AND  SAMPLE SIZE ESTIMATIONS 
 
 
 
 
Author 
 
 
 
 
Sample  
 
 
 
Comparison 
Intervention 
 
 
Time of 
Data 
Collection 
 
 
 
 
Outcome 
 
 
 
 
Effect Size 
 
Total 
Sample 
Size 
Estimate 
Heredia-Rizo 24 per group, 
Healthy 
RCT: Soft tissue 
mobilization vs sham 
mobilization 
 
Immediate 
response:  
5 minutes 
PPT, T1 -0.4288* 12  
Cuccia 25 per group, 
TMD dx 
RCT: osteopathic 
multimodal 
intervention (including 
HVLA thrust) to 
neck/jaw vs oral 
appliance, stretching, 
relaxation, and 
modality 
 
6 months 
 
6 months 
 
MMO 
 
VAS 
1.01* 
 
1.41* 
4 
 
4 
LaTouche, 
2013 
16 per group, 
TMD 
RCT: upper cervical 
mobilization vs sham 
mobilization 
2 weeks PPT, M1 -2.13 Right* 
 
-2.05 Left* 
4 
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    VAS 
 
-1.01 to -2.59 4 
Mansilla-
Ferragut 
18 treat, 19 
placebo, 
Primary c/o 
neck pain but 
did have 
limited 
MMO 
RCT: C0/1 
manipulation vs sham 
(contact) manipulation 
Immediate 
response,  
5 minutes 
MMO Authors 
report within 
group  
effect 1.5 
manip and 
0.5 sham 
 
Between 
group effect: 
2.08* 
 
4-10 
Oliveira-
Campelo 
40-42 per 
group, no 
pain or dx 
but + latent 
trigger points 
 
RCT: 3 groups.  C0/1 
manipulation, soft 
tissue mobilization, 
and no intervention 
Immediate 
response 
MMO 
 
PPT, M 
0.22  
 
0.28 
36 
 
24 
Mulla 15 per group, 
TMD  
Rocabado exercise vs 
conventional exercise 
2 weeks Jaw ROM 0.360 16 
    JFLS 0.55 
 
8 
Abbreviations: RCT, randomized controlled trial; PPT, pressure pain threshold; T1, temporalis 1; TMD, 
temporomandibular disorder; dx, diagnosis; HVLA, high velocity low amplitude; MMO, maximal mouth opening; 
VAS, visual analogue scale; M1, masseter 1; C0/1, atlanto-occipital joints; M, masseter; JFLS, Jaw Functional 
Limitation Scale. 
*Hand calculated and confirmed with online software calculating Cohen d (Program: 
http://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-SMD1.php)
 
After completing the above sample size estimations, a decision was made to power 
recruitment around MMO as this most closely relates to function in the TMD population.  The PI 
thought that if a large effect size was seen for MMO, it would be likely that there would be 
enough subjects to adequately power an analysis of functional outcome measures (TMD 
Disability index or JFLS) as well.  Given the limited evidence to consider, a conservative 
decision was made to utilize the effect size yielding the largest sample size requirement even 
though this study examined immediate effects.  Oliveira-Campelo69 et al examined 122 
participants with latent trigger points in the orofacial muscles.  Participants in this study received 
1 of 3 interventions: C0/1 TJM, soft tissue treatment, or no intervention.  The reported effect size 
related to mouth opening was d=.22.  Using the F-test family, a repeated measures within-
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between subject interaction statistical test, alpha .05, and desired power of .8, 36 participants will 
be necessary.  PEDro scale quality assessment states outcomes should be attained for more than 
85% of the subjects initially allocated to groups.250  In order to account for 15% attrition,251,252 
and maintain equal participants in each arm of this study, the desired sample size was 42 
participants.  The initial goal was to enroll 42 participants.  Data was collected by 2 clinicians 
and because of a miscommunication, more participants were enrolled and the final sample size 
was 50 participants.  
Patient Remuneration 
Patient recruitment and full participation are essential to the success of clinical trials.  
Grant funding allowed participant incentives of $50.  If participants were willing to provide 
information including name, date of birth, and social security number, Bradley University mailed 
them a $50 check after the 4-week visit.  If a participant was an employee of Bradley University, 
the controller’s office asked that the money be added to the employee’s direct deposit as opposed 
to sending a separate check.  If a participant was an employee of BU, they were informed of this 
process.  The personal health information necessary for payment is a requirement of Bradley 
University Accounting and Sponsored Programs departments.  Participants interested in 
receiving the $50 stipend received a self-addressed and stamped envelope containing a form to 
collect necessary information.  Participants were instructed to fill out the form and personally 
seal the envelope without providing this information to anyone on the research team or at the 
clinic.  Both the PI and the Director of Bradley University Sponsored Programs worked together 
to ensure integrity of funding.  Participants at UNLV were entered into this study if they did not 
meet eligibility for a cervical spine CPR validation study and wished to participate in this study 
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instead.  UNLV did not allow sharing of any of the necessary PHI; therefore, these participants 
could not receive the incentive.   
Clinician Remuneration 
Treating therapists were required to participate in training to ensure maximal consistency, 
efficiency, and reliability. Training was provided by the PI.   Treating therapists, who were 
considered independent contractors for the project, participated in a 5-hour training session to 
review and standardize evaluation and treatment procedures and will be paid for their time.  The 
treating therapists were paid a stipend of $250 per therapist for the live training and paid for their 
time in completing CITI training.  The treating therapist at UNLV declined compensation.   
Blinded assessors were required for data collection purposes in this study.  The blinded 
assessors were required to participate in a 4-hour training session, provided by the PI, to ensure 
maximal consistency, efficiency, and reliability of measurements for ROM and PPT.  Blinded 
assessors were paid a stipend of $175 for this training.  Blinded assessors traveled to data 
collection locations to take measurements at each data collection point.  The assessors were paid 
on a per-session basis ($40/session for the first visit as it requires 2 measurements and 
$30/session for subsequent visits with only 1 measurement) for the data collection to cover time 
for driving and measurement.  Compensation was declined by assessors at UNLV.  
Risks 
Risks associated with cervical spine TJM are minimal, and the examination and treatment 
procedures utilized in this study are routinely used by physical therapists.  Thrust and non-thrust 
mobilizations are a routine intervention in orthopaedic clinical PT practice and considered an 
entry-level skill.  Under the Illinois and Nevada Physical Therapy Acts, physical therapists are 
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licensed and qualified to perform these techniques.  Recommendations for evaluation and 
screening provided by the International Federation of Orthopaedic Manipulative Physical 
Therapists (IFOMPT)253 were followed to minimize the potential risk.    
It is possible that participants who receive manual therapy to their neck will experience 
mild muscle soreness, fatigue, or headache after the procedure is performed.154,254 However, this 
soreness typically resolves within 1-48 hours after the procedure.154 Risk was minimized by 
training for standardization of evaluation/screening procedures, and utilization of standardized 
cervical spine TJM techniques.  In accordance with CONSORT guidelines,185 side effects and 
adverse events were recorded and are detailed in Chapter 4.  See Appendix 7 for side effect 
record form. 
Age, Gender, and Ethnic Considerations 
Recruitment of participants, clinicians, blind assessors, and research assistants for this 
study will include individuals over the age of 18.  While exclusion criteria was closely monitored 
for safety, no individuals were otherwise excluded based on gender, race, ethnicity, religion, 
national origin, sexual orientation, disability, or health status.   
Informed Consent/Institutional Review Board (IRB) Approval 
 This research project was approved by Bradley University IRB (CUHSR 59-16) and an 
Institutional Authorization Agreement was signed by Nova Southeastern University noting 
Bradley University would be the Designated IRB.  Informed consent was attained by all 
participants prior to participation in the study.  See Appendix 4 for IRB documentation and 
Appendix 5 for the approved Informed Consent. 
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Data Safety Monitoring Plan/ Subject Confidentiality 
 The PI was responsible for educating all clinicians, research assistants, and front office 
staff with RVPT, BU, and UNLV in confidentiality measures and data safety plans.  This 
information was part of the live training and included in the Manuals of Standard Operating 
Procedures.  The PI also periodically checked in (in person or over the phone) with each 
participating clinician, blinded assessor, and clinic office staff member to review procedures and 
monitor recruitment and retention.    
HIPAA training is required and completed by all RVPT clinicians and staff; therefore, 
these individuals are already familiar with protecting confidential information.  Any 
documentation of outcomes was stored in a locked file cabinet at the sites of data collection.  
Only those directly involved in this research project and trained in data safety had access to the 
cabinet.  A case number was assigned to each folder and any electronic sharing of information 
only included the case number.  Personal health information was not shared or transmitted 
electronically.   
Assurance of Data Integrity 
 Folders were issued to participating locations and included standardized forms for 
documenting outcomes.  Self-report measures were included in this folder and marked by visit 
date to ensure they were completed on the correct days.  Individual forms marked with visit date 
were used to record measurements taken by the blinded assessor.  All forms were completed on 
the day of the data collection visit and remained in the locked cabinet. 
 When a participant completed the 4-week visit, the forms in their folder were copied and 
hard copies mailed to the PI.  Once the PI received the hard copies, the clinic would shred copied 
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pages and any remaining documentation of study materials.  All data was entered into a 
computer database to be used for analysis.  Data was entered by a research assistant and verified 
by another research assistant who would double check score totals and all data entry.  Data was 
backed up frequently to a cloud-based storage system.   
Funding and Financial Support for the Study 
Bradley University (BU) employs the PI and provided support of time and supplies for 
research activity. BU also shared existing resources available within the department.   Nova 
Southeastern University gave support in the form of scheduled and unscheduled mentoring of 
preparatory writing, IRB processes, methods and procedures, data analysis, and oral defense.   
Funding was required to support recruitment, training, and adherence to protocol for this 
research project.  The PI received internal grant funding of $10,000 from BU to support a 
summer stipend, participant incentives, clinician and blinded assessor training, blinded assessor 
time for measurements, and supplies (algometers, inclinometers, disposable jaw ROM tools, 
printing and mailing supplies, and hyperboloids to be used for exercise).  The PI also applied for 
additional external funding through the Orthopaedic Section of the American Physical Therapy 
Association (APTA) and the American Academy of Orthopaedic Manual Physical Therapists 
(AAOMPT) Cardon Foundation.  Neither grant application was funded.  Additional funding was 
requested, and the PI did receive a second internal grant from Bradley University’s Education 
and Health Sciences College, for $1,200 as well as $1,000 from an external grant funded by the 
Illinois chapter of the APTA.  In total, $12,200 in grant funding was awarded for this project.  
Both the PI and the Director of Bradley University Sponsored Programs worked together to 
ensure integrity of fund use throughout this project.     
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Summary 
 This chapter outlined the methodology used in this project.  All decisions made in 
planning were thoroughly researched for evidence-based support and discussed with the 
dissertation chair and committee members.  The chapter outlined detail of those contributing to 
the project, training involved, and specific design methods while including information about 
background protection of data and funding.  
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CHAPTER 4: RESULTS 
Introduction 
 This chapter presents results of data analysis for Thrust Joint Manipulation to the 
Cervical Spine in Participants with a Primary Complaint of Temporomandibular Disorder 
(TMD): A Randomized Clinical Trial.  Descriptions of clinicians, blinded assessors, and 
participants are included.  Results of an interrater reliability analysis during training and baseline 
group comparisons are reported.   
All statistical analyses were performed using SPSS version 23 and a significance level of 
α = 0.05.  The primary aim of this dissertation study was to assess group differences at 4-time 
intervals: baseline, immediate response, 1-week, and 4-weeks.  Participants were seen for 4 visits 
(baseline, 1-week, 2-week, and 4-week) and measurements were taken at baseline, immediately 
post treatment, 1-week, and 4-weeks.  The primary outcome of interest was the group*time 
interaction.  Groups were compared over time for pain, range of motion (ROM), pressure pain 
threshold (PPT), neck and jaw function, and fear.  Participants were dichotomized into success 
and non-success using the Global Rating of Change (GROC) and Patient Acceptable Symptom 
State (PASS).  Number needed to treat (NNT) was calculated in statistically significant 
successes.  Reported side-effects of treatment are summarized.   
One secondary aim of the dissertation study included correlations of the following data: 
jaw pain and function with neck pain and function, pressure pain threshold at the jaw and a 
remote site, changes in measured outcomes and functional score changes.  Another secondary 
aim was to examine the functional outcome tools specific to jaw dysfunction: TMD Disability 
Index (TMD-DI) and Jaw Functional Limitation Scale (JFLS).  These outcome tools have been 
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used in temporomandibular disorder (TMD) research but not studied for psychometric property 
analysis within physical therapy.     
Clinicians 
 Four clinicians, including the principal investigator (PI), were trained in evaluation and 
treatment procedures during a 5-hour training session described in Chapter 3.  A Manual of 
Standard Operating Procedures (MSOP) and videos for review were shared with each clinician.  
One clinician did not finish the Collaborative Institutional Training Initiative (CITI) program 
after the live training session; therefore, he did not collect data.  Another clinician was ready and 
able to collect data, however, there were no participants interested in coming to her location.  
Therefore, 2 clinicians participated in data collection.  Both of these clinicians held post-
professional doctorate degrees in physical therapy and were Fellows of American Academy of 
Orthopaedic Manual Physical Therapists (FAAOMPT); both utilize thrust joint manipulation 
(TJM) regularly in both clinical practice and teaching.  One treating clinician, the PI, was female, 
age 39, with 17 years of clinical experience and 4 years teaching experience in a DPT program.  
The other clinician, a 60 year-old male, had 38 years of clinical experience and 18 years teaching 
experience in both a DPT program and continuing education programs for physical therapists.  
Blinded Assessors 
 Eleven blinded assessors were trained in data collection methods and participated in a 
study of interrater reliability during the 5-hour training session described in Chapter 3.  The 
reliability analysis included measurement of PPT at the right masseter, maximal pain-free mouth 
opening (MMO), cervical flexion, and cervical right rotation in 10 participants.  Intraclass 
correlation coefficients (ICC) were assessed for each measurement using two-way random 
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effects and consistent agreement (See Table 4.1).  Results showed excellent agreement for PPT 
and good agreement for other measurements.255   
TABLE 
4.1 
BLINDED ASSESSOR 
 INTERRATER RELIABILITY: 
INTRACLASS CORRELATION COEFFICIENT 
 
Measurement  
 
ICC (2,1) 
 
95% CI 
PPT masseter; right 0.936 0.870-0.979 
MMO 0.620 0.411-0.842 
Cervical flexion 0.675 0.474-0.871 
Cervical rotation; right 0.716 0.525-0.890 
Abbreviations: ICC, intraclass correlation coefficients; PPT, pressure pain 
threshold; MMO, maximal mouth opening. 
 
Blinded assessors were present to measure participants at 3 of the 4 visits (no 
measurements were scheduled at the 2-week visit).  Given 50 total participants, there was a total 
of 150 data collection or measurement visits.  On 3 occasions (3/150, 2% of the measurements), 
there was no blinded assessor available and the treating clinician (PI in all cases) measured and 
recorded the data.  This situation occurred for 3 different participants (2 in the sham group and 1 
in the manipulation group), and only 1 measurement per participant.   
Subjects 
Participant Characteristics  
Data collection began on 10/18/17 and ended on 10/4/18.  A total of 83 participants were 
screened for eligibility; 50 participants met eligibility requirements and noted interest in 
participation.  Participants were treated in one of four locations: Rock Valley Physical Therapy 
(RVPT) in Washington, IL (n=1), RVPT in Peoria, IL (n=8), Bradley University in Peoria, IL 
(n=33), and UNLV in Las Vegas, NV (n=8).   
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A total of 33 participants were excluded for the following reasons: pain <2 on NPRS 
(n=13), cervical manipulation in the last 3 months (n=7), primary pain location was not the jaw 
(n=3), inability to comply with treatment schedule (n=2), concurrent dental (n=3) or PT 
intervention (n=1), contraindications to manipulation (n=3), and age < 18 (n=1).  The 
contraindications to manipulation included a fear of manipulation noted after reading informed 
consent, unexplained neurological findings including facial paresthesia and paresthesia in all 4 
limbs (seeking neurological evaluation concurrently), and facial paralysis due to meningioma.   
All 50 participants were scheduled for 4 visits (200 total visits) and no participants 
dropped out of the study.  Two participants missed a single visit due to illness (2/200, 1% visits 
missed).  One of the missed visits was a 1-week (measurement) and the other was a 2-week (no 
measurement).  Data for the participant who missed a measurement visit were entered using last 
observation carried forward; this was the 1-week visit, therefore the data from baseline were 
carried forward to 1-week.  This participant was present for the third and final measurement 
visit. See Flow Diagram, Figure 4.1.  
Baseline Group Variables  
Demographic information was collected on the Health History Form and during the 
baseline examination.  Forty-three of the participants enrolled were female (43/50, 86%).  All 
participants had myalgia as confirmed by Diagnostic Criteria for Temporomandibular Disorders 
(DC/TMD): pain located in a masticatory muscle, pain with palpation of the masseter and/or 
temporalis, pain with opening, and the patient’s symptoms of pain or primary complaint were 
reproduced with palpation or opening of the mouth.35  Study participants had a mean age of 35.5 
± 13.4 years and mean duration of symptoms for 72.3 ± 84.2 months (6.03 years).  Symptom 
duration ranged from 1 to 360 months; most participants (43/50, 86%) experienced chronic pain 
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of >3-month duration.  In those participants with pain duration ≤ 3 months, 4 were in the thrust 
group and 3 in the sham group.   
Most baseline continuous level data met the assumption of normality with a couple 
violations.  A decision was made to run the parametric independent sample t-test to assess group 
differences at baseline, as this test is robust enough to handle violations of normality.256,257  A 
non-parametric Mann-Whitney U test was also run to ensure the violation did not impact 
statistical significance and the results were unchanged.  A chi-square test was used to examine 
group differences for the categorical variable, gender.  Groups were similar at baseline in all 
characteristics excluding left lateral deviation of the jaw (p = .023); the thrust manipulation 
group had more left lateral deviation than the sham group.  See Table 4.2 for descriptions of the 
entire sample and group baseline differences.   
It should be noted that the PPT values at baseline for the first dorsal interossei in the 8 
participants seen at UNLV were considerably higher than those of other participants.  This trend 
carried forward at subsequent measurement visits.  There were 4 participants in each group 
(sham and thrust joint manipulation) yielding non-significant differences between groups, 
however, the mean and standard deviation (SD) noted below were impacted by this difference.  
While not reported below, another analysis excluding these 8 values was performed, yielding 
mean values around 1.5 to 2.5 kg with much smaller SD (0.78 - 1.5 kg).  Another independent 
samples t-test was run to ensure groups were similar with this data excluded, and the result for all 
PPT values was the same; all p values were non-significant indicating similarity at baseline.  The 
data presented in Table 4.2 below includes all data recorded, including these 8 values. 
  
90 
 
Figure 4.1: Participant Flow Diagram  
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TABLE 4.2 BASELINE DEMOGRAPHICS, SELF-REPORTED VARIABLES, AND CHARACTERISTICS OF PARTICIPANTS BY GROUP° 
 
 
Variable 
 
 
Entire Sample 
 
Thrust Cervical 
Group 
 
Sham Cervical 
Group 
 
 
P Values§ 
Age, y 35.5 ± 13.4 32.2 ± 11.3 38.8 ± 14.8 .082 
Gender (female), n (%) 43 (86) 20 (80) 23 (92) .417¶ 
Duration, mo 72.3 ± 84.2 81 ± 99.2 63.7 ± 67      .475 
TMD Screen Score 3.2 ± 0.6 3.2 ± 0.6 3.2 ± 0.7       .663 
Avg NPRS sum scores     
       Jaw 3.7 ± 1.5 3.7 ± 1.5 3.7 ± 1.5 .924 
       Cervical 3 ± 2.4 2.9 ± 2 3.1 ± 2.7 .783 
       Headache 2.1 ± 1.7 2.2 ± 1.7 2 ± 1.7 .660 
JFLS 47.4 ± 35.5 45.3 ± 30.4 50.2 ± 40.5 .635 
NDI   21.1 ± 12.6 19.4 ± 9.5 22.8 ± 15 .350 
TMDDI 20.7 ± 4.8 20 ± 4.1 21.4 ± 5.4 .298 
TSK-TMD 27.7 ± 5.7 27.3 ± 5.6 28.2 ± 5.8 .606 
BMI 26.2 ± 5.2 25.7 ± 5 26.7 ± 5.5 .497 
Jaw range of motion, mm     
       MMO 37.5 ± 5.9 37.8 ± 5.1 37.2 ± 6.7 .707 
       Lateral deviation; right 7.4 ± 2.7 7.2 ± 2.9 7.5 ± 2.5 .715 
       Lateral deviation; left 8.8 ± 3.5 9.9 ± 3 7.6 ± 3.7 .023* 
Cervical range of motion, deg     
       Flexion 59 ± 12.7 61.7 ± 12.6 56.4 ± 12.5 .140 
       Extension 57.1 ± 13.9 57.7 ± 14.2 56.5 ± 13.8 .764 
       Rotation; right 74.5 ± 12.9 76 ± 9.1 73 ± 15.9 .409 
       Rotation; left 76.5 ± 12.9 76.4 ± 9.5 76.6 ± 14.2 .935 
Pressure pain threshold, kg     
       Masseter; right 1.66 ± 0.85 1.68 ± 0.85 1.65 ± 0.86 .904 
       Masseter; left 1.59 ± 0.88 1.62 ± 0.94 1.56 ± 0.84 .812 
       Temporalis; right 1.92 ± 0.89 1.92 ± 0.89 1.92 ± 0.91 .989 
       Temporalis; left 1.90 ± 0.96 1.94 ± 1.06 1.86 ± 0.86 .779 
       1st dorsal interossei; right 7.03 ± 10.47 7.24 ± 11.32 6.82 ± 9.77 .889 
       1st dorsal interossei; left 6.89 ± 10.40 7.17 ± 11.12 6.61 ± 9.85 .852 
Abbreviation: y, years; mo, months; avg, average; TMD, temporomandibular disorder; NPRS, Numeric Pain Rating 
Scale; JFLS, Jaw Functional Limitation Scale; NDI, Neck Disability Index; TMDDI, Temporomandibular Disability 
Index; TSK-TMD, Tampa Scale for Kinesiophobia for Temporomandibular Disorder; BMI, body mass index; MMO, 
maximal mouth opening, pain free. 
°Values are mean ± SD unless otherwise indicated. 
§Values are independent sample t-test unless otherwise indicated. 
¶Value is a chi-square test and was a non-significant correlation. 
*Statistically significant. 
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Primary Aim: Group Differences 
 A 2 x 4 mixed model analysis of variance (ANOVA) was utilized to compare both 
within-group and between-group changes over the 4 measurements periods for all continuous 
level data.  Treatment group (sham or thrust joint manipulation) was the between-subjects factor 
and time was the within-subjects factor.  Separate ANOVAs were performed for dependent 
variables and the hypothesis of interest was the group by time interaction for each ANOVA and 
subsequent main effects or simple main effects.257,258  A repeated measures ANOVA is robust 
enough to handle violations of normality; however, violations of homogeneity of variance/co-
variance and sphericity are considered more serious.256,257 Decisions made in the presence of 
violations of assumptions are explained.  The assumption of sphericity was frequently violated, 
therefore, the Greenhouse-Geisser correction was utilized for interpretation in those cases.257,258  
Mean, standard deviation (SD) and/or 95% confidence interval (CI), change score, and between 
group change was calculated for each variable and is presented in a chart format below.  Partial 
eta squared (partial ŋ2 ) was provided as a measure of effect size from SPSS and was translated 
into Cohen d in each table below.259   
The assumption of normal distribution of data was completed using Shapiro-Wilk’s test 
and outliers were examined visually on box plots as well as through the use of studentized 
residuals.  If outliers were noted, data records were double checked for mistakes in data entry.  
When outliers remained in the presence of violations of normal distribution, data were 
transformed if there was significant skewness.258  Following standard transformation procedure, 
if data were transformed for one level of a measurement,  transformation occurred across that 
measurement through time and group; all analyses were then run again.257,260  For most of these 
transformations, the results regarding violations of assumptions did not change, with the 
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exception of 2 variables, the Jaw Functional Limitation Scale (JFLS) and Tampa Scale for 
Kinesiophobia for Temporomandibular Disorders (TSK-TMD).  In these cases, interpretation 
was based on transformed data.  If violations remained after transformation, a non-parametric 
analysis was compared.  There is no direct non-parametric alternative to the mixed ANOVA; 
therefore, any non-parametric testing could only look at the within-group change separate from 
the between-group change, unable to capture the interaction effect.258  If no change was noted 
after transformation with or without use of a non-parametric test, the results of the mixed 
ANOVA were reported.  
Independent t-test analysis was used to compare groups in change scores261 for each 
variable and those statistically significant values are reported below in each chart.  If the 
between-group change score was statistically significant and the data violated assumptions, a 
Mann-Whitney U was also run to ensure the violations were not leading to Type I error.257       
Jaw Range of Motion: Maximal Mouth Opening 
 Maximal mouth opening (MMO) was normally distributed across all time intervals and 
group as assessed by Shapiro-Wilk’s test (p > .05).  There were three outliers noted on the box 
plots; however, no outliers, as assessed by examination of studentized residuals for values 
greater than ±3. There was homogeneity of variances, as assessed by Levene’s test of 
homogeneity of variance (p > .05), and homogeneity of covariance, as assessed by Box’s test of 
equality of covariance matrices (p = .019). Mauchly’s test of sphericity indicated that the 
assumption of sphericity was violated for the two-way interaction, x2 (2) = 20.625, p = .001.  
Greenhouse-Geisser correction was utilized for interpretation.  
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 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of maximal pain-free mouth opening, F(2.372,113.869) = 
1.293, p = .28, partial ŋ2 = .026.  While there were no group*time interactions, there were 
statistically significant main effects for time, F(2.372,113.869) = 21.501, p < .001, partial ŋ2 = 
.309.  Maximal mouth opening increased from baseline to each subsequent point in time and 
each change was statistically significant. MMO increased for the sample from 37.52 ± 5.936 mm 
at baseline to 43.96 ± 8.79 mm at the final visit, a statistically significant difference of 6.44 (95% 
CI, 3.73 to 9.15) mm, p < .001.  While both groups started at 37 mm of opening, the final 
measurement was 42.08 ± 0.05 mm for the sham group and 45.84 ± 8.28 mm for the thrust 
manipulation group.  
 The main effect of group showed no statistically significant difference in maximal mouth 
opening between groups F(1,48) = 1.075, p = .305, partial ŋ2 = .022.  Overall, both groups 
showed improvement in mouth opening, however, there were no statistically significant group 
differences to report.  See Figure 4.2 and Table 4.3 for further detail.  
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Jaw Range of Motion: Jaw Lateral Deviation Right  
Jaw lateral deviation right was normally distributed across all time intervals and group as 
assessed by Shapiro-Wilk’s test (p > .05) with the exception of 4-week right deviation in both 
groups. There were multiple outliers in the thrust manipulation group and no outliers noted in the 
sham group on box plots; however, there were no outliers, as assessed by examination of 
studentized residuals for values greater than ±3. There was homogeneity of variances, as 
assessed by Levene’s test of homogeneity of variance (p > .05), and homogeneity of covariance, 
as assessed by Box’s test of equality of covariance matrices (p = .731). Mauchly’s test of 
sphericity indicated that the assumption of sphericity was violated for the two-way interaction, x2 
(2) = 21.707, p = .001.  Greenhouse-Geisser correction was utilized for interpretation.   
There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of right lateral deviation, F(2.266,108.744) = 2.721, p = 
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.063, partial ŋ2 = .054.  While there were no group*time interactions, there were statistically 
significant main effects for time, F(2.266,108.744) = 8.565, p < .001, partial ŋ2 = .151. 
Measurements were 7.52 ± 2.485 mm at baseline, with statistically significant increase to 9.05 ± 
2.591 and 8.92 ±  2.702 mm at immediate post-treatment and 1-week, respectively.   
 The main effect of group showed no statistically significant difference in right lateral 
deviation between groups F(1,48) = 1.698, p = .199, partial ŋ2 = .034.  Right lateral deviation 
improved in both groups over time.  Subsequent analysis looked at mean difference or change 
scores between groups.  An independent t-test showed a statistically significant difference in 
mean change scores between groups for right lateral jaw deviation from baseline to final 
measurement, t(48) =2.11, p = .04, favoring the thrust manipulation group.  See Figure 4.3 and 
Table 4.3 for further detail. 
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Jaw Range of Motion: Jaw Lateral Deviation Left 
Jaw lateral deviation left was normally distributed across all time intervals and group as 
assessed by Shapiro-Wilk’s test (p > .05) with the exception of 1-week left deviation in the thrust 
manipulation group.  There were no outliers as assessed by box plots for this variable, and no 
outliers noted with examination of studentized residuals for values greater than ±3. There was 
homogeneity of variances, as assessed by Levene’s test of homogeneity of variance (p > .05), 
and homogeneity of covariance, as assessed by Box’s test of equality of covariance matrices (p = 
.686). Mauchly’s test of sphericity indicated that the assumption of sphericity was violated for 
the two-way interaction, x2 (2) = 27.442, p = < .001.  Greenhouse-Geisser correction was utilized 
for interpretation.   
There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of jaw deviation left, F(2.280,109.421) = 0.939, p = .404, 
partial ŋ2 = .019.  While there were no group*time interactions, there were statistically 
significant main effects for time.  Statistically significant improvements were seen in left lateral 
deviation, F(2.280,109.421) = 3.542, p = .027, partial ŋ2 = .069.  Left lateral deviation increased 
from 8.76 ± 3.532 mm at baseline to 10.06 ± 3.594 mm at 4-weeks.   
 The main effect of group showed a statistically significant difference in left lateral 
deviation between groups F(1,48) = 5.904, p = .019, partial ŋ2 = .110.  A mean difference of 
1.860 (95% CI .321-3.399) mm was present at 4-weeks and favored the thrust group; however, a 
similar mean difference was present at baseline (statistically significant difference between 
groups).  Overall left lateral deviation improved in both groups over time and greater change was 
seen in the sham group; the thrust manipulation group had more left lateral deviation at baseline 
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and throughout subsequent measurement periods, but there was no statistically significant 
difference between groups. See Figure 4.4 and Table 4.3 for further detail. 
 
 
Table 4.3 JAW RANGE OF MOTION: WITHIN-GROUP AND  BETWEEN-GROUP CHANGE 
 
 
Measurement 
 
Cervical 
Thrust Group* 
 
Cervical 
Sham Group * 
 
Between-Group 
Difference** 
 
 
P value 
 
Effect 
Size 
MMO (mm)    .28^ 0.33 
       Baseline 37.84 ± 5.1 37.2 ± 6.7    
       Immediate 40.88 ± 7.2 38.68 ± 7.8    
       Change from baseline to immediate 3.04 ± 5.4 1.48 ± 3.2 1.56 (-0.9-4.1) .220° 0.35 
       1 wk 41.12 ± 10.0 39.52 ± 7.4    
       Change from baseline to 1 wk 3.28 ± 8.3 2.32 ± 4.6 0.96 (-2.87-4.79) .615° 0.14 
       4 wk 45.84 ± 8.3 42.08 ± 9.0    
       Change from baseline to 4 wk 8.0 ± 7.2 4.88 ± 6.7 3.12 (-0.84-7.08) .12° 0.45 
       Collapsed across time: Baseline to 4 wk    < .001§ 1.34 
Lateral Deviation    .063^ 0.48 
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Right (mm) 
       Baseline 7.24 ± 2.9 7.52 ± 2.5    
       Immediate 9.36 ± 2.7 8.68 ± 2.5    
       Change from baseline to immediate 2.12 ± 2.5 1.16 ± 1.9 0.96 (-0.28-2.20) .128° 0.44 
       1 wk 9.48 ± 3.1 8.36 ± 2.1    
       Change from baseline to 1 wk 2.24 ± 2.7 0.84 ± 2.2 0.70 (0.01-2.79) .050° 0.57 
       4 wk 9.56 ± 3.3 7.80 ± 2.6    
       Change from baseline to 4 wk 2.32 ± 3.8 0.28 ± 2.9 2.04 (0.09-4.0) .040° 0.60 
       Collapsed across time: Baseline to 4 wk    < .001§ 0.84 
Lateral Deviation Left (mm)    .404^ 0.28 
       Baseline 9.88 ± 3.0 7.64 ± 3.7    
       Immediate 10.32 ± 3.2 8.76 ± 3.0    
       Change from baseline to immediate 0.44 ± 2.4 1.12 ± 2.5 -0.68 (-2.08-0.72) .334° -0.28 
       1 wk 10.60 ± 3.1 8.20 ± 2.3    
       Change from baseline to 1 wk 0.72 ± 3.2 0.56 ± 3.5 0.16 (-1.77-2.09) .868° 0.05 
       4 wk 10.68 ± 4.2 9.44 ± 2.9    
       Change from baseline to 4 wk 0.80 ± 3.9 1.80 ± 3.3 -1.00 (-3.04-1.04) .329° -0.28 
       Collapsed across time: Baseline to 4 wk    .027§ 0.54 
Abbreviations: MMO, maximal mouth opening, pain free; wk, week.  
*Values are mean ± SD  
**Values are mean adjusted change scores (95%confidence interval); Change from baseline to 4-week final visit is 
calculated as thrust group minus sham group.   
^Value is two-way mixed ANOVA, interaction effect 
§Value is two-way mixed ANOVA, group main effect 
°Value is dependent samples t-test used to assess between-group differences in adjusted mean change scores  
P values ≤..05 are statistically significant  
 
Numeric Pain Rating Scale: Jaw  
Jaw pain was normally distributed across some intervals as assessed by Shapiro-Wilk’s 
test (p > .05), with the exception of baseline jaw pain in the thrust group, immediate post 
treatment in the jaw (thrust group), 4-week jaw in thrust group.  There were outliers noted in 
both groups via examination of box plots; as assessed by examination of studentized residuals for 
values greater than ±3, there was 1 outlier at 4-week. There was homogeneity of variances, as 
assessed by Levene’s test of homogeneity of variance (p > .05), and homogeneity of covariance, 
as assessed by Box’s test of equality of covariance matrices (p = .190). Mauchly’s test of 
sphericity indicated that the assumption of sphericity was violated for the two-way interaction, x2 
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(2) = 18.177, p = .003.  Greenhouse-Geisser correction was utilized for interpretation. The data 
were transformed (moderate positive skew) for this variable and while no outliers remained, 
there were still 2 points in time when data was not normally distributed.  The subsequent analysis 
of mixed ANOVA showed no change in results or trends of change. Reported values and the 
chart below reflect the non-transformed data.   
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of jaw pain on the Numeric Pain Rating Scale (NPRS), 
F(2.364,113.470) = 2.743, p = .059, partial ŋ2 = .054.  While there were no group*time 
interactions, there were statistically significant main effects for time, F(2.364,113.470) = 13.024, 
p < .000, partial ŋ2 = .213.   
Jaw pain decreased from baseline to each subsequent point in time, and each change was 
statistically significant. There was also a statistically significant change in pain from 1-week to 
4-weeks.  Both groups started out nearly the same on mean pain scores and the thrust 
manipulation group’s NPRS for jaw decreased more in the immediate post-treatment phase than 
the sham group; however, this difference between groups was not statistically significant.  The 
mean difference from baseline to immediate post treatment was 0.733 (95% CI .034-1.432), p = 
.035 and the mean difference from baseline to 4-week was 1.520 (95% CI .894-2.146), p < .001. 
 The main effect of group showed no statistically significant difference in jaw pain 
between groups F(1,48) = 2.069, p = .157, partial ŋ2 = .041.   
 Overall both groups had less jaw pain from baseline to 4-weeks.  The trend showed 
greater reduction in pain at the immediate post treatment visit 1 for the thrust manipulation 
group. Subsequent analysis looked at mean difference or change scores between groups.  An 
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independent t-test showed a statistically significant difference in mean change scores between 
groups for jaw pain from baseline to immediate post treatment, t(48) = -2.205, p = .032 and 
baseline to final visit, t(48) = -2.109, p =.040, favoring the thrust manipulation group.  See 
Figure 4.5 and Table 4.4 for further detail. 
 
Numeric Pain Rating Scale: Cervical 
Neck pain was normally distributed across some intervals as assessed by Shapiro-Wilk’s 
test (p > .05) with the exception of baseline cervical pain in the sham group, immediate post 
treatment in the cervical spine (both groups), and 4-week cervical both groups.  There were 
outliers noted in both groups via examination of box plots; however, there were no outliers noted 
as assessed by examination of studentized residuals for values greater than ±3. There was 
homogeneity of variance at 3 measurement intervals as assessed by Levene’s test of 
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homogeneity of variance (p > .05), however, this assumption was violated at immediate post 
treatment measurement.  The assumption for homogeneity of covariance was met, as assessed by 
Box’s test of equality of covariance matrices (p =.206). Mauchly’s test of sphericity indicated 
that the assumption of sphericity was met for the two-way interaction, x2 (2) = 2.985, p = .702.  
Data were transformed (moderate positive skew) for this variable and after transformation, 
Levene’s was no longer violated and the assumption of homogeneity of variance and covariance 
were both met.  Sphericity was then violated and the Greenhouse-Geisser correction was utilized 
for interpretation; in analyzing these data, there was no change in the outcome or the overall 
trend of scores for each group over time.  Reported values and chart below reflect the non-
transformed data.   
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of neck pain, F(3,144) = 1.773, p = .155, partial ŋ2 = .036.  
While there were no group*time interactions, there were statistically significant main effects for 
time, F(3,144) = 12.585, p < .001, partial ŋ2 = .208.  Statistically significant improvements were 
seen in neck pain at all but 2-time intervals (baseline to 1-week, immediate to 4-week).  Neck 
pain decreased from 2.96 ± 2.36 at baseline to 2.067 ± 2.06 at the final visit.  The mean 
difference for the group in neck pain from baseline to immediately post treatment was 1.180 
(95% CI .581-1.779), p < .001; the mean difference from baseline to visit four was .933 (95% CI 
.279-1.59), p = .002.  While pain did change over time, a good portion of that change appeared to 
occur early.   
 The main effect of group showed no statistically significant difference in neck pain 
between groups F(1,48) = .939 p = .337, partial ŋ2 = .019.  Subsequent analysis looked at mean 
difference or change scores between groups.  An independent t-test showed a statistically 
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significant difference in mean change scores between groups for neck pain from baseline to 
immediate post treatment, t(48) =-2.053, p=.046, favoring the thrust manipulation group. See 
Figure 4.6 and Table 4.4 for further detail. 
 
Numeric Pain Rating Scale: Headache  
Pain related to headache (HA) was normally distributed across some intervals as assessed 
by Shapiro-Wilk’s test (p > .05) with the exception of immediate post treatment HA (both 
groups), 1-week HA in both groups, and 4-week HA both groups.  There was 1 outlier at week 1, 
as assessed by examination of studentized residuals for values greater than ±3.  There was 
homogeneity of variances, as assessed by Levene’s test of homogeneity of variance (p > .05) for 
all values except pain at 4-weeks.  Homogeneity of covariance was met, as assessed by Box’s 
test of equality of covariance matrices (p =  .366). Mauchly’s test of sphericity indicated that the 
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assumption of sphericity was violated for the two-way interaction, x2 (2) = 21.493, p = .001.  
Greenhouse-Geisser correction was utilized for interpretation.  
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of maximal pain-free mouth opening, F(2.386,114.515) = 
.904, p = .423, partial ŋ2 = .018.  While there were no group*time interactions, there were 
statistically significant main effects for time, F(2.386,114.515) = 6.328, p = .001, partial ŋ2 = 
.116.  Statistically significant improvements were seen between baseline and immediately post 
treatment, baseline and 4-week and between 1-week and 4-weeks. HA pain improved 2.12 ± 1.66 
at baseline and 1.27 ± 1.24 at the final 4-week visit.  HA pain was low (NPRS of 2) for both 
groups at baseline.  Headache pain decreased by .780 (95% CI .072-1.48), p = .023 from baseline 
to immediate post treatment.  HA pain for the group decreased by .853 (95% CI .249-1.46), p = 
.002 from baseline to 4-weeks.    
 The main effect of group showed no statistically significant difference in HA pain 
between groups F(1,48) = .102, p = .751, partial ŋ2 = .002.  See Figure 4.7 and Table 4.4 for 
further detail. 
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Table 4.4 PAIN: WITHIN-GROUP AND BETWEEN-GROUP CHANGE 
 
 
Measurement 
 
Cervical 
Thrust Group* 
 
Cervical 
Sham Group * 
 
Between-Group 
Difference** 
 
 
P value 
 
Effect 
Size 
NPRS Jaw    .059^ 0.48 
       Baseline 3.69 ± 1.5 3.73 ± 1.5    
       Immediate 2.4 ± 2.2 3.56 ± 2.3    
       Change from baseline to immediate 1.29 ± 2.1 0.17 ± 1.5 -1.12 (-2.14- -0.10) .032° -0.62 
       1 wk 2.99 ± 1.5 3.15 ± 1.9    
       Change from baseline to 1 wk 0.71 ± 1.4 0.59 ± 1.3 -0.12 (-0.87-0.63) .749° -0.09 
       4 wk 1.69 ± 1.6 2.69 ± 1.9    
       Change from baseline to 4 wk 2 ± 1.7 1.04 ± 1.5 -0.96 (-1.87- -0.04) .040° -0.60 
       Collapsed across time: Baseline to 4 wk    < .001§ 1.04 
NPRS Cervical    .155^ 0.39 
       Baseline 2.87 ± 2.0 3.05 ± 2.7    
       Immediate 1.24 ± 1.3 2.32 ± 2.2    
       Change from baseline to immediate 1.63 ± 1.7 0.73 ± 1.4 -0.89 (-1.77- -0.02) .046° -0.58 
       1 wk 2.64 ± 2.0 2.84 ± 2.4    
       Change from baseline to 1 wk 0.23 ± 1.5 0.21 ± 1.6 -0.01 (-0.9-0.88) .976° -0.01 
       4 wk 1.72 ± 2.0 2.33 ± 2.1    
       Change from baseline to 4 wk 1.15 ± 1.5 0.72 ± 1.8 -0.43 (-1.38-0.53) .374° -0.25 
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       Collapsed across time: Baseline to 4 wk    < .001§ 1.02 
NPRS HA    .423^ 0.27 
       Baseline 2.23 ± 1.7 2.01 ± 1.7    
       Immediate 1.24 ± 1.7 1.44 ± 1.4    
       Change from baseline to immediate 0.99 ± 2.1 0.57 ± 1.5 -0.41 (-0.45-0.62) .425° -0.23 
       1 wk 1.76 ± 1.6 1.73 ± 1.7    
       Change from baseline to 1 wk 0.47 ± 1.2 0.28 ± 1.2 -0.19 (-0.89-0.51) .595° -0.15 
       4 wk 1.03 ± 0.9 1.51 ± 1.5    
       Change from baseline to 4 wk 1.2 ± 1.6 0.51 ± 1.5 -0.69 (-1.58-0.19) .121° -0.45 
       Collapsed across time: Baseline to 4 wk    .001§ 0.72 
Abbreviations: NPRS, numeric pain rating scale; HA, headache; wk, week. 
*Values are mean ± SD  
**Values are mean adjusted change scores (95%confidence interval); Change from baseline to 4-week final visit is 
calculated as thrust group minus sham group.   
^Value is two-way mixed ANOVA, interaction effect 
§Value is two-way mixed ANOVA, group main effect 
°Value is dependent samples t-test used to assess between-group differences in adjusted mean change scores  
P values ≤..05 are statistically significant 
 
Jaw Functional Limitation Scale  
Jaw Functional Limitation Scale (JFLS) was not normally distributed across time 
intervals and group as assessed by Shapiro-Wilk’s test (p > .05); except for 1-week data for the 
sham group.  Box plots showed outliers in both groups.  There was homogeneity of variances, as 
assessed by Levene’s test of homogeneity of variance (p > .005) at baseline and 1-week; 
however, this assumption was violated at 4-weeks.  Because of these violations in assumptions, 
the data were transformed for a moderate positive skew and analyses were run again.  In this 
subsequent analysis, the data did meet the assumption of normal distribution as assessed by 
Shapiro-Wilk test (p > .05) and only one outlier was noted at the 1-week visit in box plots.  The 
assumption of homogeneity of variance was met as interpreted from Levene’s test.  Homogeneity 
of covariance was met, as assessed by Box’s test of equality of covariance matrices (p =.055). 
Mauchly’s test of sphericity indicated that the assumption of sphericity was violated for the two-
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way interaction, x2 (2) = 18.347, p < .001.  Greenhouse-Geisser correction was utilized for 
interpretation.  
 There was a statistically significant interaction between group and time on the 
measurement of JFLS, F(1.511,7572.552) = 4.322, p = .026, partial ŋ2 = .083.  There was no 
statistically significant simple main effect of group on JFLS (F=3.934, p = .053).  For the sham 
group, JFLS showed statistically significant reduction (indicating lower levels of disability) from 
baseline to 4-week visit (M=12.96, p = .019).  For the thrust group, JFLS change was statistically 
significant from baseline to 1 week (M= 12.5, p <.001) and from baseline to 4-weeks (M=.23.4, 
p <.001).  See Figure 4.8 and Table 4.5 for further detail. 
 
Neck Disability Index 
Neck Disability Index (NDI) was normally distributed across time intervals and group as 
assessed by Shapiro-Wilk’s test (p > .05) except for 1-week and 4-week data for the sham group.  
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Box plots showed outliers in both groups: 1 outlier at each time interval, as assessed by 
examination of studentized residuals for values greater than ±3. There was homogeneity of 
variances, as assessed by Levene’s test of homogeneity of variance (p > .005) at baseline and 1-
week; however, this assumption was violated at 4-weeks.  The assumption of homogeneity of 
covariance was met, as assessed by Box’s test of equality of covariance matrices (p = .015). 
Mauchly’s test of sphericity indicated that the assumption of sphericity was violated for the two-
way interaction, x2 (2) = 6.553, p = .038.  Greenhouse-Geisser correction was utilized for 
interpretation.  Data were transformed (moderate positive skew) for this variable.  After 
transformation, normal distribution was found in the sham group, however, the thrust group no 
longer had a normal distribution at 1-week and 4-weeks.  The Box’s test of covariance, Levene’s 
homogeneity of variance, and sphericity assumptions were met with the transformed data; 
however, there was no change in the outcome or the overall trend of scores for each group over 
time.  Reported values and the chart below reflect the non-transformed data. 
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of NDI, F(1.770-84.945) = 1.905, p = .160, partial ŋ2 = 
.038.  While there were no group*time interactions, there were statistically significant main 
effects for time, F(1.770-84.945) = 28.720, p < .001, partial ŋ2 = .374.   
Statistically significant improvements were seen in NDI between baseline and 4-weeks, 
and 1-week and 4-weeks.  NDI scores are lower as the patient function improves.  Scores were 
recorded as percentage of disability; therefore, lower numbers demonstrate less neck related 
disability.  The mean difference in scores from baseline to 4-weeks was -6.660 (95% CI -4.029- -
9.291), p < .001.  Mean difference in scores from 1-week to 4-week was -4.900 (95% CI -2.788- 
-7.012), p < .001.   
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 The main effect of group was not statistically significant in NDI between groups F(1,48) 
= 2.174, p = .147, partial ŋ2 = .043.  For the sample, mean scores were 22.80 % disability ± 
15.033% at baseline and 14.46 % disability ± 11.5% at 4 weeks.  
 The baseline disability scores were 22.8% and 19.4% for the sham and thrust 
manipulation groups, respectively.  Overall both groups showed improved function of the neck 
as measured by NDI over time.  See Figure 4.9 and Table 4.5 for further detail. 
 
TMD Disability Index 
TMD Disability Index (TMD-DI) was normally distributed across time intervals and 
group as assessed by Shapiro-Wilk’s test (p > .05), except for baseline for the thrust 
manipulation group.  Box plots showed outliers in the thrust manipulation group.  1 outlier was 
noted at 4-weeks, as assessed by examination of studentized residuals for values greater than ±3. 
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There was homogeneity of variances, as assessed by Levene’s test of homogeneity of variance (p 
> .005) at baseline; however, this assumption was violated at 1-week and 4-weeks.  The 
assumption of homogeneity of covariance was met, as assessed by Box’s test of equality of 
covariance matrices (p =  .029). Mauchly’s test of sphericity indicated that the assumption of 
sphericity was violated for the two-way interaction, x2 (2) = 10.869, p = .004.  Greenhouse-
Geisser correction was utilized for interpretation.  The data were transformed (moderate positive 
skew) for this variable and there was no change in the outcome or the overall trend of scores for 
each group over time.  After transformation, normal distribution was present in both groups; 
Levene’s showed homogeneity at baseline and 1-week, but not at the 4-week visit; the 
assumption of covariance was met.  Reported values and chart below reflect the non-transformed 
data. 
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of TMD-DI, F(1.658-79.571) = 2.115, p = .136, partial ŋ2 = 
.042.  While there were no group*time interactions, there were statistically significant main 
effects for time, F(1.658-79.571) = 23.447, p < .001, partial ŋ2 = .328.   
Statistically significant improvements in TMD-DI were noted at all time intervals.  TMD-
DI scores lower as the patient function improves.  The mean difference in scores from baseline to 
4-weeks was -3.20 (95% CI -1.802- -4.598), p < .001.  For the group, mean scores were 20.68 ± 
5.439 at baseline and 17.48 ± 5.187 at 4-weeks.  
 The main effect of group was not statistically significant in TMD-DI between groups 
F(1,48) = 3.849, p = .056, partial ŋ2 = .074.  Overall both groups showed improved function of 
the jaw as measured by TMD-DI over time with greater change seen in the thrust manipulation 
group.  See Figure 4.10 and Table 4.5 for further detail. 
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Tampa Scale for Kinesiophobia for Temporomandibular Disorders  
Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD) was 
assessed at baseline and 4-weeks.  Scores were normally distributed across time intervals and 
group as assessed by Shapiro-Wilk’s test (p > .05) except at 4-weeks for the thrust manipulation 
group.  Box plots showed outliers in both groups; however, there were no outliers noted by 
examination of studentized residuals for values greater than ±3. There was homogeneity of 
variances, as assessed by Levene’s test of homogeneity of variance (p > .005) at baseline; 
however, this assumption was violated at 4-weeks.  The assumption of homogeneity of 
covariances was met, as assessed by Box’s test of equality of covariance matrices (p = .133). 
Mauchly’s test of sphericity was not indicated for this variable as there were not 3 or more 
factors for time. The data were transformed (moderate positive skew) for this variable.  After 
transformation, normal distribution was still violated at 4-weeks; however, Levene’s 
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homogeneity of variance was now met and Box’s test of equality of covariance was also met 
(p=.241). 
 There was a statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of fear with the TSK-TMD, F(1,48) = 7.69, p = .008, partial 
ŋ2 = .138.  Lower TSK-TMD scores represent less fear. There was a statistically significant 
simple main effect for group showing difference in fear between groups at 4-weeks, F(1,48 )= 
5.770, p = .020, partial ŋ2 = .107.  There was a statistically significant simple main effect for 
time showing decreased fear over time in the thrust group only, F(1,48) = 16.426, p <.001, 
partial ŋ2 =.843.   
 Overall, both groups showed reduction in fear as measured by TSK-TMD over time with 
greater change seen in the thrust manipulation group. Subsequent analysis looked at mean 
difference or change scores between groups.  An independent t-test showed a statistically 
significant difference in mean change scores between groups for fear from baseline to 4-week 
final visit, t(48) =-2.813, p=.007, favoring the thrust manipulation group.  See Figure 4.11 and 
Table 4.5 for further detail. 
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Table 4.5 SELF-REPORT FUNCTIONAL SCALES: WITHIN-GROUP AND  BETWEEN-GROUP CHANGE 
 
 
Measurement 
 
Cervical 
Thrust Group* 
 
Cervical 
Sham Group * 
 
Between-Group 
Difference** 
 
 
P value 
 
 
Effect Size 
JFLS    .026^ 0.60 
       Baseline 45.32 ± 30.4 50.16 ± 40.5    
       1 wk 32.8 ± 26.8 44.16 ± 34.6    
       Change from baseline to 1 wk 12.52 ± 14.7 6 ± 16.1 -6.52 (-15.39-2.25) .141° -0.42 
       4 wk 21.92 ± 22.9 37.2 ± 31.0    
       Change from baseline to 4 wk 23.4 ± 23.3 12.96 ± 24.6 -10.44 (-24.06-3.18) .130° -0.44 
       Collapsed across time: Baseline to 4 wk    < .001§ 2.24 
NDI    .160^ 0.40 
       Baseline 19.44 ± 9.5 22.8 ± 15.0    
       1 wk 17.28 ± 8.8 21.44 ± 15.0    
       Change from baseline to 1 wk 2.16 ± 6.7 1.36 ± 4.3 -0.8 (-4.03-2.43) .619° -0.14 
       4 wk 11.08 ± 7.3 17.84 ± 13.9    
       Change from baseline to 4 wk 8.36 ± 8.2 4.96 ± 6.7 -3.4 (-7.66-0.86) .115° -0.45 
       Collapsed across time: Baseline to 4 wk    < .001§ 1.55 
TMDDI    .136^ 0.42 
       Baseline 19.96 ± 4.1 21.4 ± 5.4    
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       1 wk 17.96 ± 3.4 20.28 ± 4.9    
       Change from baseline to 1 wk 2 ± 3.3 1.12 ± 2.4 -0.88 (-2.51-0.75) .282° -0.31 
       4 wk 15.8 ± 3.5 19.16 ± 6.1    
       Change from baseline to 4 wk 4.16 ± 4.7 2.24 ± 3.1 -1.92 (-4.19-0.35) .095° -0.48 
       Collapsed across time: Baseline to 4 wk    < .001§ 1.40 
TSK-TMD    .008^ 0.80 
       Baseline 27.32 ± 5.6 28.16 ± 5.8    
       4 wk 23.12 ± 6.2 27.48 ± 6.7    
       Change from baseline to 4 wk 4.2 ± 5.1 0.68 ± 3.6 -3.52 (-6.04- -1.0) .007° -0.80 
       Collapsed across time: Baseline to 4 wk    < .001§ 1.11 
Abbreviations: JFLS, Jaw Functional Limitation Scale; wk, week; NDI, Neck Disability Index; TMDDI, 
Temporomandibular Disorder Disability Index; TSK-TMD, The Tampa Scale for Kinesiophobia for Temporomandibular 
Disorders. 
*Values are mean ± SD  
**Values are mean adjusted change scores (95%confidence interval); Change from baseline to 4-week final visit is 
calculated as thrust group minus sham group.   
^Value is two-way mixed ANOVA, interaction effect 
§Value is two-way mixed ANOVA, group main effect 
°Value is dependent samples t-test used to assess between-group differences in adjusted mean change scores  
P values ≤..05 are statistically significant 
 
Cervical Spine ROM: Flexion 
Cervical flexion was normally distributed across all time intervals and group as assessed 
by Shapiro-Wilk’s test (p > .05) with the exception of the 4-week visit in the sham group.  
Outliers were noted in both groups via box plots; there were no outliers, as assessed by 
examination of studentized residuals for values greater than ±3 with the exception of 1 value at 
4-weeks. There was homogeneity of variances, as assessed by Levene’s test of homogeneity of 
variance (p > .05) and homogeneity of covariance, as assessed by Box’s test of equality of 
covariance matrices (p =  .369). Mauchly’s test of sphericity indicated that the assumption of 
sphericity was violated for the two-way interaction, x2 (2) = 14.110, p = .015.  Greenhouse-
Geisser correction was utilized for interpretation.  
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of cervical flexion ROM, F(2.608,125.186) = .052, p = 
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.975, partial ŋ2 = .001.  While there were no group*time interactions, there were statistically 
significant main effects for time.  Statistically significant improvements were seen in cervical 
flexion, F(2.608,125.186) = 5.512, p = .002, partial ŋ2 = .103.  Cervical flexion ROM increased 
from baseline to 4-week and from 1-week to 4-week.   Cervical flexion for the group was 59.02º  
± 12.493º at baseline, increasing to 63.98º ± 10.869º at the final visit, a statistically significant 
difference of 4.960º (95% CI, 1.138-3.938), p = .005.  
 The main effect of group showed no statistically significant difference in cervical flexion 
ROM between groups F(1,48) = 3.577, p = .065, partial ŋ2 = .069.  Overall, both groups 
improved in cervical flexion in a similar pattern as noted below.  See Figure 4.12 and Table 4.6 
for further detail. 
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Cervical Spine ROM: Extension 
Cervical extension was normally distributed across all time intervals and group as 
assessed by Shapiro-Wilk’s test (p > .05) with the exception of 4-week data in both groups.  A 
single outlier was noted in the sham group at 1-week via box plots; there were no outliers, as 
assessed by examination of studentized residuals for values greater than ±3. There was 
homogeneity of variances, as assessed by Levene’s test of homogeneity of variance (p > .05) and 
homogeneity of covariance, as assessed by Box’s test of equality of covariance matrices (p =  
.980). Mauchly’s test of sphericity indicated that the assumption of sphericity was violated for 
the two-way interaction, x2 (2) = 11.146, p = .049.  Greenhouse-Geisser correction was utilized 
for interpretation.  
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of cervical extension ROM, F(2.602,124.877) = .914, p = 
.425, partial ŋ2 = .019.  While there were no group*time interactions, there were statistically 
significant main effects for time, F(2.602,124.877) = 8.116, p < .001, partial ŋ2 = .145.  Cervical 
extension ROM increased from baseline to immediate post treatment and from baseline to 4-
weeks.  Cervical extension was 57.12º  ± 13.9º at baseline, increasing to 62.94º ± 13.564º at the 
immediate post treatment and 62.80º ± 12.204º at 4-weeks.  As the change was seen immediately 
and maintained to the end, the mean difference of baseline to immediate post treatment at 1-week 
is the most relevant data.  There was a statistically significant difference of 5.680º (95% CI, 
1.758-9.602), p = .001. 
 The main effect of group showed no statistically significant difference in cervical 
extension ROM between groups F(1,48) = .772, p = .384, partial ŋ2 = .016.  Overall both groups 
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improved in cervical extension ROM and greater difference in cervical extension was seen in the 
thrust manipulation group.  See Figure 4.13 and Table 4.6 for further detail. 
 
Cervical Spine ROM: Right Rotation 
Cervical right rotation ROM was normally distributed in the thrust manipulation group 
but not the sham manipulation group across all time intervals as assessed by Shapiro-Wilk’s test 
(p > .05).  Multiple outliers were noted in the sham group via box plots; there was 1 outlier at 
baseline and 1-week and 2 outliers at immediate post treatment and 4-week as assessed by 
examination of studentized residuals for values greater than ±3 . There was homogeneity of 
variances, as assessed by Levene’s test of homogeneity of variance (p > .05) at each time period 
except for the final 4-week visit.  Homogeneity of covariance was met, as assessed by Box’s test 
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of equality of covariance matrices (p =  .067). Mauchly’s test of sphericity indicated that the 
assumption of sphericity was violated for the two-way interaction, x2 (2) = 9.483, p = .091.  
Greenhouse-Geisser correction was utilized for interpretation. Data were transformed (moderate 
negative skew) for this variable, and there was no change in the outcome or the overall trend of 
scores for each group over time.  After transformation, normal distribution was not present in the 
sham group at baseline or visit 2, but had normalized for the other two points in time.  Levene’s 
was still violated at visit 4, but Box’s covariance and sphericity were not violated.  Reported 
values above and the chart below reflect the non-transformed data. 
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of right rotation ROM, F((2.617,125.631) = .1.030, p = 
.375, partial ŋ2 = .021.  While there were no group*time interactions, there were statistically 
significant main effects for time, F(2.617,125.631) = 10.209, p < .001, partial ŋ2 = .175.  Right 
rotation ROM increased from baseline to 4-weeks in both groups, however, the magnitude of 
difference was greater for the thrust group.   Cervical right rotation ROM was 72.96º ± 15.839º at 
baseline in the sham group and 76.00º  ± 9.074º in the thrust group.  The mean difference overall 
from baseline to final measurement was 6.140º (95% CI .2.723-9.557), p < .001.  
 The main effect of group showed no statistically significant difference in right rotation 
ROM between groups F(1,48) = 1.555, p = .218, partial ŋ2 = .031.  Subsequent analysis looked at 
mean difference or change scores between groups.  An independent t-test showed a statistically 
significant difference in mean change scores between groups for right rotation of the cervical 
spine from baseline to immediate post treatment, t(48) =2.604, p = .012 and from baseline to 1-
week, t(48) =2.495, p = .016.  Overall both groups improved in right rotation ROM and greater 
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difference in cervical R rotation was seen in the thrust manipulation group.  See Figure 4.14 and 
Table 4.6 for further detail. 
 
Cervical Spine ROM: Left Rotation 
Cervical left rotation ROM was normally distributed across all time intervals and group 
as assessed by Shapiro-Wilk’s test (p > .05) with the exception of baseline and 4-week data in 
the thrust group.  Multiple outliers were noted in the thrust group via box plots and 2 outliers in 
the sham group; there was 1 outlier at each of the following time periods: baseline, 1-week and 
4-weeks as assessed by examination of studentized residuals for values greater than ±3.  There 
were violations of homogeneity of variances, as assessed by Levene’s test of homogeneity of 
variance (p > .05) at each time period except for baseline.  Homogeneity of covariance was also 
violated, as assessed by Box’s test of equality of covariance matrices (p = .001).  Mauchly’s test 
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of sphericity indicated that the assumption of sphericity was violated for the two-way interaction, 
x2 (2) = 27.840, p < .001.  Greenhouse-Geisser correction was utilized for interpretation.  Data 
were transformed (moderate negative skew) for this variable and there was no change in the 
outcome or the overall trend of scores for each group over time.  After transformation, normal 
distribution was present for both groups at each points in time.   Box’s M test was p=.001, still 
demonstrating violation of the assumption of covariance.  Levene’s was still violated at 2-weeks 
and 4-weeks.  Reported values above and the chart below reflect the non-transformed data. 
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of left rotation ROM, F(2.275,109.212) = .2.562, p = .075, 
partial ŋ2 = .051.  While there were no group*time interactions, there were statistically 
significant main effects for time, F(2.275,109.212) = 7.826, p < .001, partial ŋ2 = .140 with 
change noted from baseline to immediate post treatment and from baseline to 4-week 
measurement. Left rotation ROM increased from baseline to visit 4 in both groups, however, the 
magnitude of difference was greater for the thrust group.  Cervical left rotation ROM was 76.64º 
± 14.23º at baseline in the sham group and 76.36º ± 9.49º in the thrust group.  At the final visit, 
mean left rotation was 80.08º ± 14.151º in the sham group and 84.44º ± 6.862º in the thrust 
group.  The mean difference overall from baseline to final measurement was 5.760º (95% CI 
1.813-9.707), p = .001.   
 The main effect of group showed no statistically significant difference in left rotation 
ROM between groups F(1,48) = 1.666, p = .203, partial ŋ2 = .034.  Overall, both groups 
improved in right rotation ROM and greater difference in cervical right rotation was seen in the 
thrust manipulation group.  See Figure 4.15 and Table 4.6 for further detail. 
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Table 4.6 
CERVICAL SPINE ROM: WITHIN-GROUP AND  
BETWEEN-GROUP CHANGE 
 
 
Measurement 
 
Cervical Thrust 
Group* 
 
Cervical Sham 
Group * 
 
Between-Group 
Difference** 
 
 
P value 
 
Effect 
Size 
Cervical Flexion    .975^ 0.06 
       Baseline 61.68 ± 12.6 56.36 ± 12.5    
       Immediate 63.12 ± 11.6 57.72 ± 13.0    
       Change from baseline to immediate 1.44 ± 5.6 1.36 ± 7.3 0.08 (-3.63-3.79) .966° 0.01 
       1 wk 62.64 ± 13.3 56.36 ± 12.3    
       Change from baseline to 1 week 0.96 ± 11.8 0 ± 6.9 0.96 (-4.57-6.49) .727° 0.10 
       4 wk 66.80 ± 11.8 61.16 ± 9.3    
       Change from baseline to 4 wk 5.12 ± 10.0 4.8 ± 9.8 0.32 (-5.3-5.94) .909° 0.03 
       Collapsed across time: Baseline to 4 wk    .002§ 0.68 
Cervical Extension     .425^ 0.28 
       Baseline 57.72 ± 14.2 56.52 ± 13.8    
       Immediate 64.44 ± 12.8 61.44 ± 14.4    
       Change from baseline to immediate 6.72 ± 7.4 4.92 ± 8.4 1.80 (-2.7-6.3) .425° 0.23 
       1 wk 61.96 ± 14.1 59.56 ± 14.5    
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       Change from baseline to 1 wk 4.24 ± 10.7 3.04 ± 10.1 1.2 (-4.7-7.1) .684° 0.12 
       4 wk 65.56 ± 12.2 60.04 ± 11.8    
       Change from baseline to 4 wk 7.84 ± 10.8 3.52 ± 9.3 4.32 (-1.41-10.05) .136° 0.43 
       Collapsed across time: Baseline to 4 wk    < .001§ 0.82 
Cervical Rotation, right    .375^ 0.29 
       Baseline 76 ± 9.1 72.96 ± 15.8    
       Immediate 78.2 ± 9.7 74.68 ± 16.1    
       Change from baseline to immediate 2.2 ± 5.9 1.72 ± 7.9 0.45 (-3.48-4.44) .808° 0.07 
       1 wk 78.92 ± 8.8 75.84 ± 13.4    
       Change from baseline to 1 wk 2.92 ± 8.6 2.88 ± 7.4 0.04 (-4.52-4.6) .986° < 0.01 
       4 wk 83.84 ± 7.5 77.4 ± 15.2    
       Change from baseline to 4 wk 7.84 ± 9.1 4.44 ± 8.4 3.4 (-1.59-8.39) .177° 0.39 
       Collapsed across time: Baseline to 4 wk    < .001§ 0.92 
Cervical Rotation, left    .075^ 0.46 
       Baseline 76.36 ± 9.5 76.64 ± 14.2    
       Immediate 82.16 ± 8.0 78.08 ± 11.9    
       Change from baseline to immediate 5.8 ± 4.7 1.44 ± 6.9 4.36 (0.99-7.73) .012° 0.74 
       1 wk 82.6 ± 6.1 76.48 ± 14.1    
       Change from baseline to 1 wk 6.24 ± 8.0 0.16 ± 10.0 6.4 (1.23-11.56) .016° 0.71 
       4 wk 84.44 ± 6.9 80.08 ± 14.2    
       Change from baseline to 4 wk 8.08 ± 10.6 3.44 ± 9.6 4.64 (-1.13-10.41) .112° 0.46 
       Collapsed across time: Baseline to 4 wk    < .001§ 0.81 
Abbreviations: ROM, range of motion; wk, week.  
*Values are mean ± SD  
**Values are mean adjusted change scores (95%confidence interval); Change from baseline to 4-week final visit is 
calculated as thrust group minus sham group.   
^Value is two-way mixed ANOVA, interaction effect 
§Value is two-way mixed ANOVA, group main effect 
°Value is dependent samples t-test used to assess between-group differences in adjusted mean change scores  
P values ≤..05 are statistically significant 
 
Pressure Pain Threshold, Temporalis Right (PPT-TR)  
PPT-TR was normally distributed across 3 points and violated normality at 5 points as 
assessed by Shapiro-Wilk’s test (p > .05).  Outliers were noted in both groups via box plots; 1 
outlier was noted at baseline and 1 at the immediate post treatment measurement, as assessed by 
examination of studentized residuals for values greater than ±3, with the exception of 1 value at 
the 4-week final visit. There was homogeneity of variances, as assessed by Levene’s test of 
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homogeneity of variance (p > .05), and homogeneity of covariances, as assessed by Box’s test of 
equality of covariance matrices (p =  .299). Mauchly’s test of sphericity indicated that the 
assumption of sphericity was violated for the two-way interaction, x2 (2) = 25.375, p < .001.  
Greenhouse-Geisser correction was utilized for interpretation. Data were transformed (moderate 
positive skew) for this variable and there was no change the outcome or the overall trend of 
scores for each group over time.  Reported values below are on the non-transformed data.   
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of PPT-TR, F(2.150-103.195) = .958, p = .392, partial ŋ2 = 
.020.  While there were no group*time interactions, there were statistically significant main 
effects for time, F(2.150-103.195) = 11.509, p < .001, partial ŋ2 = .193.  A statistically significant 
increase in PPT was noted from each visit to the 4-week final visit.   
 The main effect of group showed no statistically significant difference in PPT-TR 
between groups F(1,48) = .283, p = .597, partial ŋ2 = .006.  PPT-TR increased in both groups 
over time with a trend of greater increase for the thrust manipulation group.  See Figure 4.16 and 
Table 4.7 for further detail. 
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Pressure Pain Threshold, Masseter Right (PPT-MR) 
PPT-MR was not normally distributed across time or group as assessed by Shapiro-
Wilk’s test (p > .05).  Outliers were noted in both groups via box plots; no outliers were noted as 
assessed by examination of studentized residuals for values greater than ±3. There was 
homogeneity of variances, as assessed by Levene’s test of homogeneity of variance (p > .05), 
and homogeneity of covariances, as assessed by Box’s test of equality of covariance matrices (p 
=  .301). Mauchly’s test of sphericity indicated that the assumption of sphericity was violated for 
the two-way interaction, x2 (2) = 28.952, p < .001.  Greenhouse-Geisser correction was utilized 
for interpretation.  I did transform the data (moderate positive skew) for this variable and there 
was no change in the outcome or the overall trend of scores for each group over time.  Reported 
values below are on the non-transformed data.   
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 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of PPT-MR, F(2.085-100.092) = .1.655, p = .195, partial ŋ2 
= .033.  While there were no group*time interactions, there were statistically significant main 
effects for time, F(2.085-100.092) = 12.019, p < .001, partial ŋ2 = .200  A statistically significant 
increase in PPT was noted from baseline to immediate post treatment, from baseline to 4-weeks,  
from immediate post treatment to 4-week, and from 1-week to 4-week.  The largest mean 
difference was seen from baseline to final measurement and was 0.390 kg (95% CI .161-.619 
kg), p <.001.   
 The main effect of group showed no statistically significant difference in PPT-MR 
between groups F(1,48) = .438, p = .511, partial ŋ2 = .009.  Overall, both groups improved in 
PPT-MR with greater improvement noted in the thrust group.  See Figure 4.17 and Table 4.7 for 
further detail. 
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Pressure Pain Threshold, 1st Dorsal Interossei Right (PPT-DIR) 
PPT- DIR was not normally distributed across time or group as assessed by Shapiro-
Wilk’s test (p > .05).  Outliers and extreme outliers were noted in both groups via box plots; 1 
outlier was noted at each period of time as assessed by examination of studentized residuals for 
values greater than ±3. There was homogeneity of variances, as assessed by Levene’s test of 
homogeneity of variance (p > .05) and homogeneity of covariance, as assessed by Box’s test of 
equality of covariance matrices (p =  .025). Mauchly’s test of sphericity indicated that the 
assumption of sphericity was violated for the two-way interaction, x2 (2) = 47.871, p < .001.  
Greenhouse-Geisser correction was utilized for interpretation.  
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of PPT- DIR, F(1.795-86.140) = 2.049, p = .140, partial ŋ2 
= .041.  While there were no group*time interactions, there were statistically significant main 
effects for time, F(1.795-86.140) = 6.118, p = .004, partial ŋ2 = .113  A statistically significant 
increase was noted from baseline to 4-weeks and from immediate post treatment to 4-weeks.  
The largest mean difference was seen from baseline to 4-weeks and was 0.917 kg (95% CI .040-
1.794 kg), p =.036.   
 The main effect of group showed no statistically significant difference in PPT- DIR 
between groups F(1,48) = .103, p = .749, partial ŋ2 = .002.  Overall, both groups improved in 
PPT-DIR with greater improvement noted in the thrust group.  See Figure 4.18 and Table 4.7 for 
further detail. 
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Pressure Pain Threshold, Temporalis Left (PPT-TL) 
PPT-TL was not normally distributed across 4 points and was normally distributed in the 
other 4 as assessed by Shapiro-Wilk’s test (p > .05).  Box plots showed 1 outlier in the thrust 
group and studentized residuals for values greater than ±3 also showed 1 outlier. There was 
homogeneity of variances, as assessed by Levene’s test of homogeneity of variance (p > .05), 
and homogeneity of covariance, as assessed by Box’s test of equality of covariance matrices (p =  
.086). Mauchly’s test of sphericity indicated that the assumption of sphericity was violated for 
the two-way interaction, x2 (2) = 15.848, p = .007.  Greenhouse-Geisser correction was utilized 
for interpretation.  
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of PPT- TL, F(2.442-117.214) = 1.404, p = .249, partial ŋ2 
= .028.  While there were no group*time interactions, there were statistically significant main 
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effects for time, F(2.442-117.214) = 9.873, p < .001, partial ŋ2 = .171.  A statistically significant 
increase in PPT was noted from each baseline to 4-weeks at each interval.  The largest mean 
difference was seen from baseline to 4-weeks and was 0.412 kg (95% CI .150-.674 kg), p =< 
001.   
 The main effect of group showed no statistically significant difference in PPT- TL 
between groups F(1,48) = .964, p = .331, partial ŋ2 = .020.  Overall, both groups improved in 
PPT- TL with greater improvement noted in the thrust group.  See Figure 4.19 and Table 4.7 for 
further detail. 
 
Pressure Pain Threshold, Masseter Left (PPT-ML) 
PPT- ML was not normally distributed across any time or group variable as assessed by 
Shapiro-Wilk’s test (p > .05).  Outliers were noted in both groups via box plots, 1 outlier was 
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noted at baseline and 1-week at immediate post treatment as assessed by examination of 
studentized residuals for values greater than ±3. There was homogeneity of variances, as 
assessed by Levene’s test of homogeneity of variance (p > .05), and homogeneity of covariances, 
as assessed by Box’s test of equality of covariance matrices (p = .012). Mauchly’s test of 
sphericity indicated that the assumption of sphericity was violated for the two-way interaction, x2 
(2) = 26.622, p < .001.  Greenhouse-Geisser correction was utilized for interpretation.  
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of PPT- ML, F(2.150-103.224) = .783, p = .2468, partial ŋ2 
= .016.  While there were no group*time interactions, there were statistically significant main 
effects for time, F(2.150-103.224) = 12.240, p < .001, partial ŋ2 = .203.  A statistically significant 
increase was noted across all time points except immediate post treatment to 1-week follow up.  
The largest mean difference was seen from baseline to 4-weeks and was 0.474 kg (95% CI .223-
.725 kg), p =< 001.   
The main effect of group showed no statistically significant difference in PPT- ML 
between groups F(1,48) = .474, p = .494, partial ŋ2 = .010.  Overall, both groups improved in 
PPT-ML over time.  See Figure 4.20 and Table 4.7 for further detail. 
130 
 
 
Pressure Pain Threshold, 1st Dorsal Interossei Left (PPT-DIL) 
PPT-DIL was not normally distributed across any time or group variable as assessed by 
Shapiro-Wilk’s test (p > .05).  Outliers and extreme outliers were noted in both groups via box 
plots, 1 outlier was noted at each point in time as assessed by examination of studentized 
residuals for values greater than ±3. There was homogeneity of variances, as assessed by 
Levene’s test of homogeneity of variance (p > .05), however, homogeneity of covariances was 
violated, as assessed by Box’s test of equality of covariance matrices (p <  .001). Mauchly’s test 
of sphericity indicated that the assumption of sphericity was violated for the two-way interaction, 
x2 (2) = 31.832, p < .001.  Greenhouse-Geisser correction was utilized for interpretation.  
 There was no statistically significant interaction between the sham or thrust manipulation 
groups and time on the measurement of PPT-DIL, F(2.108-101.203) = .1.735, p = .180, partial ŋ2 
= .035.  While there were no group*time interactions, there were statistically significant main 
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effects for time, F(2.108-101.203) = 5.592, p = .004, partial ŋ2 = .104.  A statistically significant 
increase was noted between immediate post treatment and 1-week and between immediate post 
treatment and 4-weeks. The largest statistically significant mean difference was seen from 
immediate post treatment to 4-weeks and was 0.681 kg (95% CI .050-1.313 kg), p =.028.   
 The main effect of group showed no statistically significant difference in PPT-DIL 
between groups F(1,48) = .118, p = .733, partial ŋ2 = .002.  Overall, both groups improved in 
PPT-DIL over time.  See Figure 4.21 and Table 4.7 for further detail. 
  
CHART 5 PRESSURE PAIN THRESHOLD: WITHIN-GROUP AND  BETWEEN-GROUP CHANGE 
 
 
Measurement 
 
Cervical 
Thrust Group* 
 
Cervical 
Sham Group * 
 
Between-Group 
Difference** 
 
 
P value 
 
Effect 
Size 
Temporalis, right    .392^ 0.29 
       Baseline 1.92 ± 0.9 1.92 ± 0.9    
       Immediate 2.1 ± 1.0 1.94 ± 1.1    
       Change from baseline to immediate 0.18 ± 0.5 0.03 ± 0.4 0.15 (-0.08-0.39) .196° 0.37 
       1 wk 2.09 ± 1.0 1.93 ± 0.9    
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       Change from baseline to 1 wk 0.17 ± 0.6 0.01 ± 0.5 0.16 (-0.16-0.49) .316° 0.29 
       4 wk 2.44 ± 1.1 2.2 ± 1.0    
       Change from baseline to 4 wk 0.52 ± 0.8 0.28 ± 0.5 0.24 (-0.12-0.6) .190° 0.38 
       Collapsed across time: Baseline to 4 wk    < .001§ 0.98 
Temporalis, left    .249^ 0.34 
       Baseline 1.94 ± 1.1 1.86 ± 0.9    
       Immediate 2.14 ± 1.1 1.86 ± 1.0    
       Change from baseline to immediate 0.2 ± 0.5 0 ± 0.4 0.2 (-0.06-0.46) .123° 0.44 
       1 wk 2.24 ± 1.2 1.89 ± 0.9    
       Change from baseline to 1 wk 0.3 ± 0.7 0.03 ± 0.5 0.27 (-0.07-0.62) .120° 0.45 
       4 wk 2.49 ± 1.1 2.13 ± 0.9    
       Change from baseline to 4 wk 0.56 ± 0.8 0.27 ± 0.5 0.29 (-0.1-0.67) .139° 0.43 
       Collapsed across time: Baseline to 4 wk    < .001§ 0.91 
Masseter, right    .195^ 0.37 
       Baseline 1.68 ± 0.9 1.65 ± 0.9    
       Immediate 1/94 ± 1.0 1.72 ± 0.9    
       Change from baseline to immediate 0.26 ± 0.5 0.08 ± 0.3 0.18 (-0.04-10.41) .099° 0.48 
       1 wk 1.91 ± 1.1 1.77 ± 0.8    
       Change from baseline to 1 wk 0.24 ± 0.6 0.13 ± 0.5 0.11 (-0.18-0.4) .454° 0.21 
       4 wk 2.21 ± 1.1 1.9 ± 0.9    
       Change from baseline to 4 wk 0.53 ± 0.7 0.25 ± 0.5 0.28 (-0.05-0.62) .099° 0.48 
       Collapsed across time: Baseline to 4 wk    < .001§ 1.00 
Masseter, left    .247^ 0.25 
       Baseline 1.62 ± 0.9 1.56 ± 0.8    
       Immediate 1.88 ± 1.1 1.67 ± 1.1    
       Change from baseline to immediate 0.26 ± 0.4 0.11 ± 0.4 0.16 (-0.06-0.37) .155° 0.41 
       1 wk 1.96 ± 1.2 1.77 ± 0.9    
       Change from baseline to 1 wk 0.26 ± 0.4 0.11 ± 0.4 0.16 (-0.06-0.37) .155° 0.41 
       4 wk 2.21 ± 1.3 1.91 ± 0.9    
       Change from baseline to 4 wk 0.59 ± 0.7 0.35 ± 0.6 0.24 (-0.13-0.61) .193° 0.37 
       Collapsed across time: Baseline to 4 wk    < .001§ 1.01 
1st Dorsal Interossei, right    .140^ 0.41 
       Baseline 7.24 ± 11.3 6.82 ± 9.8    
       Immediate 7.88 ± 12.8 6.73 ± 10.1    
       Change from baseline to immediate 0.64 ± 1.8 0.09 ± 0.8 0.73 (-0.07-1.53) .072° 0.53 
       1 wk 8.07 ± 12.8 6.98 ± 10.3    
       Change from baseline to 1 wk 0.83 ± 2.1 0.16 ± 1.4 0.67 (-0.33-1.68) .184° 0.38 
       4 wk 8.7 ± 13.6 7.2 ± 10.4    
       Change from baseline to 4 wk 1.45 ± 2.7 0.38 ± 1.6 1.07 (-0.21-2.36) .099° 0.48 
       Collapsed across time: Baseline to 4 wk    .004§ 0.71 
1st Dorsal Interossei, left    .180^ 0.13 
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       Baseline 7.17 ± 11.1 6.61 ± 9.8    
       Immediate 7.73 ± 13.0 6.59 ± 10.0    
       Change from baseline to immediate 0.56 ± 2.2 0.02 ± 0.9 0.58 (-0.4-1.57) .235° 0.34 
       1 wk 8.22 ± 13.4 7.17 ± 10.8    
       Change from baseline to 1 wk 1.05 ± 2.7 0.56 ± 1.4 0.49 (-0.72-1.7) .421° 0.23 
       4 wk 8.73 ± 14.0 6.96 ± 10.6    
       Change from baseline to 4 wk 1.55 ± 3.2 0.34 ± 1.6 1.21 (-0.26-2.68) .103° 0.47 
       Collapsed across time: Baseline to 4 wk    .004§ 0.68 
Abbreviations: wk, week.  
*Values are mean ± SD  
**Values are mean adjusted change scores (95%confidence interval); Change from baseline to 4-week final visit is 
calculated as thrust group minus sham group.   
^Value is two-way mixed ANOVA, interaction effect 
§Value is two-way mixed ANOVA, group main effect 
°Value is dependent samples t-test used to assess between-group differences in adjusted mean change scores  
P values ≤..05 are statistically significant 
 
 
Characteristics of Success 
Global Rating of Change (GROC) and Patient Acceptable Symptom State (PASS) 
Success in this study was dichotomized based on GROC and PASS.  To be considered 
successful, only scores of GROC ≥ +5 were considered.  A “yes” response to PASS was 
considered a success.  In order to determine statistical significance, the percentage of successful 
outcomes at each time interval was examined using chi-square tests of independence.  Chi-square 
allows use of nominal variables and assumes independence of observations.  Another assumption 
of chi-square is that each cell of the frequency comparison has 5 or more; in this analysis, there 
were cells with less than 5 and cells with a frequency of 0.  In those cases, a decision was made 
to run the Fisher’s exact test acknowledging the assumption was not met.  See Figures 4.22 and 
4.23.   
At the immediate post treatment response, there were no participants reporting success on 
GROC in the sham group and 6 in the thrust group; therefore, 100% of the successful outcomes 
at this immediate response were in the thrust manipulation group.  A chi-square tests of 
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independence with Fisher’s Exact test showed a statistically significant association, p = .022 
between the percentage of successful outcomes in each group.   
At 1-week, success on GROC was reported in 1 participant in the sham group and 6 in 
the thrust manipulation group; therefore, 85.7% of the success reported at this visit was in the 
thrust manipulation group. A chi-square test of independence with Fisher’s Exact test shows a 
non-significant association, p = .098. 
At 4-weeks, there were 10 participants reporting success on GROC in the sham group 
and 17 in the thrust group; therefore, 63% of the successful outcomes at this final visit were in 
the thrust manipulation group.  All cells had >5 counts.  A chi-square test of independence 
showed a statistically significant association between group and success, 2(1)=3.945, p = .047 
between the percentage of successful outcomes in each group.   
At 4-weeks, there were 18 participants reporting success on PASS in the sham group and 
23 in the thrust group; therefore, 56% of the successful outcomes at this final visit were in the 
thrust manipulation group.  All cells had >5 counts.  A chi-square test of independence showed a 
no statistically significant association between group and success, 2(1)=3.388, p = .066.   
The percentage of individuals experiencing success on GROC differed statistically at the 
immediate post treatment response and at 4-weeks.  Therefore, success at these 2 points in time 
was used to determine number needed to treat (NNT).  NNT is the number of patients you would 
need to treat in order for 1 to improve or benefit from the treatment.  While NNT does not tell us 
how much they would improve, it is an indication of effectiveness of treatment. The NNT based 
on GROC at immediate response was 4.17 (95% CI 2.5,13.8).  For every 5 patients receiving 
treatment, 1 would get better compared to the control /sham group.  At 4-weeks the NNT is 3.57 
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(95% CI 1.8-67.4). At 4-weeks, 4 patients receiving intervention with thrust manipulation would 
need to be treated for 1 to get better compared to the control/sham group.  While the NNT is 
better at the 4-week interval, caution is used in interpretation due to the large confidence interval.  
FIGURE 4.22 GLOBAL RATING OF CHANGE (GROC) SUCCESS  (+5 OR GREATER) BY GROUP AND TIME 
 
FIGURE 4.23 PATIENT ACCEPTABLE SYMPTOM STATE (PASS)  SUCCESS VS. FAILURE AT 4-WEEKS 
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Secondary Aim 1: Correlations 
Function and Fear 
Previous research has supported a correlation in neck disability and jaw disability.  NDI, 
TMD-DI, JFLS, and TSK-TMD were used to assess neck function, jaw function, and fear in this 
dissertation study.  Spearman’s rank order correlation was used to measure the strength and 
direction of relationship between these outcomes in baseline data of all 50 participants.  A non-
parametric correlation was indicated due to violations of the assumption of a linear relationship, 
noted outliers, and violation of normal distribution of data in the all measures except the TSK-
TMD.  Because a larger score on each of these functional scales represents a greater degree of 
disability, a positive correlation was expected.  There was a statistically significant correlation 
noted among each of the measures.  See Figure 4.24.  
FIGURE 4.24 CORRELATION: FUNCTIONAL SCORES  AND FEAR AT BASELINE 
 
Tests 
 
Spearman rank, r 
 
P value 
 
Interpretation of association257 
JFLS and NDI 0.286 .044 Positive and Fair at best 
JFLS and TMD-DI 0.639 <.001 Positive and moderate to good 
JFLS and TSK-TMD 0.605 <.001 Positive and moderate to good 
NDI and TMD-DI 0.592 <.001 Positive and moderate 
NDI and TSK-TMD 0.571 <.001 Positive and moderate 
TMD-DI and TSK-TMD 0.724 <.001 Positive and good 
Abbreviations: JFLS, Jaw Functional Limitation Scale; NDI, Neck Disability Index; TMD-DI, 
Temporomandibular Disorder Disability Index; TSK-TMD, Tampa Scale of Kinesiophobia. 
 
Pain, ROM, and Function 
Spearman’s rank order correlation was used to measure the strength and direction of 
relationship between NPRS of the jaw and neck, MMO, and functional outcomes for the 50 
participants’ baseline data.  A non-parametric correlation was indicated due to violations of the 
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assumption of a linear relationship, noted outliers, and violation of normal distribution of data in 
the all measures except the TSK-TMD.  Higher pain and function scores represent higher 
disability, while lower MMO scores represent higher dysfunction.  There was a statistically 
significant correlation noted among each of the measures with the exception of jaw pain and 
mouth opening.  See Figure 4.25.  It should be noted that while neck pain and jaw pain had a 
moderate correlation at baseline, this correlation was good at 1-week, rs(48) =0.724, p<.001 and 
4-week analysis, rs(48) = 0.708, p<.001.  Correlations between jaw pain and mouth opening also 
increased over time, but no greater than rs(48) = 0.403, or fair relationship. 
FIGURE 4.25 CORRELATION: PAIN, MMO, AND FUNCTION AT BASELINE 
 
Tests 
 
Spearman rank, r 
 
P value 
 
Interpretation of association257 
Jaw Pain and Neck pain 0.547 < .001 Positive and moderate 
Jaw Pain and MMO -0.153 .289 Negative and little to no relationship 
Jaw Pain and JFLS 0.573 < .001 Positive and moderate 
Jaw Pain and TMD-DI 0.476 < .001 Positive and fair 
Jaw Pain and TSK-TMD 0.435 .002 Positive and fair 
MMO and JFLS -0.391 .005 Negative and fair 
MMO and TMD-DI -0.334 .018 Negative and fair 
MMO and TSK-TMD  -0.317 .025 Negative and fair 
Abbreviations: MMO, maximal mouth opening; JFLS, Jaw Functional Limitation Scale; TMD-DI, 
Temporomandibular Disorder Disability Index; TSK-TMD, Tampa Scale of Kinesiophobia. 
 
Pressure Pain Threshold  
Spearman’s rank order correlation was used to measure the strength and direction of 
relationship between PPT in each location and jaw pain for all 50 participants in baseline data.  A 
non-parametric correlation analysis was indicated due to violations of the assumption of a linear 
relationship, noted outliers, and violation of normal distribution of data in all measures.  
Increased thresholds of pain generally represent improvement.132,140  A statistically significant 
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correlation was noted among each of the PPT measures including masseter, temporalis, and first 
dorsal interossei bilaterally.  There were no statistically significant associations between jaw pain 
and PPT at any location.  See Figure 4.26 
FIGURE 4.26 CORRELATION: PRESSURE PAIN THRESHOLD  AT BASELINE  
 
 
 
Test for Correlation with all 
other PPT measures 
 
Spearman rank, r 
Range for each 
measure 
 
 
 
P value 
 
 
 
Interpretation of association257 
Temporalis Right  0.712-0.903 < .001 for all Positive and good to excellent 
Masseter Right  0.769-0.903 < .001 for all Positive and good to excellent 
1st Dorsal Interossei Right 0.650-0.891 < .001 for all Positive and good to excellent 
Temporalis Left  0..650-0.916 < .001 for all Positive and good to excellent 
Masseter Left  0.823-0.922 < .001 for all Positive and excellent 
1st Dorsal Interossei Left 0.698-0.891 < .001 for all Positive and good to excellent 
 
Secondary Aim 2: Test-Retest Reliability and Construct Validity of JFLS and TMD-DI 
As noted in previous chapters, the TMD-DI is a functional outcome measure used in 
physical therapy research with no evidence to support reliability or validity.  The JFLS has been 
studied in a dental population for reliability and validity, but not within a physical therapy 
population.  Previous research has used GROC to classify patients into groups for the purpose of 
analyzing psychometric properties in outcome measures.198,200,262  In this dissertation study 
analysis, a range of GROC, -2 to +2, was used to define stability or minimal to no change.  If a 
participant is stable, functional outcome scores should be relatively unchanged.  If a participant 
perceives improvement, a change in functional outcome is expected.  Before examination of 
correlations, participants were categorized based on progress at the 1-week and 4-week visit.   
Those reporting GROC -2 to +2 were considered unchanged or stable, and GROC ≥ +4 was 
considered improved.  A GROC of +3 was unclear and not used in analysis.  It should be noted 
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that a GROC of +4 was included in the success group in this analysis as opposed to the more 
stringent stipulation of a GROC of +5 to quantify success for the treatment outcomes.   
It is important to note change over time for the stable and improved groups.  An 
independent t-test was performed to compare only these two groups on change scores for the 
JFLS and TMD-DI.  In order to discuss construct validity, it was hypothesized that the change 
scores of the improved and stable groups would be statistically different.   
Intraclass Correlation Coefficient (ICC) is used to measure reliability of data that has 
been collected as groups and has been used to assess test-retest reliability in this fashion in 
previous research.198,200,262  ICC values represent both correlation and agreement between 
measures;255,257 the agreement and correlation between baseline functional scores and follow-up 
scores were compared.  A two-way (model 2,1) repeated measures assessment was used as all 
participants were fixed and the scores were from a single rating as opposed to a mean.  ICC 
values range from 0-1; the closer to 1, the stronger a relationship.  If an ICC is positive, the 
direction of the relationship is the same: as one score increases, so does the other and vice versa 
for negative correlations.  The degree of agreement will be structured according to Shrout and 
Fleiss: <0.10 indicates no agreement, 0.11-0.40 indicates slight agreement, 0.41-0.60 is fair 
agreement, 0.61-0.80 is moderate agreement, and >0.80 is excellent agreement.263   
Jaw Functional Limitation Scale 
There was homogeneity of variance in each change score variable (stable and improved 
at 1-week and 4-weeks).  There was no statistically significant difference in mean change scores 
on JFLS between improved (n=11) and stable (n=31) patients at 1-week, t(40) = -0.307, p=.761.  
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There was also no statistically significant difference in mean change scores on JFLS between 
improved (n=31) and stable (n=11) patients at 4-weeks, t(40) = -1.929, p = .061.  
The ICC calculated for stable patients at 1-week (n=31) and 4-weeks (n=11) for the JFLS 
were 0.897 (95% CI 0.797-0.949) and 0.949 (95% CI 0.824-0.986) respectively. At both time-
periods, the agreement was excellent.  These correlations were compared to the correlation of the 
improved group.  The ICC calculated for improved patients at 1-week (n=11) and 4-weeks 
(n=31) for the JFLS were 0.790 (95% CI .392-.939) and 0.632 (95% CI 0.363-0.804) 
respectively.   
TMD-Disability Index 
There was homogeneity of variance in each change score variable (stable and improved 
at 1-week and 4-weeks).  There was a statistically significant difference in mean change scores 
on TMD-DI between improved (n=11) and stable (n=31) patients at 1-week, t(40) = -2.513, 
p=.016.  There was also a statistically significant difference in mean change scores on TMD-DI 
between improved (n=31) and stable (n=11) patients at 4-weeks, t(40) = -2.180, p = .035.  
The ICC calculated for stable patients at 1-week and 4-weeks for the TMD-DI were 
0.870 (95% CI 0.748-0.935) and 0.912 (95% CI 0.707-0.975) respectively.  At both time-
periods, the agreement was excellent.  These correlations were compared to the correlation of the 
improved group.  The ICC calculated for improved patients at 1-week (n=11) and 4-weeks 
(n=31) for the TMD-DI were 0.589 (95% CI 0.020-0.870) and 0.408 (95% CI 0.069-0.663) 
respectively. 
 
 
141 
 
Side-Effects 
An adverse event can describe any range of unwarranted or undesirable side-effects from 
treatment.  Adverse events range from mild to severe; severe events can include life threatening 
or life altering situations.  There were no serious adverse events reported in this dissertation 
study.  Mild treatment side-effects are an expected potential consequence of cervical spine 
manual therapy interventions (thrust joint manipulation, non-thrust joint mobilization, or soft 
tissue mobilization).  Treatment side-effects include neck pain, headache, aggravation of present 
complaints, and fatigue.159  Previous research notes up to 50% of participants may have mild 
side-effects that begin within 24 hours of treatment and resolve within 72 hours.177,264  Treatment 
side-effects were tracked in this dissertation study and were considered mild if the intensity of 
symptoms was rated 1 or 2 (1-4 intensity scale) and symptoms resolved within 48 hours.   
Thrust Manipulation Group 
 In the cervical TJM group, 9 out of the 25 participants (36%) experienced treatment side-
effects.  Of those 9 participants, 8 (89%) were mild and only 1 participant (11%) reported 
moderate treatment side-effects.  This participant described a headache (HA) after the baseline 
visit with intensity of 3 on the 1-4 scale; however, it only lasted 2 hours after treatment.  The 
mild treatment side-effects reported in this group included headache, stiffness in neck or jaw, 
fatigue of jaw with exercises, and aggravation of current symptoms. 
Sham Manipulation Group 
In the sham group, 12 out of the 25 participants (48%) experienced treatment side-effects.  
Of those 12 participants, 5 (42%) were mild and 6 (50%) reported moderate treatment side-
effects.  Moderate effects had intensity of symptoms score of 3 to 4 on the 1-4 scale; however, 
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almost all symptoms resolved within 48 hours.  One participant reported severe (intensity of 4 on 
1-4 scale) aggravation of neck pain after the 1-week visit lasting 7 days.  The mild treatment 
side-effects reported in this group included aggravation of present complaints (most frequent), 
jaw discomfort or pain, soreness, neck pain, and tenderness.   
Summary of Results 
 There were no baseline differences between groups except left lateral deviation of the 
jaw.  The mixed model ANOVA revealed significant group by time interaction for JFLS 
indicating both groups had statistically significant simple main effects of time from baseline to 4-
weeks.  The thrust manipulation group also had statistically significant simple main effect of 
time from baseline to 1-week.  A statistically significant interaction was also noted for the TSK-
TMD showing simple main effects of time in the thrust group only and a statistically significant 
simple main effect of group, favoring the thrust manipulation group.  Measurement of variables 
that did not have a statistically significant interaction effect did demonstrate a statistically 
significant main effect of time. 
Change scores examining group differences from baseline to 4-weeks revealed 
statistically significant differences favoring the thrust manipulation group for right lateral 
deviation of the jaw, NPRS of the jaw, NPRS of the neck, TSK-TMD, and cervical right rotation.  
There were no statistically significant change scores favoring the sham group.  
GROC and PASS scores favored the thrust manipulation group with a larger percentage 
of patients reporting success.  Functional outcomes for the jaw, neck, and fear scales did show 
statistically significant correlations of varying strengths.  The strongest positive correlation was 
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between TMD-DI and TSK-TMD.  Jaw pain was moderately correlated to neck pain and JFLS.  
Pressure pain thresholds were all strongly correlated with one another.   
Psychometric analysis of the JFLS and TMD-DI showed moderate to excellent agreement 
of scores in stable participants.  However, there was also moderate correlation in the improved 
group for the JFLS.  The TMD-DI showed only fair agreement in the improved group.  
Statistically significant differences in the change scores between the improved and stable groups 
were only present for the TMD-DI.  
There were no associated adverse events related to this study.  Participants in both groups 
experienced mild treatment side-effects (greater percentage in the sham group) and one 
participant in the sham manipulation group experienced moderate to severe side-effects lasting 7 
days after treatment.   
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CHAPTER 5: DISCUSSION 
Introduction 
Temporomandibular disorder (TMD) is the third most common chronic pain condition,40 
with an estimated 15% of individuals with TMD developing chronic pain.6  Chronic TMD, like 
other chronic pain conditions, can affect quality of life and place an economic burden on 
society.40,53 Effective treatment interventions may have an impact on the economic burden of 
TMD related pain and dysfunction as well as the prevalence of chronicity. The relationship 
between the cervical spine and TMD has been established, yet treatment of the cervical spine for 
TMD has only been examined in a limited fashion.  There is some support for the use of cervical 
thrust joint manipulation (TJM) in individuals with TMD through multimodal intervention 
studies59,152; however, the specific effect of TJM could not be determined due to other 
differences between groups.  Other studies have examined TJM through a randomized design; 
however, the populations studied were children with a history of trauma160 subjects with neck 
pain,68 or subjects with the presence of latent trigger points69 as opposed to jaw pain or 
dysfunction. The primary aim of this dissertation’s randomized controlled trial (RCT) was to 
examine 2 groups treated in similar fashion with randomization of either cervical TJM or sham 
manipulation.  To this author’s knowledge, this is the first study examining the specific impact of 
cervical spine TJM on adults with a primary complaint of TMD.  Chapter 5 will interpret 
findings of group differences and group by time interactions for measured variables.  Cohen’s 
criteria will be utilized to interpret effect size results as follows: 0.2 small, 0.5 moderate, and 0.8 
large effect.265  Discussion of success rates between groups, secondary findings of meaningful 
correlations, and the TMD functional outcome tools used in this analysis will also be presented.  
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Chapter 5 will conclude with acknowledgement of limitations, delimitations, and 
recommendations for future research.  
Primary Aim-Group Differences 
Jaw Range of Motion 
Range of motion (ROM) for mouth opening is the most frequently reported objective 
outcome measure related to TMD; maximal mouth opening (MMO) and lateral deviation ROM 
are important considerations in temporomandibular function.  MMO changes in previous 
research report effect sizes ranging from d = 0.22 to d = 2.08 (see Table 3.3).  Results of this 
dissertation study showed jaw ROM improved in both groups over time for MMO and lateral 
deviation.  The overall change in MMO for the entire sample in this dissertation study (collapsed 
over time) showed a large effect (d = 1.34).  The interaction effect of group and time revealed a 
small effect (d = .33) favoring the TJM group.  While the interaction effect size was small, it 
may have clinical value if participants gain enough ROM to improve function.   
Normal MMO has been reported in large ranges in the literature; however, 40-55 
mm7,9,187 is generally accepted. Both the thrust group and the sham group started with a mean of 
37 mm MMO.  ROM for jaw opening improved in both groups over time with a mean of 45 mm 
in the thrust group and 42 mm in the sham group at the final 4-week visit.  While both groups 
moved into the normal functional range with MMO over time, there was no statistically 
significant group by time interaction for MMO or lateral deviation ROM.  There was a trend for 
improvement in all planes (MMO and deviation) over time for both groups, and these main 
effects were statistically significant.  Looking at the entire sample, 36 participants (72%) had 
final MMO values ≥ 40 mm.   
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Previous research has shown an immediate change in MMO with cervical TJM.  
Mansilla-Ferragut68 et al performed atlanto-occipital TJM or sham manipulation on a group of 
women with neck pain; these authors reported a statistically significant improvement for MMO 
(p < .001) with an increase of 3.5 mm in the thrust group and a 0.3 mm reduction for the sham 
group.  In this dissertation study, immediate post treatment response showed a similar gain of 3 
mm MMO for the thrust group; however, the sham group showed a 1.5 mm improvement.  
Changes from baseline to final measurement were 8 mm in the thrust group and 4.9 mm in the 
sham group.  The minimal detectable change (MDC) is the amount of change needed to improve 
confidence the change is greater than measurement error.  MDC for MMO has been reported to 
range from 1.73-6 mm.190,193,194  Change from baseline to final measurement in the thrust group 
meets the highest reported MDC.  Minimal clinically important difference (MCID) is the change 
in a measurement that is meaningful to the patient.266  MCID has not been established for MMO.  
The sample size estimation in this clinical trial was powered on detecting a significant 
difference for MMO.  As there were no statistically significant interaction effects to report, it is 
possible previous reports of effect size for MMO overestimated the effect, and this dissertation 
study did not include a large enough sample size to show a difference if one exists.  It is also 
possible this dissertation study was adequately powered, and there exists no difference between 
groups.  The participants in the sham group from Mansilla-Ferragut68 et al had a mean reduction 
in opening, but that was not the case in this dissertation study.  Mansilla-Ferragut68 et al did not 
provide any additional treatments, while this dissertation utilized a multimodal treatment 
including education, exercise, soft tissue mobilization (STM) of suboccipitals, and the cervical 
intervention (thrust versus sham).  The addition of these other treatments in the current study 
may have led to smaller differences between groups.  
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Numeric Pain Rating Scale  
Numeric Pain Rating Scale (NPRS) is an 11-point scale used to measure pain intensity.  
In this dissertation study, the NPRS was used for jaw, neck, and headache (HA) pain.  A mean of 
best, worst, and current pain for each location in a 24-hour period was reported.  The minimal 
level of disability set for inclusion in this dissertation was jaw pain ≥ 2 on NPRS.  There was no 
minimal disability set for neck or headache (HA) pain as the population of interest was 
individuals with a primary complaint of TMD.  Neck pain and HA are common complaints 
associated with TMD7,9; however, average pain for the population studied in this dissertation was 
lower than expected.  Average neck pain at baseline was < 2 for 25 participants, and average HA 
pain was < 2 for 23 participants.  Baseline NPRS for neck pain ranged from 0 (n=6) to 9.7 (mean 
= 3.0) in this sample, and baseline HA pain ranged from 0 (n=8) to 6.3 (mean = 2.1).  It is 
possible the low level of baseline neck and HA pain created a floor effect on these variables.  
Between-group effect sizes for neck and HA pain were small; however, a large effect for neck 
pain (d = 1.02) and a moderate effect (d = 0.72) for HA pain was noted for the entire sample 
(collapsed over time).   
Patients with TMD often have neck pain complaints, and some neck pain patients have 
findings of TMD related impairment.  Cervical spine disorders can exacerbate or contribute to 
orofacial pain complaints.47,114  Bevilaqua-Grossi112 et al examined 100 women with TMD, 
noting greater severity of TMD pain was associated with increase prevalence of cervical pain.  
At baseline, the sample in this dissertation study did show moderate correlation (r = 0.547) 
between jaw pain and neck pain, despite the lower baseline levels of pain.   
NPRS of the jaw at baseline was 2 for 13 participants and ≤ 3 for 30 participants.  While 
there was no difference between groups at baseline, perhaps the low initial level of baseline pain 
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had an impact on the potential for change.  Mean NPRS for jaw pain at baseline was 3.7 in each 
group.  Final NPRS was 2.7 in the sham group (change = 1.04) and 1.7 in the thrust group 
(change = 2.0).  Psychometric property analysis of NPRS relevant to the TMD population is 
limited; however, NPRS has demonstrated responsiveness in a neck pain population with a 
MCID of 1.3.198 A study conducted of a large heterogeneous chronic pain population suggested 
an average of 2 points reflected change that was clinically meaningful on the NPRS.201 Farrar201 
et al examined the NPRS in patients with chronic pain, reporting a 1.74-point decrease 
represented clinically meaningful change.  Kalamir97,100 et al defined clinically important change 
in their intervention study with a population of TMD participants as ≥ 2 on NPRS.  Based on 
these reports in literature, it is appropriate to say the thrust group may have achieved a clinically 
meaningful change in jaw pain from baseline to 4-week follow-up.  It is worth noting there was 
little to no association between jaw pain and MMO (r = 0.153).   
The immediate post treatment response for jaw and neck NPRS represents an interesting 
topic of discussion.  The immediate response of jaw pain showed greater change in the thrust 
group.  NPRS for jaw pain decreased to a mean of 2.40 (change = 1.29) in the thrust group and 
3.56 (change = 0.17) in the sham group; the independent t-test was statistically significant for 
between group difference (p = .032) in jaw pain change scores from baseline to immediate post 
treatment, favoring the thrust group.  The independent t-test for change in neck pain was also 
statistically significant (p = .046) favoring the thrust group in the immediate response.  There 
was a moderate effect size favoring the thrust group for both jaw pain (d = 0.62) and neck pain (d 
= 0.58) in change from baseline to immediate post treatment.  Previous studies of cervical TJM 
in a neck pain population report baseline NPRS values of  3.7,159 5.6,173 and 5.3,267 compared to 
a lower baseline in this dissertation sample (NPRS = 3 ± 2.4).  It is possible higher levels of 
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baseline jaw or neck pain could show larger changes.  The trend in this dissertation of greater 
improvement in neck pain for the thrust group was consistent with these previous studies.  In 
previous studies utilizing cervical TJM with TMD populations, neither Mansilla-Ferragut68 nor 
Oliveira-Campelo69 reported pain as an outcome measure, and Cuccia152 et al tested pain at 
baseline but not again until 24 and 36 weeks.  The differences in study design make subsequent 
comparisons difficult.  The immediate post treatment reduction in jaw and neck pain may 
provide a small window of improvement that could be clinically meaningful.  It is possible 
cervical TJM would allow an individual to tolerate exercise or other intervention sooner than 
without the TJM.   
Self-Report Functional Outcome Scales 
The Jaw Functional Limitation Scale (JFLS) is a 20 item self-report scale assessing three 
constructs (mastication, vertical jaw movement, emotional/verbal expression) to quantify 
functional limitation.203  Each item is scored by the patient from 0 (no limitation) to 10 (severe 
limitation); higher scores represent increased level of disability.  JFLS did show a statistically 
significant group by time interaction with a moderate effect size (d = 0.60) favoring the thrust 
group.  A large effect size (d = 2.24) was noted in the main effect collapsed over time.  While no 
MDC or MCID has been established for JFLS, moderate to large effect sizes have been 
documented for dental treatments (d = .41-.92).106,204  In the current dissertation study, a mean 
change of 23.4 was noted in the thrust group and 12.96 in the sham group.  A Global Rating of 
Change (GROC) ≥ +5 was used to dichotomize success in this study.  Further examination of 
change scores for JFLS in all individuals who were considered a success at the 4-week visit 
revealed an average change of 23.8 points.  JFLS has been used in dental literature, but has not 
been reported in physical therapy (PT) literature; however, a cross-sectional study published in 
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October 2017 suggested use of this tool for future research as a measurement of function.268  A 
standardized self-report functional outcome tool is one piece of an assessment of functional 
performance,269 allowing for interpretation of functional level from the patient’s perspective and 
change over time.270  Self-report scales allow readers to discuss effect size of functional change 
and make comparisons across studies.  An applicable functional outcome tool for TMD is needed 
in research and clinical practice.  Examination of JFLS reliability and validity within PT could 
improve confidence in the use of this tool in the future.   
Previous research has supported a strong correlation (r = 0.82, r = 0.95) between jaw 
dysfunction and neck disability in persons with chronic TMD.20,21 Neck Disability Index (NDI) 
is a self-report functional outcome tool frequently used in clinical practice and research 
surrounding a neck pain population.  This 10-question scale generates a total score interpreted as 
a percentage of perceived disability, with higher scores representing greater disability.  While 
there are no reports of MDC or MCID for a TMD population, MDC for NDI in a neck pain 
population has been reported as a 10%-21%;206,207 MCID reports range from 10-38% change in 
perceived disability.206 A systematic review published in 2009 reported a score of 5 (10%) for 
MDC and 7 (14%) for MCID.206  Both groups in this study showed reduction in neck disability 
from baseline to 4-weeks; an 8.36% change in disability was noted in the thrust group and 4.96% 
in the sham group.  The initial baseline disability was 19.44% and 22.80% for the thrust and 
sham groups, respectively.  The low baseline neck disability may have created a floor effect; 
neither group met the minimum 10% disability change needed for MCID.  Further examination 
of change scores for NDI in all participants considered a success (GROC ≥ +5) at the 4-week 
visit, revealed an average change of 8.53% on NDI.   
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 TMD Disability Index (TMD-DI) is a 10 question self-report scale and has been used in 
clinical practice and published studies of intervention effectiveness,58,208,209 yet there are no 
reports of psychometric property analysis in the literature.  Previous use of the TMD-DI 
demonstrated improvement of 43.4% (21.7 points) in one study, while another study showed 
only a 13.9% change in TMD-DI for individuals who demonstrated progress.  In the current 
dissertation study, TMD-DI scores improved in both groups; however, the overall change was 
small.  Scores improved by 15.4% (4.2 points) in the thrust group and 10.5% (2.24 points) in the 
sham group.  A large effect size (d = 1.40) was noted in the main effect collapsed over time.  
This tool is difficult to interpret due to the lack support for reliability and validity and the small 
changes noted in this study.    
The Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD) is a 12-
item measure assessing fear of movement or (re)injury.  TSK-TMD is adapted from the original 
Tampa Scale for Kinesiophobia (TSK) that has been used to assess fear in individuals with low 
back pain (LBP), osteoarthritis, and other chronic pain conditions.223  TSK-TMD did have a 
statistically significant group by time interaction with a moderate to large effect size (d = 0.80) 
favoring the thrust group.  A large effect (d = 1.11) was noted in the main effect collapsed over 
time.  Mean change score in the thrust group was 4.2 and 0.68 in the sham group.  Some 
functional limitations in the TMD population have demonstrated a stronger association with fear 
than pain,223 and the association between fear of movement and chronicity of TMD has been 
supported.225 MDC and MCID have not been established for use of the TMD specific version of 
this tool, making it difficult to compare cut points to the 13-item tool used for chronic neck and 
back pain.  In chronic back pain, research has reported a MDC of 5.6226 on the 13-item Tampa 
Scale for Kinesiophobia (TSK); therefore it is possible the change of 4.2 in the thrust group did 
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not exceed measurement error.  Further examination of change scores for TSK-TMD in all 
participants considered a success (GROC ≥ +5) at the 4-week visit revealed an average change of 
5.49 on TSK-TMD.   
In this dissertation study, correlations between neck function, jaw function, and other 
measurements were examined.  JFLS and NDI only had a fair correlation (r = 0.29); however, 
the strength of this correlation increased over time (r = 0.54).  TMD-DI and NDI only had a 
moderate correlation (r = 0.59) at baseline.  MMO has been utilized to describe functional 
limitation in the TMD population; however, there was only a fair association (r = 0.32-0.40) 
between pain-free MMO and any of the functional outcome measures utilized (JFLS, TMD-DI, 
or TSK-TMD).  There was good strength in correlation between TMD-DI and TSK-TMD at 
baseline (r = 0.72) and moderate to good association between JFLS and TSK-TMD (r = 0.60) 
and JFLS and TMD-DI (r = 0.64).  It is important to keep in mind that functional outcome scale 
scores, specifically TMD-DI, did not change much over time; therefore, interpretation of 
correlations may be misleading.   
Cervical Spine ROM 
ROM of the cervical spine was measured for flexion, extension, rotation right, and rotation 
left.  ROM improved for both groups in all directions, and the change scores from baseline to 4-
week visit favored the thrust group for all measurements.  The only measurement to show 
statistically significant differences using the independent t-test for change scores was cervical 
right rotation ROM, favoring the thrust group.  Fletcher231 et al report the standard error of 
measurement for cervical spine ROM is between 2.5º and 4.1º; these authors also report at least 
5º is necessary to demonstrate true change.  Mean change for this dissertation from baseline to 4-
weeks was > 5º in the thrust group for all measurements and < 5º in the sham group for all 
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measurements.  Between-group effect sizes were small; however, a moderate to large effect was 
noted in all movements for the entire sample (collapsed over time): flexion, d = 0.68; extension, 
d = 0.82; rotation right, d = 0.92; rotation left, d = 0.81.   
Pressure Pain Threshold  
Pressure Pain Threshold (PPT) is a quantifiable palpatory assessment defined as the 
minimum amount of pressure needed to cause a sensation of pain.232  Previous research has 
demonstrated reduced pain thresholds in persons with TMD.133  Increases in masticatory muscle 
PPT has been demonstrated in intervention studies for various populations including individuals 
with TMD, myofascial facial pain, and neck pain.22,23,153,238   
PPT values found in this study are similar to mean values reported in the literature (See table 
5.1).  There was an overall improvement in both groups for PPT over time.  A notable trend was 
an increase in PPT immediately post treatment in thrust group more than sham group for all 
points tested; however, this change, and all change scores noted for PPT of the masseter and 
temporalis, were < 1 kg/cm2.  It is possible the trajectory of immediate improvement has 
meaning, as the thrust group had higher PPT values for all tests.  However, this difference was 
not statistically significant.  While no specific MCID has been established for PPT in the TMD 
population, two studies have reported MCID values of ≥1.10 kg/cm2; however, it is important to 
note these studies were performed on healthy participants.237,240  The mean difference between 
groups in this dissertation study ranged from 0.11-0.29 kg.  Voogt241 utilized  ≥15% change in 
PPT to represent MCID.  Further examination of dissertation results show the MCID was met 
from baseline to immediate response in masseter right and left for only the thrust group.  At 
baseline to 1-week, MCID was met for the thrust group only for temporalis left and masseter left.  
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MCID was met for both groups from baseline to 4-week in temporalis right, masseter right, 
masseter left, and only the thrust group for temporalis left.   
TABLE 5.1 MEAN PPT VALUES (kg/cm2)  COMPARED TO REPORTS IN LITERATURE 
 
Author: Population 
 
Location 
 
PPT 
Reynolds: TMD Masseter, Right 1.66 kg ± 0.85 
 Temporalis, Right 1.92 kg ± 0.89 
LaTouche132: Neck Pain Masseter 2 kg ± 0.4 
        Temporalis 2.2 kg ± 0.5 
LaTouche: Healthy Masseter 3.4 kg ± 0.5 
 
Fernandez-Camero238: TMD 
Temporalis 
Masseter 
3.7 kg ± 0.6 
1.0-1.11kg 
Garrigos-Pedron271: TMD and migraine 
 
Masseter 
Temporalis 
1.78-1.89 kg 
1.81-2.08 kg 
Abbreviations: PPT, Pressure Pain Threshold; TMD, Temporomandibular Disorder; kg, kilogram  
Results are mean ± SD or range of mean values 
 
In this dissertation, none of the PPT values were correlated with jaw pain; however, all PPT 
values were correlated to one another, including the first dorsal interossei.  The first dorsal 
interossei was chosen to represent a remote site (ulnar nerve innervation, C8/T1), distant to the 
dermatomal site of interest (C0-3).233,234 There was a good to excellent correlation between PPT 
of each dorsal interossei location and the masticatory muscles in this study.  Reduced thresholds 
have been seen in distant sites as well as contralateral locations with chronic TMD populations, 
leaving speculation of the role of central sensitization.149,235,236  Central sensitization refers to a 
mal-adaptive process of reduced stimulus threshold with increased facilitation based on potential 
overload of nociceptive afferent information to second order neurons.4,73  There is often a 
simultaneous reduction in inhibitory responses.  The increased responsiveness to stimulation 
presents clinically as pain without tissue provocation, hypersensitivity to stimulus (hyperalgesia), 
155 
 
or pain from normally non-painful stimuli (allodynia).73,133  Clinical signs of central sensitization 
include reduction in PPT.140  Patients with chronic TMD have demonstrated widespread pain, 
abnormal central nervous system changes in the brain,141 and signs of central sensitization 
alongside peripheral sensitization.140,142  Sault174 et al described a case study of a woman with 
bilateral TMD and cervical pain.  Manual therapy and exercise treatment directed at both the 
temporomandibular joint and cervical spine resulted in reduction of pain, improved function of 
the jaw, and increased PPT at the jaw and a remote location at the thenar eminence.  In this 
dissertation, there was an increase of > 1.10 kg/cm2 for the 1st dorsal interossei on both sides in 
the thrust group from baseline to 4-weeks.  The mean difference between groups for 1st interossei 
measurements was 1.07 and 1.21 kg for the right and left side, respectively. 
La Touche132 et al examined PPT in 23 patients with mechanical neck pain demonstrating 
reduced PPT in masticatory muscles (masseter and temporalis) as well as the upper trapezius and 
C5-6 facet joint.  They also examined a remote location at the anterior tibialis.  While 
statistically significant changes in PPT were present for the masticatory and cervical regions, the 
difference between groups (neck pain and healthy controls) at the anterior tibialis was not 
statistically significant.132  Fernandez-de-las-Penas133 et al also examined PPT values of anterior 
tibialis in a TMD population and did show statistically significant differences.  LaTouche140 et al 
published a meta-analysis examining central sensitization in patients with TMD in 2017.  The 
meta-analysis indicated statistically significant reduction in PPT levels was present in both 
trigeminal and remote areas in patients with TMD, suggesting both peripheral and central 
nervous system involvement.  Chronic pain conditions like TMD, low back pain (LBP), and neck 
pain may involve both peripheral and central pain mechanisms.  Understanding the differences as 
well as the relationship between the two can guide treatment.272,273  The population examined in 
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this dissertation study did present with signs of both peripheral and central pain mechanisms.  
The presence of centrally mediated pain in individuals with TMD may suggest an appropriate 
indication for spinal TJM,273 or a combination of manual therapy and pain neuroscience 
education.274-276 
Characteristics of Success 
This dissertation study was powered around MMO, yet there was no statistically 
significant interaction effect identified.  There was a difference in patient perceived change as 
measured by GROC.  Previous research has used ≥ + 4165,215 or a more stringent ≥ +5154,159,277 to 
dichotomize success.  A cut-score of +5 or higher on the GROC was used as a measure of 
success in this dissertation study.  Immediately post treatment, 6 individuals in the thrust group 
and 0 in the sham group reported success.  At 1-week, success was noted in 6 participants in the 
thrust group and 1 in the sham group.  At the 4-week visit, 17 participants in the thrust group and 
10 in the sham group reported success.  
It is interesting to note that if the cut-off for success had been set at ≥ +4, the number of 
successful outcomes would not change at any time period for the sham group.  However, there 
were participants in the thrust group with +4 on GROC that would have been considered a 
success.  The number of successful outcomes would have increased from 6 to 10 at the 
immediate response, from 6 to 10 at 1-week, and 17 to 21 at 4-weeks; again, all numbers in the 
sham group would have remained the same.  If GROC ≥ +4 had been set as the criteria of 
success, the separation between groups would have been larger at each time interval.  Figure 5.1, 
5.2, and 5.3 detail the percentage of participants with a successful outcome at each data 
measurement point using the a-priori choice of ≥ +5 GROC to describe success.   
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FIGURE 5.1 GLOBAL RATING OF CHANGE SUCCESS AT  IMMEDIATE RESPONSE 
     
 
 
FIGURE 5.2 GLOBAL RATING OF CHANGE SUCCESS AT  1-WEEK 
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FIGURE 5.3 GLOBAL RATING OF CHANGE SUCCESS AT  4-WEEKS 
     
 
 
Controversy surrounding the construct validity278,279 of this measure was taken into 
account when interpreting results. Previous authors have reported the correlations between 
GROC and functional outcome measures were weak the further patients got from their initial 
evaluation.  These correlations and predictions of functional outcome scores with GROC were 
tested in a knee pain population278 as well as a population with hip, foot, and ankle complaints by 
Schmitt280 et al.  In both studies, moderate correlations were seen between functional outcomes 
scores or change scores in 0-30 days, but that relationship weakened over time.  Schmitt278,280 et 
al and Wang279 et al suggest GROC should not be a replacement to functional outcome tools, 
especially beyond the 30-day recall period.  As noted previously, functional outcome tools for 
TMD have not been studied to the same degree as functional outcome measures for other chronic 
pain populations.  Given the duration of data collection in this study was 4 weeks, some 
confidence in GROC values is warranted.  Even if values at the 4-week visit were called into 
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question, the immediate response differences between groups are less likely to be influenced by 
recall period.   
A 3 point change from baseline on GROC has been used to define MCID.211  In this 
dissertation study, the immediate post treatment response showed 17 participants (34%) reported 
GROC ≥ +3 (sham = 6, thrust = 11).   At the 1-week visit, 14 participants (28%) reported ≥ +3 
on GROC (sham = 4, thrust = 11).  At the final 4-week visit, 38 participants (76%) scored ≥ +3 
on GROC (sham = 15, thrust = 23).  Discussing findings with GROC ≥ +5 cut-off for success, 
there is confidence this change represents a clinically important difference.  Results did show a 
statistically significant difference in the percentage of successful outcomes (GROC ≥ +5) for 
each group at the immediate response (p = .022) as well as 4-week measurement (p = .047).  
Number needed to treat (NNT) is the number of patients who would need to be treated in order 
for 1 to improve or benefit from the treatment.  While NNT does not tell us how much they 
would improve, it is an indication of effectiveness of treatment. The NNT based on GROC at 
immediate response is 4.17 (95% CI 2.5,13.8).  For every 5 patients receiving treatment, 1 would 
get better compared to the control/sham group.  At 4-weeks the NNT is 3.57 (95% CI 1.8-67.4); 
4 patients receiving intervention with TJM would need to be treated for 1 to get better compared 
to the control (sham) group.  While the NNT is better at the 4-week interval, caution is used in 
interpretation due to the large confidence interval.  It is possible a larger sample would yield 
NNT values at 4-weeks with a smaller confidence interval.  The value in perceived success, 
especially at the immediate response, may relate to patient buy-in, tolerance to initiation of an 
exercise program, expectation of benefit,281 or therapeutic alliance.274  
Patient Acceptable Symptom State (PASS) asks participants if their current status is 
acceptable or unacceptable to them.216  The use of this tool allows for enhanced understanding of 
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the participant’s perception of their well-being218 and may suggest they are unlikely to seek 
further treatment.220  Examination of PASS success (answering yes, my current state is 
acceptable) at the final 4-week visit reveals interesting points of discussion.  In the sham group, 7 
participants (28%) responded “no”.  Of those 7 participants, the GROC score at this time period 
ranged from -1 to +2 for all but one participant.  There was a single participant in the sham group 
reporting “no” on PASS but a +6 on GROC; therefore, this participant was considered a success 
on GROC but not successful regarding PASS.  For the thrust group, there were 2 participants 
(8%) who responded “no” on PASS.  One of them had a GROC of -4, and this participant 
phoned the principal investigator (PI) 2 days later reporting she had a sinus infection that had 
made her much worse on the final measurement day, which was not diagnosed until the day after 
the 4-week visit.  The other participant who responded “no” on PASS was also considered a 
success on GROC with a score of +5 at this final visit.  Figure 5.4 represents the percentage of 
successful PASS outcomes in each group at 4-weeks.  
FIGURE 5.4 PATIENT ACCEPTABLE SYMPTOM STATE AT 4-WEEKS 
     
 
Sham 4‐Weeks
Yes No
Thrust 4‐Weeks
Yes No
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A determination of a successful outcome may be represented in various ways; perhaps an 
optimal analysis would include functional outcome measures, GROC, and PASS when 
determining success.  Wright282 et al used PASS as an anchor to define success and determine 
sensitivity and specificity of multiple outcomes.  These authors discuss PASS as an alternative to 
MCID analysis of other measures, even noting it may be the most appropriate tool as it captures 
“the personal experience of the patient”.282  Wright282 et al noted less predictable relationships 
between a functional outcome scale (Lower Extremity Functional Scale) and PASS, and more 
predictable relationships between pain based on NPRS and PASS.  These authors conclude 
PASS is related to patient satisfaction and influenced by baseline levels of pain, functional status, 
depression, or socioeconomic status.282   
Secondary Aim- Test-Retest Reliability and Construct Validity  
The jaw function self-report scales were analyzed further for evidence of reliability and 
validity.  TMD-DI has been reported in literature but has no evidence to support psychometric 
properties.  JFLS has been examined, although not extensively, in a dental population.  In this 
analysis, a GROC range of -2 to +2 was used to define stability or minimal to no change.  If a 
participant is stable, functional outcome scores should be relatively unchanged.  If a participant 
perceives improvement, a change in functional outcome is expected.  Correlation statistics were 
utilized to assess the similarity in scores for those considered stable (GROC = -2 to +2) or 
improved (GROC = ≥ + 4) in this dissertation study.  The expectation was that stable participants 
would show high correlation of scores while those who were improved would show 
improvement in scores with lower correlation.  Change scores for outcomes were also compared 
with an independent t-test.  Readers are reminded that GROC  ≥ +4 was included in the success 
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group in this particular analysis as opposed to the more stringent stipulation of  GROC ≥ +5 to 
quantify success for treatment outcomes.   
Intraclass Correlation Coefficient (ICC) was used to measure agreement and correlation. 
The degree of agreement was structured according to Shrout and Fleiss: <0.10 indicating no 
agreement, 0.11-0.40 indicating slight agreement, 0.41-0.60 was fair agreement, 0.61-0.80 is 
moderate agreement, and >0.80 was excellent agreement.263  JFLS showed excellent agreement 
in scores for stable patients at 1-week (ICC = 0.897) and 4-weeks (ICC=0.949).  Moderate 
agreement was noted in the improved group at 1-week (ICC = 0.790) and 4-weeks (ICC = 
0.632).  There was no statistically significant difference in change scores of the stable vs 
improved participants at 1-week or 4-weeks.  While these initial findings may indicate test-retest 
reliability in stable participants, the moderate correlation in the improved group may be 
concerning.  The lack of difference between groups (stable and improved) in change scores may 
indicate the JFLS is not valid to capture functional change.   
TMD-DI showed excellent agreement in scores for stable participants at 1-week (ICC = 
0.870) and 4-weeks (ICC = 0.912).  In this measure, only fair agreement was noted in the 
improved group at 1-week (ICC = 0.589) and 4-weeks (ICC = 0.408).  An excellent correlation 
in stable participants accompanied by only a fair correlation in improved participants may 
indicate good test-retest reliability.  There was a statistically significant difference in change 
scores for the stable vs improved participants at 1-week (p = .016) and 4-weeks (p = .035).  
These results could indicate TMD-DI does distinguish improved vs stable participants better than 
JFLS and may capture functional change in this population.   
It is important to note findings in this dissertation study showed a statistically significant 
group by time interaction for JFLS and not TMD-DI.  Effect sizes were larger for JFLS as well.  
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The total sample size was 50 participants for this RCT.  Therefore, the sample of participants 
who were considered improved or stable was small for each measure at each time-period.   
Implications 
Fifteen percent of individuals with TMD develop chronic pain.6  Most participants in this 
dissertation study (43/50, 86%) experienced chronic pain of >3-month duration.  The prevalence 
of TMD diagnosis is higher in females; however, this is confounded by the increased likelihood 
of females to seek care.11,12  Eighty-six percent of participants in this study were female.  
Likelihood to seek care is also influenced by greater intensity of pain;13 this sample had an 
average pain level of 3.7 in the jaw, 3.0 in the neck and 2.1 for headache on NPRS.   
TMDs are heterogeneous, and the classification system has changed over time.  Several 
authors report TMD is correlated with stress, anxiety, depression, and pain catastrophization.283-
285  Ohrbach and Slade27,45 et al acknowledge TMD is more than a local dysfunction, and other 
factors must be considered.  Deyo286 et al note chronic TMD shares similarities with other 
chronic musculoskeletal pain conditions, such as LBP, chronic HA, or fibromyalgia.  Two 
participants in this dissertation study tested positive for the depression screen, and many reported 
concurrent treatment for anxiety and/or depression.  Those who tested positive were referred to 
counseling services or their primary care physician for follow-up.  As acknowledgement of the 
biopsychosocial model impacts discussions of other pain disorders, and specifically chronic pain 
syndromes, the importance of broadening diagnostic categories as well as treatment options for 
TMD has been recognized.7   
Researchers in dentistry and PT acknowledge the current diagnostic criteria for TMD 
lacks information pertaining to pain science, which may be especially helpful in chronic TMD, 
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and the cervical spine.7  There is evidence to support the relationship between the cervical spine 
and TMD related pain and dysfunction.  In the population studied for this dissertation, all 
participants had a primary complaint of TMD, and 30/50 (60%) had at least 2/10 cervical pain on 
NPRS.  Previous authors have reported concurrent cervical pain in individuals with TMD 
ranging from 43%8-68%.15  Participants in this dissertation study demonstrated statistically 
significant main effects for time in all measurements of pain, ROM, PPT, and function.  Only 2 
variables (JFLS and TSK-TMD) had a statistically significant group by time interaction, both 
favoring the thrust group.  A general trend of greater improvement in all measured variables was 
noted, favoring the thrust group, and success according to GROC and PASS were higher in the 
thrust group.  While cervical TJM has been supported for chronic neck pain,158 the impact of 
cervical TJM on chronic TMD is not clear.   
Limitations and Delimitations  
Limitations of this dissertation study are acknowledged.  Clinical trials attempt to utilize 
multiple therapists and locations to increase generalizability.  While efforts were made to utilize 
4 clinicians in 4 locations, only 2 clinicians (1 male and 1 female clinician, both with manual 
therapy backgrounds including fellowship in AAOMPT) and 2 locations enrolled participants 
(Las Vegas, NV and Peoria, IL).  Results should be generalized with caution beyond these 
parameters.   
Another threat to external validity exists in the methodology of a RCT.  Measurement of 
differences between the group receiving cervical TJM and sham manipulation required all other 
treatments be consistent.  Standardized treatments for all patients does not reflect clinical 
practice; however, there is a known trade-off of generalizability for increasing internal validity in 
this design.   
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An instrumentation threat to validity was present, specifically for the measurement of 
PPT with a digital algometer.  The algometry readings were higher overall for measurements 
taken in Las Vegas, NV.  Specifically, PPT for the first dorsal interossei averaged 2.6-2.7 kg for 
the Peoria, IL group; whereas the Las Vegas, NV group averaged 29.6-29.9 kg.  The average 
PPT at masseter and temporalis were 2.3-2.6 kg in Las Vegas, NV and 1.4-1.8 kg in Peoria, IL.  
Algometers were calibrated and all assessors utilized the same Manual of Standard Operating 
Procedures (MSOP) and video training.  There were 8 total participants (4 in each group) in Las 
Vegas, NV.  Data for PPT were run with and without the values from the NV location, and 
results remained the same.  Therefore, a decision was made to include these data in all PPT 
analyses while acknowledging the potential limitation.   Another delimitation relevant to PPT is 
that the PI did not require a notation of the more painful side with PPT assessment.  Previous 
authors have analyzed data using the most painful side as opposed to only recording right and 
left sides; future research should consider noting the more painful side.   
Additional internal validity threats included history, maturation, repeated testing, and 
regression toward the mean.  The use of 2 groups and random group assignment can decrease the 
potential impact of these internal validity threats; however, the threat still exists.  Both groups 
were equivalent on all factors except jaw deviation left at baseline, indicating the random 
assignment may have helped minimize the impact of these threats.  Participants in this 
dissertation study were excluded if they had recent chiropractic, dental, or PT intervention for the 
neck or jaw and were asked not to add new treatments during the 4-week duration of this study.  
Participants were also asked not to add new exercise routines and continue what they had been 
doing on a regular basis.  While these efforts were made to minimize the potential impact of 
confounding variables, there is no guarantee all participants followed instructions.   
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A true control group would have allowed for examination of each group against the 
control; however, this was not feasible for this dissertation study and may not be clinically 
valuable.  Previous research has supported treatment is better than no treatment for the chronic 
TMD population.  In this dissertation study, both groups improved over time.  Most participants 
presented with chronic pain; therefore, it is unlikely improvements seen in both groups would 
have occurred without intervention.   However, without a control group, we cannot be certain.  
Clinicians were recruited as blinded assessors to collect ROM and PPT data.  These 
clinicians and all participants were blinded to group allocation.  However, the wording of the 
informed consent required by IRB included a brief description of the 2 groups (TJM or sham).  
The majority of participants did not ask questions about this group assignment and appeared 
surprised to learn about the difference between the 2 groups at the last visit during debriefing.  
The potential for participants to realize what group they were allocated to could affect participant 
blinding to group allocation.   
Statistical validity relates to the choice of an appropriate statistical procedure to analyze 
data.  The primary statistical analysis in this dissertation study was a mixed analysis of variance 
(ANOVA) looking at between-group and within-group differences as well as interaction effects.  
A nonparametric alternative to a mixed ANOVA including interaction effects does not 
exist.257,258,260,287  Separate repeated measures ANOVAs can be run, and in the presence of 
violations of assumptions, Friedman’s F test is used; however, this test does not answer the 
initial hypothesis of interest in the interaction effect and would pose an increased risk of Type I 
error with multiple tests performed.  Chapter 4 of this dissertation outlines choices made to 
manage violations of assumptions, including transformation of data when appropriate.     
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The use of outcome measures without support for reliability and validity could pose a 
threat to statistical validity as well.  The functional outcome tools for self-assessment of jaw 
function (JFLS and TMD-DI) lack psychometric analysis, therefore challenging the validity of 
potential findings.  This dissertation examined the test-retest reliability and construct validity of 
these measures; however, the small sample size should be considered in interpretation.  A larger 
sample of study is indicated and may reveal very different findings.  Future research into the 
reliability and validity of these jaw-specific functional outcome measures is warranted.   
Finally, low baseline levels of pain and function in multiple tests used in this dissertation 
led to potential floor effects.  Low NPRS values were noted for jaw, neck, and HA; the choice to 
use NPRS jaw ≥ 2 for inclusion may have been too low to capture change.  Low baseline scores 
were noted for NDI as well.  There are no criteria to quantify the level of dysfunction of jaw 
functional outcome scales; therefore, it is also possible the JFLS and TMD-DI had floor effects.   
Recommendations for Future Research 
 Future research should include analysis of jaw specific functional outcome tools for use 
in PT practice.  Reliability, validity, and responsiveness should be measured and could include 
JFLS, TMD-DI, or other tools commonly used in practice.   
 Future study of cervical TJM in the TMD population could use functional outcome tools 
to determine sample size estimations needed for 80% power.  This information may lead to a 
change in the required sample size.  Future study of this topic should also include a higher level 
of disability to avoid the impact of floor effects.  Future research could include the use of known 
predictors of success for cervical TJM in neck pain to determine if those patients have greater 
success with the intervention for TMD as well.   
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Little is known about the most effective treatments for TMD through RCTs.  Studies 
examining clinician decision making in the TMD population would be valuable.  Examination of 
treatments as a whole, impairment-based decision-making, or diagnosis-specific intervention 
could be compared.  Multimodal intervention combinations may produce greater and longer 
lasting improvement in pain, function, and quality of life than isolated interventions.93  While 
standardizing treatments for study improves internal validity of research, clinical application and 
external validity can be discussed if clinicians are allowed to manage patients individually.  
We have learned from lumbar and cervical spine chronic pain conditions that the 
mechanical diagnosis may not have much relevance to the most valuable treatments; however, in 
clinical practice with TMD, much time is spent in specific mechanical diagnosis.  Understanding 
normal biomechanical relationships is important, and anatomical changes may be noted in 
imaging; however, the course of treatment likely remains unchanged.40  As with other chronic 
pain conditions, radiographic or image findings demonstrating abnormal positioning of the disc 
or other anatomical abnormalities are poorly correlated with pain, tenderness, and/or 
dysfunction.7  Chantaracherd41 et al performed a cross-sectional study looking at imaging 
findings as well as pain, function, and disability associated with TMD.  These authors concluded 
there was no relationship found between joint status and pain or dysfunction.  Orhrbach27 et al 
acknowledge the current diagnostic criteria for TMD (DC-TMD) focuses on the ‘bio’ of 
biopsychosocial, and treatment for chronic TMD may be less dependent on these criteria than 
previously hypothesized.  As acknowledgement of the biopsychosocial model impacts 
discussions of other pain disorders, and specifically chronic pain syndromes, the importance of 
broadening diagnostic categories has been recognized.7  Further research of treatments based on 
mechanical diagnosis versus more impairment-based models should be examined.   
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Pain neuroscience education (PNE) refers to a management strategy in chronic pain 
conditions focused on teaching patients both neurobiology and neurophysiology of pain.38,39  
Marcos-Martin288 et al conducted a prospective case series including 9 participants with chronic 
TMD and neck pain utilizing a biobehavioral intervention focused on helping participants 
understand and manage their pain. This biobehavioral intervention was added to traditional 
education, exercise, and manual therapy.  Authors report this intervention was effective for pain, 
function, fear, and ROM, noting previous research had supported the approach with other 
chronic pain regions (neck, back, knee), and further research should be done studying the impact 
on chronic TMD.288 The role of PNE treatment for chronic TMD should also be further explored.  
Summary 
TMD refers to conditions, pathologies, or dysfunctions impacting the temporomandibular 
joints, masticatory muscles, and associated musculoskeletal and neurovascular structures.7  TMD 
symptoms may include pain in the jaw, head, and neck regions, headaches, periauricular pain, 
tinnitus, palpable tenderness, joint sounds, limited jaw opening, and loss of function.7,9  Only a 
small percentage of individuals with TMD (5-10%) seek treatment.6,9  TMD is the third most 
common chronic musculoskeletal pain condition,40  and like other chronic pain conditions, TMD 
can affect quality of life and place an economic burden on society.40,53  The overall healthcare 
costs for persons seen at least once for a diagnosis of TMD is 1.6 times higher than that of 
persons without a TMD diagnosis.11   
The National Institute of Health (NIH) and National Institute of Dental and Craniofacial 
Research (NIDCR) recognize the TMD population is often left with no clear path to specialists in 
TMD.6,54  Dental professionals may not be aware of PT options in the management of TMD.  A 
survey of Florida dentists asked participants about their TMD treatment methods, including 
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inquiry of PT management for TMD.  Only 59% of the 256 dentists responding the survey 
reported they were aware physical therapists were “capable of treating patients with TMD.”289  
Dentists who reported making interdisciplinary referrals for TMD management only chose PT 
31% of the time; the most frequent referral was to an oral surgeon.289   
Brown61 et al reported individuals with TMD do not spontaneously recover without 
treatment intervention.  Given the chronic nature of pain associated with TMD, the fact that all 
variables measured in this dissertation showed statistically significant change over time is 
promising. Interdisciplinary management of chronic pain conditions is important, and physical 
therapists must continue to educate dentists on the role of PT in TMD management.  Evidence 
does exist to support improvement over time with manual physical therapy, education, and 
exercise.22,58,59,67,153    
Biomechanical and neurophysiological relationships between the cervical spine and 
temporomandibular joint support the potential benefit of cervical spine manual therapy on TMD 
related pain and dysfunction.  Evidence from La Touche et al22,23,132 support cervical spine non-
thrust joint mobilization (NTJM) in treatment of TMD.  Other authors have supported manual 
therapy to the cervical and thoracic spine to adjunct TMD treatment, but without 
randomization.152  Some authors have suggested both TJM and NTJM are valuable in chronic 
neck pain.290,291  A narrative review by Butts292 et al in 2017 reports spinal TJM and NTJM are 
“generally supported in the literature”292 to decrease pain and disability in TMD.  It is possible 
that a combination of TJM and NTJM or patient-specific treatment decisions may be valuable.   
Evidence supporting the use of TJM of cervical and thoracic spine for TMD is available 
but limited.67,109,151  A systematic literature review by Adelizzi59 et al (2016) examined the use of 
cervical spine TJM for TMD, noting most of the evidence was based on weak study designs, 
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limited availability of research, small samples, and multimodal or combined treatment 
intervention packages.  The use of multimodal interventions where groups were different on 
variables other than the TJM of the cervical spine make it difficult to interpret the effect of this 
intervention specifically.  There were only 2 quality RCTs to discuss; however, authors neglect 
to acknowledge the study designs used did not include individuals with a primary complaint of 
TMD.   
Research and clinical practice guidelines promote use of cervical TJM for various 
conditions including neck and upper extremity pain and dysfunction.63,70  There is growing 
support for a neurophysiological effect of spinal TJM with changes seen in pain inhibition, 
muscle recruitment, and/or function.22  The effect of spinal TJM on remote locations has 
demonstrated both local and remote effects.71,72  The most current clinical practice guidelines for 
neck pain support the use of TJM in acute, subacute, and chronic neck pain with mobility deficits 
as well as acute and chronic neck pain with cervicogenic HA.158  Given the chronic nature of 
TMD as well as known associated cervical mobility deficits116,117 and HA,7,9 it is reasonable to 
assume cervical TJM would also be potentially helpful in the TMD population.   
To the knowledge of the PI, there are no previous studies examining the specific effect of 
cervical TJM on a population of individuals with TMD.  Understanding the impact of various 
interventions on pain modulation and functional change can guide informed and evidence-based 
clinical practice.  While cervical TJM is only one part of potential intervention packages, a better 
understanding of the specific effect of this intervention using a randomized design may guide 
decision making in PT treatments for the TMD population.   
The purpose of this dissertation was to determine the immediate and short term (1 and 4-
week) effects of cervical TJM on pain, dysfunction, and perception of change in persons with a 
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primary complaint of TMD.  A sample of 50 participants were randomized to a cervical thrust 
group or cervical sham group.  All participants received behavioral education, a home exercise 
program, and soft tissue mobilization to the suboccipital region.  The cervical TJM or sham 
manipulation was the only difference between groups.  Study participants had a mean age of 35 
years and mean duration of symptoms for 72 months.  Most participants (86%) were female and 
had chronic nature pain (86%) of > 3 month duration.  A 2 x 4 mixed model ANOVA was 
utilized to compare both within-group and between-group changes over the 4 measurement 
periods for all continuous level data.  Separate ANOVAs were performed for dependent 
variables; the hypothesis of interest was the group by time interaction for each ANOVA and 
subsequent main effects or simple main effects.  Independent t-test analysis was used to compare 
groups in change scores for each variable.   
MMO was used as a measure of function and was the measurement used to power this 
dissertation study.  The sample started with an average of 37.5 mm opening and improved to >40 
mm; however, the interaction of group and time for this measure did not show statistically 
significant differences.  Statistically significant interaction effects were noted for function (JFLS) 
and fear (TSK-TMD).  JFLS effect was noted in both groups from baseline to 4-weeks and only 
the thrust group from baseline to 1-week.  TSK-TMD at 4-weeks favored the thrust group.  Fear 
and jaw function had moderate to good correlation at baseline.  However, subsequent analysis of 
the functional outcomes used for jaw function showed the change scores in improved patients 
compared to stable patients were not statistically different.  While there was excellent agreement 
in scores for stable participants, the lack of statistically significant change in scores for the 
improved participants must be considered in interpreting results.   
173 
 
Statistically significant main effects for time were noted for all other measured outcomes 
(MMO, jaw deviation right and left, NPRS for each location, NDI, TMD-DI, cervical ROM all 
planes, and PPT at all locations tested).  A statistically significant independent t-test comparing 
change scores was noted for jaw deviation right, NPRS jaw, NPRS cervical, TSK-TMD, and 
cervical R rotation ROM.  Each statistically significant independent t-test favored the thrust 
group.   
Patient perception of change was measured through GROC and PASS.  Results of both 
tests favored the thrust group at all points.  Statistically significant differences in the percentage 
of success between groups was noted for GROC at immediate response and 4-weeks.  NNT was 
calculated based on the statistically significant GROC findings.  NNT was 4 at immediate 
response and 3 at 4-weeks.  PASS favored the thrust group, but the difference was not 
statistically significant.  PASS may reflect patient satisfaction and likelihood to seek further 
treatment220; PASS may be influenced by baseline levels of pain, functional status, depression, or 
socioeconomic status.282 
There were no serious adverse events to report and only mild treatment side-effects were 
noted.  Participants in both groups (thrust = 36%, sham = 48%) reported treatment side effects.  
The majority of side effects were mild in nature and resolved within 48 hours of treatment.  One 
participant in the sham group reported severe aggravation of symptoms lasting 7 days after a 
treatment visit.  This aggravation was related to jaw and neck pain as well as overall soreness.   
Both groups were expected to improve over time as evidence does support behavioral 
modification and exercises can be enough to show meaningful change.17,19,57,101 This dissertation 
study included education, behavioral modifications, exercise for the neck and jaw, and manual 
therapy.  Both groups did improve over time for all measured variables, and this improvement 
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was statistically significant.  The addition of cervical TJM to one group did not show statistically 
significant interaction effects for most variables.  Both groups received multimodal 
interventions; therefore, it is not surprising that the differences between groups was small.   
However, multiple independent t-tests showed statistically significant differences in change 
scores favoring the thrust group.  GROC and PASS favored this group as well, with statistically 
significant differences at immediate response and 4-weeks.  The known relationship between the 
cervical spine and jaw, concepts of regional interdependence, previous research supporting 
cervical interventions, and results of this RCT support continued examination of the effect of 
cervical spine treatments for the TMD population.  It is possible treatment of a location outside 
the primary area of pain can provide clinically meaningful change in the primary location of 
pain.75  Evaluation and treatment directed at the cervical spine is warranted in a TMD 
population.  Future studies should include larger samples, study of psychometric property 
analysis of TMD functional outcome tools, use of these supported functional tools in treatment 
intervention studies, and the inclusion of PNE intervention in the TMD population.  
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Appendix 3 
Facilities 
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1. Rock Valley Physical Therapy 
1524 W Glen Ave 
Peoria, IL  61614  
Phone: 309-691-1986 
2. Rock Valley Physical Therapy 
1003 North Cummings Lane 
Washington, IL  61571 
Phone: 309-444-1030 
3. UNLV Department of Physical Therapy School of Allied Health Sciences 
4505 S. Maryland Parkway, Box 453034 
Las Vegas, NV  89754-3034 
4. Bradley University Department of Physical Therapy and Health Sciences 
1501 W Bradley Ave 
Peoria, IL 61625 
Phone: 309-677-3293 
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4/26/17
Sandra Shumaker Exec. Dir. Research and Sponsored 
Programs
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RESEARCH STUDY 
Informed Consent Form 
 
Study Title:   Thrust Joint Manipulation to the Cervical Spine in Patients with a 
Primary Complaint of Temporomandibular Disorder (TMD): A 
Randomized Clinical Trial 
Faculty Advisor:  Breanna Reynolds, PT, DPT, FAAOMPT 
344 Olin Hall, 1501 W. Bradley Ave, Peoria, IL 61625 
309-677-3293 
Principal Investigator:  Breanna Reynolds, PT, DPT, FAAOMPT 
Co-Investigators:  Clara Tostovarsnik SPT, Amanda Baker SPT, Clint Sestak SPT 
    Emilio Puentedura PT, DPT, PhD, OCS, FAAOMPT 
    
Introduction: 
The Bradley University Department of Physical Therapy is conducting a randomized controlled 
clinical trial with Rock Valley Physical Therapy and UNLV.  The goal is to determine if physical 
therapy to the neck and exercise improve pain and dysfunction for persons experiencing jaw 
pain.  You are being invited to participate in this study because you have a primary complaint of 
jaw pain.  Your participation is voluntary.  If you are being seen in a physical therapy office, 
your decision to participate or not to participate will have no effect on the quality of your 
medical care.  All of the procedures associated with this study are commonly used treatments in 
standard physical therapy practice.  Please ask questions if there is anything you do not 
understand.     
Adults between the ages of 18-65 with current jaw pain will be recruited.   
What is Involved in the Study? 
This study involves four sessions of physical therapy over one month as well as follow-up 
surveys in the mail at 3 months and 6 months.  If you agree to participate, you will be asked to 
fill out prescreening forms to tell us about your health status and to check for conditions that may 
exclude you from the study.  In addition, you will be asked to complete a set of questionnaires to 
help us understand the pain or limitations you are experiencing.  Measurements of your range of 
motion, strength and pain sensitivity will be assessed along with additional screenings.   
A licensed physical therapist specializing in manual therapy will perform a standard physical 
therapy evaluation to include further questions related to history and objective measurements.  
You will be randomly assigned to 1 of 2 treatment groups, and the physical therapist will initiate 
treatment.  Both groups will receive interventions.  One group will receive cervical spine (neck) 
thrust joint manipulation while the other will receive sham manipulation.  You will be positioned 
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comfortably on your back and a licensed, qualified physical therapist will perform a neck 
intervention.  There will be no manual treatment to the jaw itself.     
After this cervical intervention, the clinician will educate you on behavioral modifications and 
exercises to perform on your own.  You will be asked to complete a log tracking progress with 
your home program and to return for two additional follow-up visits.   
One week from the first session (visit 2) you will receive the same intervention and will review 
your exercises and educational material.  Measurements will be taken on this day as well.  Two 
weeks from the first session (visit 3), you will receive treatment without any measurements 
taken.  Four weeks from your first session you will return for a final visit (visit 4) consisting of 
measurement of progress.  At that time the therapist can discuss further treatment options with 
you.  Follow-up surveys will be mailed to your home address at 3 months and 6 months after 
your first visit.   
How many people will take part in the study? 
It is anticipated that up to 50 persons will participate in this research study. 
How long will I be in the study? 
You will be asked to attend 4 sessions of physical therapy over a 4-week period.  After the first 
visit, the second session will be one week later, third 2 weeks later, and a final visit will take 
place at 4 weeks.  The first session is anticipated to last 60-75 minutes while the next three 
sessions are expected to last 30-45 minutes.  Follow up surveys will be sent at 3 months and 6 
months, and this will conclude the duration of the study.  The estimated time of completion for 
mailed surveys is 15 minutes total.     
When does the study end? 
Participation is voluntary and you can stop participating at any time.  However, if you decide to 
stop participating in this study, we strongly encourage you to talk to the researcher first as there 
may be information the researcher could provide through telephone, email, or other forms of 
communication.  There are no consequences if you choose to suddenly withdraw.  If you choose 
to remain in the study, your participation for physical appointments will end after the 4-week 
follow up, and completion of the study will occur after the 6-month mailing is received.  At 4-
weeks, your physical therapist will talk with you about the need for continued physical therapy 
or other services.   
What conditions exclude me from being able to participate? 
Certain conditions will prevent you from participating in this study.  These include whiplash in 
the past 6 weeks, prior neck surgery, spinal manipulation of the neck in the last 3 months, 
osteoporosis, tumor, rheumatoid arthritis, traumatic onset of symptoms, medical red flags 
suggestive of non-musculoskeletal origin of pain, systemic, or neurologic disease, and 
contraindications to cervical intervention.  Any other exclusion factors applicable would be 
noted in the first visit examination.   
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What are the risks of participating in the study? 
The risks you will be exposed to in this study are not greater than other risks you experience in 
receiving regular physical therapy treatment.  All of the procedures associated with this study are 
commonly used treatments in standard physical therapy practice and risk is minimal.  Please ask 
questions if there is anything you do not understand.     
It is possible that subjects who receive manual therapy to their neck will experience some very 
mild muscle soreness, fatigue, or headache after the procedure is performed. However, this 
soreness typically resolves within 1-48 hours after the procedure.  If you feel discomfort you can 
apply cold to the area to minimize symptoms.   
 
There is a small, albeit rare, risk of a serious adverse event associated with some cervical 
interventions.  This risk is reported to range from 1/50,000 to 1/5.85 million.  Similar risk has 
been noted in activity involving head movements such as leaning the head back at a beauty 
parlor, coughing, sneezing, or performing yoga.  In order to mitigate this risk, researchers will 
conduct a thorough screening process and exclude individuals who may be at a higher risk for a 
serious adverse event.  Physical therapists are qualified to perform these procedures, and trained 
in appropriate screening procedures to improve safety.  If you have questions about the risks, 
please contact the researcher. 
 
It is important to call the researcher or your regular physician when you think you are having 
problems, even if they are not included on the above list. 
What are the benefits of participating in the study? 
Based on current research supporting the use of cervical intervention, education, and exercise for 
other conditions, we believe you may experience a positive change in pain, movement, or 
function related to your jaw pain.  However, you may not benefit from being in this study.  The 
information gathered may help people with jaw pain in the future.   
You may opt for financial compensation for your participation.  Participants attending scheduled 
visits will be paid $25 after the second visit, and $25 after the forth visit.  Participants will be 
given an IRS Form W-9 to complete and sign if they are interested in the incentive payment for 
participation.  This completed IRS Form W-9 will be immediately placed in a self-addressed 
envelope and sealed by the participant to protect their privacy.  The form will be mailed to 
Bradley University Controller's Office and payment will be processed accordingly.  Participants 
will receive payment for participation in the form of a check.  
What other options are there? 
Participation in this study is optional.  Instead of being in this study, you have the option to see a 
medical physician, dentist, physical therapist or other medical provider of your choosing.  You 
also have the option to decline any treatment.   
What about Confidentiality? 
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All efforts will be taken to keep your personal information as confidential as possible, although 
there is no absolute guarantee that all information will remain confidential.  You understand 
that any information about you or your physical therapy management will be handled in a 
confidential (private) manner consistent with other hospital medical records in the Physical 
Therapy office.  Federal Privacy Regulations provide safeguards for privacy, security, and 
authorized access. Except when required by law, you will not be identified by name, social 
security number, address, telephone number, or any other direct personal identifier in study 
records disclosed outside of this clinic. All records pertaining to your involvement in this 
research study will be stored in a locked file cabinet in the Physical Therapy Department.  You 
will not be specifically identified in any publication of research results. However, in unusual 
cases, your research records may be inspected by appropriate government agencies or be 
released in response to an order from a court of law. 
Personal health information about you that will be collected in this study 
Personal health information will be collected and used for research.  All efforts will be made to 
protect the privacy of your personal information. 
Why your personal health information is being used? 
Your personal contact information is important for the study team to contact you during the 
study. Your health information and results of tests and procedures are being collected as part of 
this research study and for the advancement of medicine and clinical care.   
The treating therapist may also use the results of these tests and procedures to guide further 
treatment.  If researchers/clinicians feel your medical history, risk factor screen, tests or 
procedures warrant further consult, you will be informed, and we will call your primary care 
physician.  Your signature below authorizes consent to make this phone call when indicated.      
The personnel who may use or disclose your personal health information 
A case number will indicate your identity on these records. This information will only be 
accessible to the investigators listed on the first page of this document and the research study 
staff. 
Who, outside of this institution, might receive your personal health information? 
As part of the study, the Principal Investigator, study team and others listed above in item 
number 3, may disclose your personal health information, including the results of the research 
study tests and procedures to the following: 
 Bradley University Committee on the Use of Human Subjects in Research 
 Investigators and data coordinators affiliated with this study 
 
The Principal Investigator or study team will inform you if there are any changes to the list 
above during your active participation in the trial.  Once information is disclosed to others 
outside this institution, the information may no longer be covered by the federal privacy 
protection regulations. 
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What are the costs? 
Your insurance will be billed by Rock Valley Physical Therapy as is customary for physical 
therapy evaluation and treatment.  You will be responsible for any co-pay, co-insurance, or 
deductible specific to your personal insurance plan. 
There are no additional costs for participation in this study.  In the case of injury or illness, 
emergency medical services will be enacted if necessary and handled through the individual’s 
own insurance plan.  No funds have been set aside to compensate you in the event of injury.  
Voluntary follow-up to a medical provider based on the recommendation of researchers is 
outside the scope of this research study and will be handled through the individual’s own 
insurance plan.   
The physical therapy procedures you receive while participating in this study will be billed 
according to standard practice.  Because of the short duration of time spent on the randomized 
portion of treatment, neither group will be charged for the manual therapy intervention.  Co-
payments will be the same as if you were not part of the research study. These procedures will be 
charged because they are “standard of care” procedures you would receive regardless of 
participation in this study. The procedures will be documented in the medical record and are 
being provided because they are medically indicated and are not being provided simply because 
of participation in this study.  
 
What are my rights? 
Taking part in this study is voluntary; you may leave the study at any time.  This study is 
expected to end after you have completed your physical therapy and all information has been 
collected.   
Who should I call with questions or problems? 
Questions about therapy can be directed to your physical therapist.  Questions specific to this 
study may be directed to the researcher in charge of this study, Dr Breanna Reynolds.  She can 
be reached at (309) 677-3293 during normal business hours.  If you have general questions about 
being a research participant, you may contact the Bradley University CUHSR office at (677-
3877) during normal business hours. The Chairperson of this committee will discuss the matter 
with you. 
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Documentation of Informed Consent 
You are voluntarily making a decision to participate in this study. Your signature means that you 
have read and understood the information presented and have decided to participate. Your 
signature also means that the information on this consent form has been fully explained to you 
and all your questions have been answered to your satisfaction. If you think of any additional 
questions during the study, you should contact the researcher(s).  
I agree to participate in this study. 
___________________________ ______________________________ 
Printed Name of Subject Signature of Subject 
 
___________________________ 
Date 
 
 
__________________________ ______________________________ 
Printed Name of Person  Signature 
Obtaining Consent 
  
______________________________ 
Date 
 
CODE: _____________ 
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Entry process: 18‐65 with primary complaint of 
TMD related pain 
Is the person interested? 
NO 
Treatment Group 1:  
Visit ONE: 
Education 
 Avoid parafunctional habits 
 Behavioral modification 
 HEP 
Manual Therapy‐Sham 
 Suboccipital STM and Sham 
manipulation C0/1 and C2/3 with 
15 second holds shy of end range 
Baseline Testing 
NPRS, AROM neck and 
jaw, PPT, JFLS, TMD 
Disability Index, NDI, 
TSK‐TMD  
Meets inclusion 
criteria?
Consent received? 
Yes. Proceed with informed 
Yes: Is the participant eligible?No further research 
related contact/exclude 
Yes: Proceed with 
randomization 
Treatment Group 2:  
Visit ONE: 
Education 
 Avoid parafunctional habits 
 Behavioral modification 
 HEP 
Manual Therapy‐TJM 
 Suboccipital STM and Cervical 
spine manipulation C0/1 and 
C2/3 Right and left sides 
Visit TWO, One‐week: Assessment: Repeat measures above; Add GROC 
and PASS, Repeat SAME treatment
Visit FOUR, Four‐week: Assessment: All measures repeated, no 
prescribed treatment 
Referral if needed, further treatment at provider discretion 
Visit THREE, Two‐week: Treatment Only, No measurement 
Key:                 Proceed 
                         Stop 
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Appendix 7 
Self-Report Scales and Outcome Measures 
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Initial TMD Screening Tool (Gonzalez et al) 
In the last 30 days, on average, how long did any pain in your jaw or temple area on either 
side last?   
c. No pain (0) 
d. From very brief to more than a week, but it does stop (1) 
e. Continuous (2) 
In the last 30 days, have you had pain or stiffness in your jaw on awakening? 
f. No (0) 
g. Yes (1) 
In the last 30 days, did chewing hard or tough food change any pain (that is make it better or 
make it worse) in your jaw or temple area on either side? 
h. No (0) 
i. Yes (1) 
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NPRS:  
Please rate your CURRENT jaw pain 
Please rate your CURRENT neck pain 
 
Please rate your CURRENT headache 
 
Please rate your jaw pain at it’s BEST over 
the last 24 hours 
 
 
Please rate your neck pain at it’s BEST over 
the last 24 hours 
 
 
Please rate your headache at it’s BEST over 
the last 24 hours 
 
 
Please rate your jaw pain at it’s WORST 
over the last 24 hours 
 
 
Please rate your neck pain at it’s WORST 
over the last 24 hours 
 
 
Please rate your headache at it’s WORST 
over the last 24 hours 
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GROC: 
Global Rating of Change Scale 
Please rate the overall condition of your Jaw/Neck/Headache Pain FROM THE TIME THAT 
YOU BEGAN TREATMENT UNTIL NOW (Check only one): 
 
□ A very great deal worse (-7) □ About the same (0)  □ A very great deal better (7) 
□ A great deal worse (-6)      □ A great deal better (6) 
□ Quite a bit worse (-5)      □ Quite a bit better (5) 
□ Moderately worse (-4)      □ Moderately better (4) 
□ Somewhat worse (-3)      □ Somewhat better (3) 
□ A little bit worse (-2)      □ A little bit better (2) 
□ A tiny bit worse (-1)      □ A tiny bit better (1)  
 
 
From: Jaeschke R, singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal 
clinically important difference. Control Clin Trials 1989: 407-15.  
 
 
PASS: 
Patient Acceptable Symptom State 
“Taking into account all the activities you have during your daily life, your level of pain, and also 
your functional impairment, do you consider that your current state is satisfactory?” 
Yes 
No 
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Neck Disability Index (NDI) 
This questionnaire has been designed to give us information as to how your neck pain has 
affected your ability to manage in everyday life. Please answer every section and mark in each 
section only the one box that applies to you. We realize you may consider that two or more 
statements in any one section relate to you, but please just mark the box that most closely 
describes your problem. 
Section 1: Pain Intensity 
 
□ I have no pain at the moment 
□ The pain is very mild at the moment 
□ The pain is moderate at the moment 
□ The pain is fairly severe at the moment 
□ The pain is very severe at the moment 
□ The pain is the worst imaginable at the 
moment 
Section 6: Concentration 
 
□ I can concentrate fully when I want to with 
no difficulty 
□ I can concentrate fully when I want to with 
slight difficulty 
□ I have a fair degree of difficulty in 
concentrating when I want to  
□ I have a lot of difficulty in concentrating 
when I want to  
□ I have a great deal of difficulty in 
concentrating when I want to  
□ I cannot concentrate at all 
 
Section 2: Personal Care (Washing, 
Dressing, etc.) 
□ I can look after myself normally without 
causing extra pain 
□ I can look after myself normally but it 
causes extra pain 
□ It is painful to look after myself and I am 
slow and careful 
□ I need some help but can manage most of 
my personal care 
□ I need help every day in most aspects of 
self care 
□ I do not get dressed, I wash with difficulty 
and stay in bed  
 
Section 7: Work 
 
□ I can do as much work as I want to  
□ I can only do my usual work, but no more 
□ I can do most of my usual work, but no 
more 
□ I cannot do my usual work 
□ I can hardly do any work at all 
□ I can’t do any work at all 
 
Section 3: Lifting 
 
□I can lift heavy weights without extra pain 
□ I can lift heavy weights but it gives extra 
pain 
□ Pain prevents me lifting heavy weights off 
the floor, but I can manage if they are 
conveniently placed, for example on a table 
Section 8: Driving 
 
□ I can drive my car without any neck pain 
□ I can drive my car as long as I want with 
slight pain in my neck 
□ I can drive my car as long as I want with 
moderate pain in my neck 
□ I can’t drive my car as long as I want 
because of moderate pain in my neck 
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□ Pain prevents me from lifting heavy 
weights but I can manage light to medium 
weights if they are conveniently positioned 
□ I can only lift very light weights 
□ I cannot lift or carry anything 
□ I can hardly drive at all because of severe 
pain in my neck 
□ I can’t drive my car at all 
 
 
 
 
 
 
Section 4: Reading 
 
□ I can read as much as I want to with no pain 
my neck 
□ I can read as much as I want to with slight 
pain in my neck 
□ I can read as much as I want with moderate 
pain in my neck 
□ I can’t read as much as I want because of 
moderate pain in my neck 
□ I can hardly read at all because of severe 
pain in my neck 
□ I cannot read at all 
 
Section 9: Sleeping 
 
□ I have no trouble sleeping 
□ My sleep is slightly disturbed (less than 1 hr 
sleepless) 
□ My sleep is mildly disturbed (1-2 hrs 
sleepless) 
□ My sleep is moderately disturbed (2-3 hrs 
sleepless) 
□ My sleep is greatly disturbed (3-5 hrs 
sleepless) 
□ My sleep is completely disturbed (5-7 hrs 
sleepless) 
 
Section 5: Headaches 
 
□ I have no headaches at all 
□ I have slight headaches, which come 
infrequently 
□ I have moderate headaches, which come 
infrequently 
□ I have moderate headaches, which come 
frequently 
□ I have severe headaches, which come 
frequently 
□ I have headaches almost all the time 
 
Section 10: Recreation 
 
□ I am able to engage in all my recreation 
activities with no neck pain at all 
□ I am able to engage in all my recreation 
activities, with some pain in my neck 
□ I am able to engage in most, but not all of 
my usual recreation activities because of pain 
in my neck 
□ I am able to engage in a few of my usual 
recreation activities because of pain in my 
neck 
□ I can hardly do any recreation activities 
because of pain in my neck 
□ I can’t do any recreation at all 
 
 
Score: __/50  Transform to percentage score x 100 =   % points 
NDI developed by: Vernon, H. & Mior, S. (1991). The Neck Disability Index: A study of 
reliability and validity. Journal of Manipulative and Physiological Therapeutics. 14, 409-415.  
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TMD Disability Index: 
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Tampa Scale for Kinesiophobia for Temporomandibular Disorders 
(TSK-TMD 12-item version from Visscher, Ohrbach et al Pain 2010;150(3):492-500) 
 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
I’m Afraid that I might injure myself if I move my 
jaw 
1 2 3 4 
If I ignored my jaw symptoms, they would get 
worse 
1 2 3 4 
My jaw is telling me that something is seriously 
wrong with it 
1 2 3 4 
Other people do not take my jaw symptoms 
seriously enough 
1 2 3 4 
My jaw symptoms have put my health at risk for 
the rest of my life 
1 2 3 4 
My jaw symptoms mean that I have injured my 
jaw 
1 2 3 4 
The safest way to prevent my symptoms from 
getting worse is to be careful and not to move my 
jaw any more than necessary 
1 2 3 4 
I would not have this many jaw symptoms if there 
was not something potentially harmful going on. 
1 2 3 4 
My jaw symptoms let me know when to stop 
moving my jaw so that I do not injure myself 
1 2 3 4 
I cannot do everything other people can do, 
because it is too easy for me to injure my jaw. 
1 2 3 4 
No one should have to move the jaw when he/she 
has a jaw problem.   
1 2 3 4 
I am afraid to open my mouth wide because then I 
may not be able to close it again 
1 2 3 4 
 
A total score is calculated. 
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Side-Effect Questionnaire 
1. Did you experience any discomfort after (and related to) any of the physical therapy 
treatments?   YES  /  NO 
2. If Yes, Please mark all that apply by checking the box to the left.  Describe where 
symptoms were located or what specific symptoms you experienced.  Describe when they 
started (onset), how long they lasted (duration), and the severity.   
 
 
 Symptom Description Onset Duration Severity 
1= light 
2= mild 
3= 
moderate 
4= severe 
  Aggravation 
of your 
present 
complaints 
 ____Min/Hrs ____Min/Hrs/Days  
  Spasm  ____Min/Hrs ____Min/Hrs/Days  
  Stiffness  ____Min/Hrs ____Min/Hrs/Days  
  Dizziness  ____Min/Hrs ____Min/Hrs/Days  
  Headache  ____Min/Hrs ____Min/Hrs/Days  
  Radiating 
Discomfort 
 ____Min/Hrs ____Min/Hrs/Days  
  Fatigue  ____Min/Hrs ____Min/Hrs/Days  
  Nausea  ____Min/Hrs ____Min/Hrs/Days  
  Vomiting  ____Min/Hrs ____Min/Hrs/Days  
  Swallowing 
Problems 
 ____Min/Hrs ____Min/Hrs/Days  
  Visible 
Changes 
 ____Min/Hrs ____Min/Hrs/Days  
  Breathing 
Changes 
 ____Min/Hrs ____Min/Hrs/Days  
  Other  ____Min/Hrs ____Min/Hrs/Days  
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Appendix 8 
Health History and Screening Form 
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Health History and Screening Form 
(Initial Visit)  
First Name:________________________    Last Name:__________________________ 
Date of birth: ______________________Age:_______  Gender (circle one):   Male/Female 
Can you read/write English (circle one):  Yes/No 
Phone number: ____________________    Email address: _______________________ 
Mailing address: ____________________________    
__________________________________________    
 
Preferred contact method (RANK 1‐3):      Phone_____  Email_______  Mail_______ 
Occupation: ___________________________________ 
PRIMARY CARE PHYSICIAN: 
  Name: ________________________________________ 
  Phone Number: _________________________________ 
EMERGENCY CONTACT:  
  Name:_______________________________  Relationship: _____________________ 
  Phone number: ___________________________________ 
 
 
ASSIGNED CASE NUMBER:  ___________________________ 
 
W 9 Payment Form Mailed In?     YES    NO 
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Medical History 
1. Does your jaw LOCK?                  YES/NO 
2. Have you had a whiplash injury in the last 6 weeks?          YES/NO 
3. Have you ever had neck surgery?              YES/NO 
4. Have you received spinal manipulation in the last 3 months?        YES/NO 
5. Do you have Osteoporosis?                YES/NO 
6. Do you have rheumatoid arthritis or ankylosing spondylitis?        YES/NO 
7. Has a Doctor ever told you your blood pressure was too high?         YES/NO 
8. Has a Doctor ever told you your cholesterol was too high?         YES/NO 
9. Do you have Diabetes?                  YES/NO     
a. If YES, is it Insulin Dependent / Non‐Insulin Dependent            
10. Do you take medication to control your 
a. Blood Pressure                YES/NO 
b. Cholesterol                 YES/NO 
c. Diabetes                 YES/NO 
11. Are you currently pregnant?                 YES/NO 
12. Have you been pregnant or delivered a child in the 6 months?        YES/NO 
13. Do you take birth control pills?                YES/NO 
14. Do you smoke?                    YES/NO 
15. Have you been diagnosed with migraines?            YES/NO 
16. Do you have a new or sudden onset of head/neck pain?          YES/NO 
17. Do you currently have cancer?                YES/NO 
18. Do you have a history of cancer in the last 6 months?          YES/NO 
19. Have you had previous use of steroids?              YES/NO 
20. Do you have drop attacks?                YES/NO 
21. Do you have any current fractures?              YES/NO 
22. Do you have any current infection?              YES/NO 
23. Do you currently have nausea?                YES/NO 
24. Do you currently have any of the following:            YES/NO 
a. Dizziness, blurred vision, double vision, ringing in your ears, difficulty swallowing, 
difficulty speaking  (Please CIRCLE all that Apply) 
25. Have you had a heart attack, stroke, or mini‐stroke (Transient Ischemic Attack)    YES/NO 
 
When did the symptoms in your jaw begin? ___________________________________________ 
Please list any previous treatments you have received for your jaw pain noting if they were helpful, 
harmful, or indifferent: 
_______________________________________________________________________________ 
_______________________________________________________________________________ 
Have you ever used an oral splint or mouth guard? Yes/No    
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Please utilize this body diagram to mark an ‘X’ in the location of any pain.   
 
What makes your pain worse?  
________________________________________________________________________________ 
What makes your pain better?  
________________________________________________________________________________ 
Are you physically active?  If so, what do you do for exercise? 
________________________________________________________________________________ 
________________________________________________________________________________ 
Please list any major surgeries and approximate dates: 
________________________________________________________________________________ 
________________________________________________________________________________ 
_________________________________________________________________________________ 
List of other medical/health conditions: 
________________________________________________________________________________ 
________________________________________________________________________________ 
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_________________________________________________________________________________ 
List of Medications and dosage:  
________________________________________________________________________________ 
________________________________________________________________________________ 
_________________________________________________________________________________ 
List any Known Allergies:  
________________________________________________________________________________ 
________________________________________________________________________________ 
_________________________________________________________________________________ 
 
 
General Screen: 
4. In the last 30 days, on average, how long did any pain in your jaw or temple area on either 
side last?32   
a. No pain (0) 
b. From very brief to more than a week, but it does stop (1) 
c. Continuous (2) 
5. In the last 30 days, have you had pain or stiffness in your jaw on awakening? 
a. No (0) 
b. Yes (1) 
6. In the last 30 days, did chewing hard or tough food change any pain (that is make it better or 
make it worse) in your jaw or temple area on either side? 
a. No (0) 
b. Yes (1) 
Total Score:  
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TO BE COMPLETED BY THE CLINICIAN  
VISIT ONE:  Please initial this box if medical history form AND informed consent 
were completed by the subject and fully reviewed by the researcher/clinician.  
15 sec HR: _______________________    BP: ____________________________ 
Height: ___________________________  Weight: ___________________     
 
If any of the following are Positive, STOP and make a medical referral: 
Resting Nystagmus:        Positive/Negative 
Cranial Nerve Screen:        Positive/Negative 
Have you noticed change in your ability to smell, read clearly, eat, speak, taste food, or 
hear? 
Pupil constriction to light 
Eye movement down and in away from midline by following your finger with eyes 
Facial light touch x3 regions 
Smile, pucker lips, raise eyebrows, and stick out tongue  
Finger rub hearing 
Shoulder shrug resisted  
Sharp Purser:          Positive/Negative 
Upper Motor Neuron Assessment:       Positive/Negative 
Signs of Bilateral or Quadrilateral Paresthesia or Motor Deficits:   Positive/Negative 
Signs of Cervical Nerve Root Compression: Circle one 
2 or more signs present (reflex, sensation, myotome): Positive 
1 or none present: Proceed 
Vertebral Artery Screen:       Positive/Negative 
Alar Ligament Screen:        Positive/Negative 
Transverse Ligament Screen:       Positive/Negative 
 
 
 
 
211 
 
**Review of Inclusion Criteria 
Is NPRS ≥ 2 for jaw pain?    Yes: Proceed  No: Exclude 
  
Is pain-free MMO ≤ 50 mm?   Yes: Proceed  No: Exclude 
 
Is TMD Screen score ≥ 2   Yes: Proceed  No: Exclude 
 
STOP HERE AND PASS TO BLINDED ASSESSOR  
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VISIT ONE Pre and Post Treatment Data.  To Be Completed by a Blinded Assessor: 
Forms To Be Completed by a Blinded Assessor: 
Seated VCs 
“Sit up tall and ….. Nod head forward as far as possible brining the chin to the chest 
Extend the head backward as far as possible looking up toward 
ceiling 
   Open the mouth as wide as possible without pain” 
  
 
 
 
 
 
 
 
  
 
Supine VCs:  “turn the head as far as possible to the right/left” 
“maintain the teeth slightly apart (holding lip if necessary) and move the 
lower jaw to the right/left” 
 
 
 
 
 
 
 
AROM 
 
Baseline 
Seated Cervical flexion  
Seated Cervical extension  
Seated MMO PAIN-FREE  
Able to fully close? YES/NO  
AROM 
 
Baseline 
Supine Cervical Rotation R  
Supine Cervical Rotation L  
Supine Lateral jaw excursion R  
Supine Lateral jaw excursion L  
Circle Left or Right lower incisor AND mark 
the same on future tagged pages for blind 
assessor measurement
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PPT VCs:  “Sit up tall with your lips together and teeth apart during testing.  I am going 
to apply some pressure, let me know when the sensation of pressure turns to pain” 
Pain pressure threshold Baseline 
Temporalis R 
 
Trial 1: 
Trial 2: 
Trial 3: 
Masseter 1 R 
 
Trial 1: 
Trial 2: 
Trial 3: 
1st Dorsal Interossei R 
 
Trial 1: 
Trial 2: 
Trial 3: 
Temporalis L 
 
Trial 1: 
Trial 2: 
Trial 3: 
Masseter 1 L 
 
Trial 1: 
Trial 2: 
Trial 3: 
1st Dorsal Interossei L 
 
Trial 1: 
Trial 2: 
Trial 3: 
 
M1 T1 1st DI 
  
 
Blinded Assessor signature: _______________________________ 
STOP HERE AND RETURN TO CLINICIAN **A similar form 
will be used for visit 2 (1 week) and visit 4 (4 week).   
  
Image from 
McSweeney 
et al1 
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Appendix G 
Home Exercise Program and Behavioral Education 
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HEP LOG 
The exercise handouts provided to you include instructions on the number of repetitions to be 
performed.  In addition to performing these exercises, you should maintain your usual activities 
that do not increase your symptoms; avoid activities that aggravate your symptoms.  You do not 
have to discontinue other forms of exercise during participation in this study, however, do not 
begin new forms of exercise.  You should not experience any significant increase in your pain 
while performing these exercises.  Discontinue the exercise if it causes you significant increased 
pain, and notify your physical therapist.  Please record your home exercise sessions in the 
exercise log provided below.  See codes for recording.  We ask that you honestly reflect your 
performance of exercises here.  Thank you for your participation in this research and please let 
your physical therapist know if you have any questions.   
Please use the following Codes in each box to record your exercise sessions 
PT: If you attended Physical Therapy on this day 
Y: If you completed your home exercise program 
N: If you did not complete your home exercise program and please note the reason why (ex: 
pain, ran out of time, forgot) 
P: If you completed part of the exercise program, and please note the reason why (ex: pain, ran 
out of time, forgot) 
Date Sunday Monday Tuesday Wednesday Thursday Friday Saturday 
Week 1 
Date: 
       
NOTES        
Week 2 
Date: 
       
NOTES        
Week 3 
Date: 
       
NOTES        
Week 4 
Date: 
       
NOTES        
Week 5 
Date: 
       
NOTES        
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Everyday Suggestions for Jaw Pain 
The Temporomandibular joint (TMJ) is much like other joints in the body in that it has muscles, 
ligaments, a capsule, cartilage, and joint fluid.  Like other joints, it can be a source of pain and limit daily 
activities.  Physical therapy can help minimize pain and improve range of motion and functional use of 
the jaw.  There are also many things you can do to decrease the pain throughout the day.  Please use 
the following list as a reminder.   
 Use the resting position of the jaw as often as you can throughout the day.  Lips together, teeth 
apart, tongue on the roof of the mouth.  Think of this as you are driving, working, lying in bed at 
night and really anytime you can! 
 Place the tongue on the roof of the mouth during yawning 
 Do your best to decrease the emotional and physical stress on the body that can contribute to 
clenching, grinding, and pain 
 Choose soft foods when you can 
 Cut food into smaller bites when possible 
 Avoid the following 
o Chewing/biting nails 
o Chewing gum 
o Eating hard candy/food 
o Eating firm or hard breads 
o Wide yawning or singing 
o Chewing only on one side 
o Teeth clenching and grinding 
o Teeth touching‐ Remember lips together teeth apart! 
o Biting your cheeks, lips or other areas of the mouth 
o Resting your jaw on your hands 
o Jaw strain with playing musical instruments 
 Be sure to get a good night’s sleep!  
Thank you very much for your participation.  Please contact your PT or the primary researcher with any 
questions or concerns.  When the study is complete we are 
happy to talk with you about further options for treatment!  
  
 
 
Bre Reynolds, PT, DPT, FAAOMPT
Assistant Professor Bradley University 
(309)677‐3293, bcreynolds@fsmail.bradley.edu  
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Home Exercise Program  
Exercise  Instructions  Picture  Sets/Reps 
Jaw Resting 
Position 
Place the tip of your 
tongue on the roof of 
your mouth with your 
lips together and 
teeth apart.  Focus on 
relaxing the muscles 
of the jaw and face. 
Perform 
throughout the 
day as often as 
possible.  
Specifically times 
of stress, 
concentration, 
driving, working, 
falling asleep, 
etc. 
Controlled 
Jaw Opening 
Place the tip of your 
tongue on the roof of 
your mouth and 
slowly lower your jaw 
to open your mouth. 
Your tongue should 
stay in contact with 
the roof of your 
mouth throughout the 
movement. Look in a 
mirror to avoid 
deflecting to one side. 
 
Perform 6 
repetitions,  
4‐6 x/day 
Hyperboloid 
Lateral Jaw 
Movement 
Place the hyperboloid 
between the top and 
bottom front two 
teeth. Use the string 
to catch the 
hyperboloid if it falls.  
Only provide enough 
pressure with your 
teeth to keep the 
hyperboloid in place 
and avoid squeezing 
it.  Gently move your 
lower jaw to the right 
10 times and to the 
left 10 times. 
 
Perform 10 reps 
in each direction 
4‐6x/day.  When 
this becomes 
easy, use one 
finger resistance 
on the side of 
your lower jaw 
to provide some 
resistance. This 
can be 
progressed to 2 
and finally 3 
fingers of 
resistance each 
direction. 
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Upper Neck 
Stretch 
Sit up tall with your 
head facing forward.  
Lace your fingers 
together and place 
them at the base of 
your head. Move your 
elbows close together.  
Slowly bring your chin 
down toward your 
chest about 20º and 
then lift your head up 
toward the sky with 
your hands. 
Hold the stretch 
position for 5‐10 
seconds and 
repeat 6 times.  
Perform 4‐
6x/day. 
3 Finger 
Cervical 
Rotation 
Place three fingers on 
your chest as shown 
and rotate to one side 
as far as possible, then 
return to neutral.  
Alternate right and 
left rotation. 
Perform 6 reps 
each direction 4‐
6x/day. You may 
start with 5 
fingers and work 
toward 3 fingers 
if necessary. 
Shoulder 
Blade 
Squeeze 
Sit or stand with 
upright posture and 
draw both shoulder 
blades down and 
back. Avoid lifting 
your shoulder up 
toward your ears 
during this exercise. 
Hold the position 
for 6 seconds 
and repeat 6 
times.  Perform 
4‐6x/day. 
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Appendix 10 
Manual of Standard Operating Procedures 
(Excluding appendices and reference list as they repeat above appendices and references) 
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Thrust Joint Manipulation to the Cervical Spine in Participants with a Primary Complaint 
of Temporomandibular Disorder (TMD): A Randomized Clinical Trial 
Manual of Standard Operating Procedures  
This manual will serve as a reference guiding standardization of screening, evaluation, and 
treatment of eligible participants as well as data collection and recording.   
Study Introduction 
Jaw pain is noted in up to 60% of the population293 and many of these people do not seek 
treatment or know that treatment is available.  Diagnosis is generally made via clinical symptom 
presentation.  Pain can be experienced in the jaw, neck, ear, eye, or other facial regions.  Other 
symptoms can include limited range of motion (ROM) in the jaw or cervical spine, headache, 
sleep disorders, and vertigo.293 
An anatomical, biomechanical and neurophysiological relationship between the cervical 
spine and temporomandibular joint (TMJ) has been established.161  One potential explanation for 
the relationship between the cervical spine and jaw is regional interdependence.  Regional 
interdependence refers to the relationship between various joints and pain responses attempting 
to explain why impairments at one region may contribute to pain in another region.108,151 
Manual therapy and exercise targeting the cervical spine has been examined in persons 
with temporomandibular disorder (TMD).22,23  Cervical mobilization has shown promise with 
large effect sizes noted for decreasing pain, increasing mouth opening and lowering pressure 
pain threshold.22  Cervical thrust joint manipulation has been studied as part of a multimodal 
intervention plan but the specific impact of cervical thrust manipulation is yet to be determined.  
Atlanto-occipital thrust joint manipulation has been utilized on populations with neck pain or 
those with latent trigger points but not specifically on a population with a primary complaint of 
jaw pain.69,161 
This study is a prospective longitudinal randomized clinical trial.  Subjects will be 
recruited and will enter the study voluntarily.  Intervention will be delivered at the first visit, 1 
week, 2 weeks, and 4 weeks.  Data related to outcomes will be collected at the first visit, 
immediately following the first intervention, 1 week and 4 weeks.  All subjects will receive 
suboccipital release, behavioral education, and exercise.  The randomized intervention is cervical 
thrust manipulation vs sham manipulation.  The estimated sample size will be 42 patients with 21 
per group.   
 
Eligibility Criteria 
A total of 42 participants referred from local dentists or recruited from the general 
population will be needed for completion of this study.  All participants consenting to 
participation will be screened for eligibility using a health record form, physical objective 
examinations, and self-report measures.  Participants will be screened by the evaluating physical 
therapist An initial screening tool has been established and demonstrated high specificity (.97) 
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and sensitivity (.99) to identify those with and without TMD.32  It is suggested that this tool be 
used to determine the presence of pain related TMD and the potential need for treatment.33  The 
screen listed below is included on the last page of the evaluation/health history form and should 
be scored to ensure each participant meets inclusion criteria.  
7. In the last 30 days, on average, how long did any pain in your jaw or temple area on either 
side last?32   
a. No pain 
b. From very brief to more than a week, but it does stop 
c. Continuous   
8. In the last 30 days, have you had pain or stiffness in your jaw on awakening? 
a. No 
b. Yes 
9. In the last 30 days, did chewing hard or tough food change any pain (that is make it better or 
make it worse) in your jaw or temple area on either side? 
a. No 
b. Yes 
Scoring: all “a” responses are scores as 0, “b” response is 1 point, and “c” response is 2 points.  
A threshold of a total score of 2 is needed for a positive screen.32 
Inclusion Criteria: 
8. Numeric Pain Rating Scale (NPRS) score ≥ 2 in jaw at baseline 
9. Pain-free mouth opening ≤ 50 mm   
10. Age 18-65 
11. Primary complaint of TMD pain 
12. TMD pain confirmed by screen listed above 
13. Proficiency in the English Language 
14. Availability to attend 4 appointments in 4 week 
A minimum level of disability was established to increase likelihood of capturing change in 
pain or function.  While there is no established minimum level of disability for the TMD 
population with NPRS, a score of  ≥2 at baseline was chosen based on previous 
research156,186 related to neck pain and the minimum NPRS score noted in a case series 
performed by the PI before the start of this study.  Cervical thrust manipulation has been 
studied in a population of persons with neck pain, however, the intent of this study is to look 
at the impact of thrust joint manipulation of the cervical spine in a TMD population; 
therefore, persons included must have a primary complaint of TMD pain.    
 
Exclusion Criteria: 
7. Traumatic onset of symptoms in the last year 
8. History of whiplash in the last 6 weeks; Prior neck surgery 
9. TMJ locking in the last month 
10. Medical red flags suggestive of non-musculoskeletal origin of pain, systemic or 
neurological disease 
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a. Two or more signs of cervical nerve root compression (major muscle weakness, 
diminished upper extremity reflexes, diminished or absent pinprick sensation in a 
dermatomal pattern); Evidence of central nervous system involvement 
(hyperreflexia, gait disturbance, nystagmus, impaired facial sensation, change in 
taste, loss of visual acuity, positive pathological reflexes (Hoffman, Babinski, 
Inverted supinator, clonus)); unremitting night pain or non-mechanical pain. 
11. Contraindications to thrust joint manipulation: active cancer, history of prolonged steroid 
use, acute fracture or tumor in the area to be treated, osteoporosis, joint ankyloses, 
dislocation, cervical ligament ruptures, acute active inflammatory or infectious disease, 
rheumatoid arthritis, vertebral artery abnormalities, connective tissue disease (Muscular 
dysplasia, Marfan syndrome, Down syndrome, Ehlers Danlos syndrome), prolonged 
anticoagulant therapy, signs of cranial nerve involvement, drop attacks, dysarthria, 
dysphagia, nystagmus, new or recent onset of dizziness, new or recent onset neck pain or 
headache “unlike any other”, previous cerebrovascular accident or transient ischemic 
attack, or uncontrolled hypertension, diabetes, or hyperlipidemia.   
12. Previous cervical spine thrust joint manipulation intervention in the last 3 months; 
Worker’s compensation or any pending litigation regarding their pain or injury.   
***It is important that all evaluating therapists and researchers document any reason for 
exclusion (including not meeting inclusion/exclusion criteria or patient declination) as well as 
any attrition at follow-up.   
Informed Consent 
Have subjects read and sign the Informed Consent document. Any of the participating therapists 
may consent a patient to participate; however, no other individuals may consent a patient into the 
study. Ensure the patient initials all pages of each of the two copies of the Informed Consent 
document (except for the last page where their signature will be present). Both copies should 
then be signed by one of the participating therapists in the “Investigator’s Signature” block and 
by another clinic staff member in the “Witness Signature” block (if applicable on your form). Do 
not have a friend or family member of the subject sign in the “Witness Signature” block. Hand 
one copy of the Informed Consent document to the subject for them to keep and place the other 
copy of the Informed Consent document in a folder in the appropriate location. Patients are 
considered enrolled into the study once they sign this statement. 
 
Health History/ Historical Information 
1. Demographic information used for data collection, contact information, and emergency 
contacts. 
2. Medical history check list: Any questions answered ‘yes’ or circled require further 
examination/explanation from evaluating therapist.  If concerns are raised, make a phone 
call to inform their primary care or referring physician.  Any aspect of medical history 
meeting contraindications for PT or manipulation should be noted and the patient is to be 
excluded from the study.  Keep the documentation of exclusion in his/her file in the 
locked cabinet.   
3. Onset Date: Can be listed as an exact date with note of preceding incident, or a general 
timeframe of number of days/weeks/months/years ago. 
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4. Treatment for Prior Episodes of Jaw Pain: If a patient does not have a history of jaw pain, 
you may proceed to the next question.  If the patient does note a prior history, be sure 
treatments and response to treatment are recorded. 
5. PHQ-2 Depression Screen: A patient who scores ≥3 should be referred to their primary 
care physician for follow-up, but may continue participation in the study. 
6. Pain Diagram: The pain diagram is used to record the location and nature of pain by 
drawing it on a human figure.  The pain diagram has shown to be a reliable tool to 
localize patient’s symptoms.   
7. Aggravating/Relieving Factors: If this is left incomplete, ask the patient directly and fill 
in information.  
8. Activity Level: To indicate mode, duration, frequency of exercise. 
9. Past Medical History: To note any other surgery, diagnosis, or medications not already 
covered in the check list. 
10. General TMD Screen: A score of 2 is needed for inclusion 
 
Self-Report Measures and Outcome Data  
All subjects will complete several commonly used instruments to assess pain and function in 
patients with TMD. There is no consensus in the literature regarding the most appropriate 
outcome measures to use with this population.  Therefore, we will use a spectrum of outcome 
measures that attempt to capture the effect of treatment on the level of the patient’s perceived 
recovery, disability, and functional limitations.  Other measurements for cervical range of motion 
(ROM), jaw ROM, and pressure pain threshold (PPT) will be taken by an assessor blind to 
treatment group allocation.  The timing of data collection for the self-report and outcome 
measures is listed below in Table 1.  Outcomes at 3 and 6 months will be mailed or emailed by 
the researchers.  See Appendix for copies of all Self-Report Measures. 
 
Table 1: Timing of Data Collection 
Measurement Baseline Immediate 1  
week 
2  
week 
4  
Week
3  
Month 
6 
Month 
ROM Jaw Yes Yes Yes No Yes No No 
NPRS Yes Yes Yes No Yes No No 
JFLS Yes No Yes No Yes Yes Yes 
NDI Yes No Yes No Yes Yes Yes 
TMD Disability 
Index 
Yes No Yes No Yes Yes Yes 
GROC No Yes Yes No Yes No No 
PASS No No No No Yes Yes Yes 
TSK-TMD Yes No No No Yes Yes Yes 
ROM Cervical Spine Yes Yes Yes No Yes No No 
Pressure Pain 
Threshold 
Yes Yes Yes No Yes No No 
Mailed by     
Researchers 
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PHQ-2 Depression 
Screen 
Yes No No No No No No 
Side Effect 
Questionnaire 
No No No No Yes No No 
 
The self-report measures that will be used include the following: 
1. Numeric Pain Rating Scale (NPRS): The NPRS allows patients to quantify their pain on an 
11-point scale used to measure pain intensity.  Pain is given a number from 0 (representing 
no pain) to 10 (representing the worst pain imaginable).195  Psychometric property analysis 
relevant to the TMD population is limited.  Sum scores have been suggested to improve 
reliability,165 and will be utilized for this study.  Participants will be asked to rate their 
current pain as well as the best and worst pain scores over the last 24 hours resulting in an 
average pain score165,197 that will be recorded for jaw pain, neck pain, and headache.   
**This is the only scale the clinician must partially score themselves, as a sum score of 
NPRS for the jaw must be ≥2.  You will add all 3 pain scores for the jaw (present, best, 
worst) and divide by 3.  This is only necessary on the first visit.  
2. Jaw Functional Limitation Scale (JFLS): The JFLS is a 20 item self-report scale assessing 
three constructs (mastication, vertical jaw movement, emotional/verbal expression) to 
quantify functional limitation.203  Each item is scored by the patient from 0 (no limitation) to 
10 (severe limitation).  The recorded score is the total score of the 20 items, ranging from 0-
200.  Higher scores reflect greater level of dysfunction.   
3. Neck Disability Index (NDI): The NDI is a 10 question self-report scale assessing levels of 
neck pain and related disability.  Each item is scored from 0-5 with a maximum score of 50 
points.  The total score is doubled and interpreted as a percentage of the patient perceived 
disability.  Higher scores represent increased level of disability.   
4. TMD Disability Index: The TMD Disability Index is a 10 question self-report scale utilized 
in research (including a study of manual therapy for TMD).208  Each item is scored 1-5 with a 
minimum score of 10 and a maximum score of 50.  Higher scores are representative of higher 
levels of disability.  However, there are no reports of psychometric property analysis in the 
literature.  It is a goal of this study to begin reporting psychometric analysis of this tool.     
5. Global Rating of Change (GROC): The GROC scale asks patients to rate their perception of 
overall change.  The scale ranges from -7 (a very great deal worse) to zero (about the same) 
to +7 (a very great deal better).210,211  Intermittent descriptors of worsening or improving are 
assigned values from –1 to –6 and +1 to +6 respectively.  The global rating will be 
administered at the follow-up examinations only and will serve as the reference criterion for 
establishing when a successful outcome occurs.  Controversy surrounding the construct 
validity278 of this measure will be taken into account when interpreting results.  
6. Patient Acceptable Symptom State (PASS): The PASS is a single question asking patients if 
their current status is acceptable or unacceptable.216  Some authors have noted patients who 
found their current state acceptable, often had “unexpectedly high”217,218 pain ratings.  The 
use of this tool allows for a better understanding of the participants’ perception of their well-
being218 and may suggest they are unlikely to seek further treatment.220 Wording is modeled 
after Mintken et al 2016; “Taking into account all the activities you have during your daily 
life, your level of pain, and also your functional impairment, do you consider that your 
current state is satisfactory?”221  Individuals are to respond yes or no; those responding yes 
will be categorized as a success.  
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7. Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD): TSK-TMD 
is a self-report scale modified from the original Tampa Scale for Kinesiophobia utilized to 
assess fear of movement commonly associated with chronic pain conditions including neck 
pain.222  It is a 12 item measure assessing fear of movement/(re)injury.  Patients rate each 
item on a 4-point Likert scale and total scores range from 11-48.  Higher scores represent 
higher levels of fear.   
8. PHQ-2 Depression Screen: The PHQ-2 is a 2 question screen used to identify persons at risk 
for depression.  This test is not diagnostic for depression, but a recognized brief and effective 
first step in identification of those at risk.242,243  A patient who scores ≥3 should be referred to 
their primary care physician for follow-up, but may continue participation in the study. 
9. Side Effects Questionnaire: At visit 4 (week 4), patients will complete a questionnaire asking 
about side effects or adverse events associated with their treatment.  This information will be 
summarized and reported.   
**Payment for Participation: Participants can be paid for participation if they complete the 
required form and place it into the self-addressed envelope.  Participants are to close this 
envelope themselves to ensure this information remains completely confidential and is only 
shared with Bradley University for the purpose of processing payment.  Please drop these 
envelopes into the mail.   
Physical Examination 
To be performed by the treating clinician 
1. 15 second heart rate 
2. Blood Pressure 
3. Height and Weight: Verbal, BMI ok to leave blank 
4. Safety screen: Stop and make a medical referral if any of these are positive 
a. Resting Nystagmus: note if present 
b. Cranial Nerve Screen  
i. Ask the patient: Have you noticed a change in your ability to smell, read 
clearly, eat, speak, taste food, or hear? 
ii. Assess pupil constriction to light. 
iii. Assess eye movement down and in as well as away from midline by 
asking the patient to follow your finger with their eyes. 
iv. Assess facial sensation in the region of the ophthalmic (above eye brow), 
maxillary (above upper lip), and mandibular (below lower lip) branches of 
the trigeminal nerve. 
v. Ask the patient to smile, pucker the lips, raise the eyebrows (note if 
impaired), and stick out their tongue (look for deviation to one side). 
vi. Rub your fingers by each ear asking if the patient hears them both equally. 
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c. Sharp-Purser Test: To perform the test, the patient is seated. 
The examiner places the palm of one hand over the patient’s 
forehead while the opposite hand stabilizes the spinous 
process of the axis. With the neck in approximately 20-30 of 
flexion, the examiner applies a posterior shearing force with 
the hand on the patient’s forehead.  A positive test is a 
reduction in signs and symptoms.  
d. Upper Motor Neuron Assessment: Testing 
of the Hoffman and Babinski reflexes may 
be necessary if the patient reports symptoms 
consistent with an UMN lesion. Most 
therapists are familiar with the Babinski 
reflex. However, the Hoffmann’s reflex is 
also useful to detect the presence of an 
UMN lesion. This test is conducted with the 
patient’s hand in the neutral position. The 
examiner flicks the distal phalanx of the middle finger. Hoffman’s reflex is 
considered positive if there is flexion of the interphalangeal joint of the thumb, 
with or without flexion of the index finger proximal or distal interphalangeal 
joints. A positive reflex may denote spinal cord compression or intracranial 
pathology. A positive test in a patient with other neurologic signs and symptoms 
warrants referral to a specialist for appropriate management.  
e. Signs of Bilateral or Quadrilateral Paresthesia or Motor Deficits: Note if present. 
f. Vertebral Artery Screen: This test is performed in supine. The patient is moved 
passively and sequentially into right and left rotation, followed by extension, then 
extension with rotation in each direction. During each movement the patient holds 
the position while counting backwards from 15, with the therapist monitoring for 
the nystagmus or presence of cranial nerve signs and symptoms as previously 
described. If any one of these signs or symptoms is observed, the therapist should 
forgo testing of more extreme movements, immediately move the patient’s head 
into a more neutral position, and refer the patient for further consultation. 
g. Alar Ligament Testing: The Alar Ligament Test assesses the integrity of the alar 
ligaments, which provide stability to the atlanto-occipital complex. With the 
patient supine, the examiner stabilizes the axis by placing the pad of the left 
thumb immediately adjacent to the left aspect of the spinous process of the axis. 
With the right hand, the examiner side bends the patient’s head to the right. The 
examiner should feel the spinous process of the axis immediately move into the 
left thumb. If the alar ligament is intact, little to no sidebending can occur and the 
end feel should be capsular.  A delay, or lag, in the movement of the spinous 
process of the axis is suggestive of injury to the alar ligament. The test is then 
repeated to the opposite side 
h. Transverse Ligament Screen: The Transverse Ligament Test assesses the integrity 
of the transverse ligament, which provides stability to the dens at the atlantoaxial 
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joint.  With the patient supine, the examiner stabilizes the axis by placing the left 
thumb and index finger on the transverse processes of C2.  With the right hand, 
the examiner provides an anterior shearing force to the occiput/C1 and should feel 
a firm end feel to this motion.  Excessive anterior shear without a firm end point, 
a sensation of a lump in the throat, abnormal pupil response, nystagmus, 
dizziness, paresthesia in the face or lips indicate a positive test. 
 
i. 2 or more signs of cervical nerve root compression 
i. Sensory Exam: Test key UE dermatome sensation (see Table below), 
After each limb is pricked, ask the patient “Does that feel the same to you 
on each side?”  If a difference is noted, the area should be explored further 
to map the extent of the sensory deficit.  Results are recorded as 
absent/diminished or normal compared to the other side. 
ii. Muscle Stretch Reflexes (MSR): The biceps brachii reflex tests the C5 
nerve root. The reflex is tested by placing the patient’s arm in about 45 of 
flexion with the muscle relaxed. The examiner strikes the tendon in the 
cubital fossa, just proximal to its insertion. The thumb may be placed over 
the tendon to insure proper technique. The brachioradialis reflex primarily 
tests the C6 nerve root. The arm is positioned as for the biceps reflex. The 
examiner strikes the tendon at the distal aspect of the radius with the flat 
edge of the reflex hammer. The triceps reflex is used to test the C7 nerve 
root. The examiner supports the patient’s arm and strikes the triceps 
tendon just proximal to the olecranon.  Each reflex is graded as 
absent/diminished, WNL, or hyperactive. 
iii. Motor Exam: Key muscles for each cervical nerve root are tested.  Each 
muscle test is graded as WNL or diminished.  The examiner should also 
note if pain was produced during the muscle test.  Muscle testing 
procedures are outlined in the table below. 
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 Key Muscles for MMT Dermatomal 
areas 
Key Muscle for MSRs 
C5 deltoid (shoulder in 90 abduction, resistance against lateral 
upper arm into adduction) 
Mid-deltoid biceps brachii (C5, C6) 
brachioradialis (C5, 
C6) C6 biceps brachii (elbow at 90 flexion with forearm supinated, 
resistance against lower forearm into extension) 
extensor carpi radialis longus/brevis (wrist extended/ radially 
deviated with forearm pronated, resistance against dorsum 
of hand into flexion/ulnar deviation) 
radial aspect of 2nd 
metacarpal/ digit 
C7 triceps (arm is placed overhead with elbow slightly flexed, 
resistance against forearm into flexion) 
flexor carpi radialis (wrist flexed/radially deviated with 
forearm supinated, resistance against thenar eminence into 
extension/ulnar deviation) 
dorsum of 3rd finger triceps (C7) 
C8 abductor pollicis brevis (thumb placed in abduction, 
resistance against proximal phalanx into adduction) 
medial aspect of 5th 
finger 
N/A 
T1 first dorsal interossei (index and middle finger are 
separated, resistance against the medial aspect of proximal 
phalanx of the index finger into adduction) 
medial forearm N/A 
*** The nerve root in bold is the primary nerve root assessed by the MSR. 
 
5. Move to measurement by a blind assessor while treating therapist opens envelope to 
reveal treatment group allocation.  The blind assessor should not know what the envelope 
reveals and should step out of the treatment area during intervention to avoid visual or 
auditory clues as to group assignment.   
6. Blinded assessor/data collector to measure the following: 
AROM of the jaw: A disposable range of motion scale tool (Therabite™) will be utilized to 
measure seated maximum mouth opening and supine lateral deviation.  Mouth opening is an 
essential function of chewing and speech and often a limitation in those with jaw or neck 
pain.9,161  Care should be used during seated measurements to ensure the patient maintains an 
upright sitting position throughout the examination and during subsequent follow-up 
examinations.  The following procedures are used to measure the range of motion for the jaw. 
a. Maximal Mouth Opening (MMO): The patient is seated with the feet on the floor 
and told to sit up tall.  The patient is asked to “sit up tall and open the mouth as 
wide as possible without pain.”  Measurement is taken as the distance between 
maxillary and mandibular central incisor edges, with the Therabite notch resting 
on the most vertical incisor.113 You will circle on this page which tooth was used 
AND mark it on subsequent pages (flagged) if you are the first to measure a 
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patient.  The amount of pain-free mouth opening is recorded.  Inclusion criteria 
require this initial measurement is ≤ 50 mm.   
 
 
 
b. Lateral Deviation: The patient will be supine with the neck in a neutral position.  
The patient is told to move their lips in order to show the teeth and open the 
mouth only enough to avoid tooth contact.  The Therabite’s flat edge is used to 
record right/left lateral deviation. 
i. The flat edge of the Therabite is placed so that 0 is aligned with the space 
between the mandibular central incisors.  The patient is asked to “maintain 
the teeth only slightly apart, and move the lower jaw to the right.”  The 
therapist will note the distance from the mandibular central incisors to 0 
and record the amount of deviation.  
ii. This process is repeated for left lateral deviation.  
 
AROM of the cervical spine: Measurements of AROM are performed to determine limitations in 
motion, and the impact of movement on symptoms.  A bubble inclinometer will be used to 
measure seated flexion/extension and supine rotation.  Care should be used during seated 
measurements to ensure the patient maintains an upright sitting position throughout the 
examination and during subsequent follow-up examinations.  The following procedures are used 
to measure the range of motion for the cervical spine.   
Circle Left or Right lower incisor AND mark 
the same on future tagged pages for blind 
assessor measurement
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b. Flexion/Extension:  The patient is seated with the feet on the floor and told to sit 
up tall.  The inclinometer is placed on the top of the patient’s head with the 
fulcrum aligned with the external auditory meatus and then zeroed.   
i. The patient is asked to “sit up tall and nod the head forward as far as 
possible, bringing the chin to the chest.”  The amount of neck flexion is 
recorded from the inclinometer. 
ii. The patient is asked to “sit up tall and extend the neck backwards as far as 
possible looking up toward the ceiling.”  The amount of neck extension is 
recorded from the inclinometer.  
 
c. Rotation:  The patient will be supine with the neck in a neutral position.  The 
inclinometer is placed on the anterior base of the forehead with the fulcrum 
aligned with the center of the forehead and then zeroed.   
i. The patient is asked to “rotate the head as far as possible to the right.”  
The amount of right rotation is recorded from the inclinometer. 
ii. The patient is asked to “rotate the head as far as possible to the left.”  The 
amount of left rotation is recorded from the inclinometer. 
 
d. **Both extension and end range rotation ROM may produce dizziness or nausea 
in patients with vertebrobasilar insufficiency (VBI). 
Pressure threshold (PPT): A digital algometer will be used to assess PPT at the masseter, 
temporalis, and a remote location in the C8 dermatome at the hand.  The PPT is the amount of 
pressure needed for a subject to report the sensation of pressure changes to pain at a specific 
location.233  A mean of 3 trials will be used for each site tested, with a 30 second pause between 
each trial.99   The patient will be asked to keep their lips together and teeth apart during testing in 
order to avoid clenching or muscle contraction during testing.   
PPT will be assessed bilaterally at one point on the masseter (M1) and one point on the anterior 
temporalis (T1) as has been done in previous research.2,99  The first dorsal interossei (DI) will 
represent a remote site (C8/T1), distant to the dermatomal site of interest (C0-3).233  
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Assessors will 1st use the stencil to mark the skin at M1 and T1 on both sides.   
 M1: 2.5 cm anterior and 1.5 cm below the tragus 
 T1: 3 cm above an imaginary line drawn between the edge of the lateral eye and the 
superior external ear and 2 cm posterior to the anterior edge of the temporalis muscle
 
 
  
Image from LaTouche et al2 
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The images below show the placement of the stencil and marking location.   
M1 
   
 
T1 
   
Once marking is complete, you are done with the stencil.   
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The 3rd and final location for PPT is the 1st dorsal interossei of the RIGHT hand. 
 DI: Forearm pronated and resting on solid surface, applied at middle medial aspect of 1st 
MC1   
 
The algometer is applied perpendicular to the region of interest.  One hand will need to provide a 
counterforce on the head in order to stabilize the cervical spine when testing the jaw 
musculature.  Assessors will go through one round of each point B, then repeat that cycle so as to 
allow rest between each of the 3 testing points.  With testing all locations, the assessor will tell 
the patient to “sit up tall with your lips together and teeth apart during testing.  I am going to 
apply some pressure, let me know when the sensation of pressure turns to pain”.99   
Measurements taken by the blinded assessor will be recorded on standardized documentation 
records and returned to the locked file cabinet each visit.  See Appendix for copies of the 
Standardized Form.   
The person measuring cervical ROM, jaw ROM, and PPT will be blinded to this treatment 
allocation and must now leave the area during treatment. 
Final Clinician Testing Before Treatment: 
1. Test Position Hold: The patient will be placed in the position of TJM and held for 10 
seconds.  Stop if the patient experiences dizziness, nystagmus, nausea or sign of 
vascular/neurological compromise in the manipulation hold position.   
2. Initial the box noting you have fully reviewed the health record and physical examination 
confirming it is safe to proceed with treatment.  
 
  
Image from McSweeney et al1 
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Treatment  
Interventions 
Upon completion of health history forms, self-report questionnaires, physical exam, and 
objective measurements, patients will be randomized to receive either cervical TJM or sham 
manipulation.  Patients in both groups will attend PT at initial evaluation, 1 week, 2 weeks, and 4 
weeks for a total of 4 visits in four weeks.  Follow up at 3 and 6 months will occur via mail or e-
mail.  
Group One:  Suboccipital release (2 minutes), cervical spine TJM (5 minutes or less), 
behavioral modification (10 minutes), and exercise (15 minutes).  Suboccipital release will be 
used to allow the patient to gain comfort with manual cervical contact.  Cervical spine TJM will 
be performed in supine using a rotational up-slope manipulation at C2/3 and a distraction 
manipulation at C0/1 (see below for further detail regarding TJM intervention).  Cervical TJMs 
will be performed on the right and left side and will follow common research practice154 to 
include delivery of a high-velocity, low amplitude (HVLA) thrust.  If cavitation occurs on the 
first trial, the therapist will move to the next location.  If there is no cavitation the participant will 
be repositioned and the procedure will be performed a second time.  A maximum of two trials at 
each level on each side will be performed yielding 4-8 HVLA thrusts.  See Appendix for 
handouts that will be issued describing behavioral modification and exercise.   
Group Two: Suboccipital release (2 minutes), sham manipulation (5 minutes or less), 
behavioral modification (10 minutes), and exercise (15 minutes).  Sham manipulation will be 
performed in a similar supine position as noted above.  Clinicians will place the participant in the 
manipulation position, stop short of tissue tension, hold for 15 seconds,150 and reposition to 
neutral or resting position.175,244,245  A thrust will not be performed and while cavitation may 
occur, there is no expectation of cavitation.  Therefore, these participants will receive 4 manual 
sham manipulation techniques, one at each of 4 locations.  See Appendix for handouts that will 
be issued describing behavioral modification and exercise.   
Verbal instruction for cervical intervention will be modeled after the cervical spine 
mobilization versus sham mobilization study by La Touche et al in 2013.  Therapists will give all 
participants the same verbal description, regardless of group assignment.  Therapists will say “I 
am going to apply a technique to your neck with my hands placed here.  The purpose of this 
technique is to obtain change in your jaw and/or neck pain”.23 
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Intervention Description Image  
Suboccipital 
Release 
The patient is positioned supine for comfort.  
The therapist places both hands on the posterior 
aspect of the neck, allowing the fingertips to 
sink into the space between the occiput and the 
spinous process of C2.  The base of the head is 
supported with 90º of flexion at the MCP joints 
of fingers 2-4 on both hands.246  The therapist 
may allow slight traction cranially.  This 
technique is performed for 2 minutes.  
C0/1 
Distraction 
TJM  
The patient is positioned supine without a 
pillow.  The therapist passively sidebends the 
head and neck to the left and then rotates to the 
left.  The first MCP of the right hand contacts 
the right mastoid process.  The therapist 
passively moves the occiput into slight 
extension while maintaining left rotation.  The 
right hand will direct the force of the 
manipulation in a cranial direction, 
perpendicular to the surface of the R C0/1 joint, 
with a gentle rotatory force.247  The patient will 
be told to inhale and manipulation performed 
after exhalation.  This procedure will be 
repeated to the other side.  
  
C2/3 Upslope 
TJM 
The patient is positioned supine for comfort.  
The therapist will use a cradle hold contacting 
the posterior right articular pillar of C2 with the 
lateral border of the proximal or middle 
phalanx.  The left hand will be under the head 
with the fingers spread out to maximize contact.  
The therapist passively moves the head and 
neck into right sidebending and left rotation 
with no significant degree of flexion or 
extension.  The right hand directs the force of 
the manipulation in a direction upward toward 
the patient’s left eye.154,247  This procedure will 
be repeated to the other side.   
 
 
 
 
 
  
236 
 
Exercise Intervention 
The Rocabado 6x6 has been utilized in practice and research248 with minimal evidence to support 
use and no comparative exercise studies to date.  Lateral jaw movement training has been 
suggested and is utilized in clinical practice.249  The Rocabado program includes jaw, cervical 
spine, and postural exercises.  A combination of the Rocabado program, cervical ROM exercise, 
and lateral jaw training will be used and standardized for a home exercise program (HEP) in this 
study.  See Appendix for the handout of exercise to be provided to all patients.   
Treating clinicians will fully review this home exercise handout with each participant. 
Clinicians will describe and demonstrate each exercise, then ask the participant to perform the 
exercise in front of them.  After all exercises have been instructed, the therapist will ask the 
patient to demonstrate each exercise again with as few verbal cues as necessary.     
Visit 1:  Baseline and First Treatment 
Informed consent procedures followed by the patient completing self-report scales and the health 
record form.  Clinicians will review this health record and complete objective evaluation 
excluding measurements to be taken by the blinded assessor.  The blinded assessor will enter the 
room to measure cervical ROM, jaw ROM, and PPT.  The blinded assessor will then leave the 
area so that they cannot hear or see which treatment group a patient has been randomized to.  As 
noted above, suboccipital release, behavioral education and exercise will be standardized and 
consistent between groups.  Group One (cervical spine TJM group) will receive C0/1 and C2/3 
TJM as described previously.  Group Two (minimal intervention group) will receive sham 
manipulation (15 second hold before tissue tension) as described previously.   
After cervical TJM/sham, immediate response measurements will be taken by the blinded 
assessor before the introduction of any education or exercise program.  Clinicians will then 
utilize the behavioral education document to discuss recommendations.  The standardized HEP 
will be instructed and participants will be given a chart to track compliance.   
Visit 2: Week 1 
Measurements of ROM and PPT will be taken by a blinded assessor before intervention.  
Treatment will begin with two minutes of suboccipital release for both groups.  Barring no 
change in medical history or known contraindications cervical spine TJM/sham will proceed as 
done in visit 1 unless a participant notes a complete resolution of complaints (score of 0 on JFLS 
or +7 GROC).  If a complete resolution is noted, no TJM/sham will be performed.  All 
participants will receive education reviewing the behavioral modification instructions and 
exercise instructions. 
Visit 3: Week 2  
No measurement or self-report scale data will be collected on this date.  Treatment will begin 
with two minutes of suboccipital release for both groups.  Barring no change in medical history 
or known contraindications cervical spine TJM/sham will proceed as done in visit 1 unless a 
participant notes a complete resolution of complaints (score of 0 on JFLS or +7 GROC).  If a 
complete resolution is noted, no TJM/sham will be performed.  All participants will receive 
education reviewing the behavioral modification instructions and exercise instructions. 
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Visit 4: Week 4  
No prescribed treatment on this date, only self-report scales and assessment by the blinded 
assessor.  After measurement is complete, clinicians will debrief participants explaining the 
intent of the research study, group allocation, and potential impact of results.  Clinicians will 
inform the patient they will receive outcome measures to complete at 3 and 6 months and ask 
them if they prefer mail or email.  Participants will be reminded they will receive an incentive 
payment for completion of these outcomes as well.   
Continued treatment frequency, duration, and interventions are at the discretion of the treating 
clinician.  Referral to another provider (medical, dental, or other) will be done on this date if 
needed.  Please record this information on the last page of the evaluation form. 
**At each treatment visit, be sure to record if cavitation was present with TJM or sham 
manipulation and verify that suboccipital release, behavioral education, and exercise instruction 
were completed. 
Billing: participants attending Rock Valley Physical Therapy will be billed according to standard 
clinical practice.  Front office staff will check benefits and inform participants of any limitations, 
co-pay, co-insurance, or remaining deductible.  The formal informed consent process and 
informal discussion with office staff will inform participants that their insurance will be billed 
and they are responsible for any associated cost.  Physical therapists will bill for their time in 
evaluation and treatment, however, will not bill for the 7 minutes (or less) of manual therapy 
(cervical spine TJM or sham manipulation).  Volunteers at UNLV will be attending a PT 
research laboratory rather than a clinic and will not be billed.   
Handling Data Sets 
Each treating location will use a locked file cabinet to store patient data.  The PI will be 
responsible for educating all clinicians, research assistants, and front office staff with Rock 
Valley Physical Therapy in confidentiality measures and data safety plans.  Front office staff will 
be responsible for the locked files and scheduling patient appointments.  Only those directly 
involved in this research project and trained in data safety will have access to the cabinet.  A case 
number will be assigned to each folder and any electronic sharing of information will only 
include the case number.  Personal health information will not be shared or transmitted 
electronically.  The front office staff will mark scheduled appointments on a shared calendar 
using the case number.  A research assistant at Bradley University will contact the blinded 
assessors to get someone to the appointment.  If a patient cancels or changes their appointment 
time, a phone call or email to the PI would be appreciated so that schedules for the blinded 
assessor can also be modified. 
It is suggested that patients are asked to come 15-20 minutes early for the first evaluation, and 10 
minutes early for visit 2 and 4 in order to complete paperwork.   Patients are to fill out self-report 
questionnaires before seeing the treating clinician.  These forms will be returned to the locked 
file cabinet when complete.  The forms completed by a blinded assessor will be returned to the 
locked file cabinet each visit.  No forms should ever leave the clinic. 
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The PI will also periodically check in with each participating clinician, blinded assessor, and 
clinic office staff member to review procedures and monitor recruitment and retention.  This 
check will occur once per month over the phone.   
When a participant has completed the 4 week visit, the forms in their folder will be copied and 
hard copies mailed to the PI at the address below.  Once the PI receives the hard copies, the 
clinic will shred copied pages and any remaining documentation of study materials.   
Dr. Breanna Reynolds Department of Physical Therapy and Health Sciences 
Bradley University 344 Olin Hall 
1501 W Bradley Avenue 
Peoria, IL  61625 
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